News items constitute an arbitrary selection of events. Links to some news items may no longer be active. News items are for the current and prior year only. Canadian news is covered in What's New and Monthly newsletters

Index: General | Specific countries (change over time)

GENERAL

• TraQ's February newsletter
• In Memoriam: Kay Ollech, BSN, RN (23 Aug. 2022)
• In Memoriam: Lawrence ‘Larry’ Petz, MD (15 June 2022)
• In Memoriam: Dr. Gordon Stuart Whyte, 1943–2022 (5 Aug. 2022)
• Canada: 2021 Lifetime Achievement Awards recognize eminent Canadian researchers | Dr. Gilles Delage, Dr. Heather Hume, Dr. Mel Krajden
• Canada: McMaster University's Gordon Guyatt receives 2022 Einstein Foundation individual award for contributions to evidence-based medicine (12 Dec. 2022)
• "The Blood Typing Game - about blood groups, blood typing and blood transfusions". Nobelprize.org. Nobel Prize Outreach AB 2022.
• Library resource: More than a medical journal | Related:
  • The Lancet. The Lancet at 200: a start, but more to do. Lancet. (Editorial) 2023 Jan 7;401(10370):1. (Free full text)
• Library resource (Canada): The OrbCon Report February 2023
• Industry news (USA): Fresenius Kabi partners with America's blood centers through the Donation Hall of Fame (2022 inductees)
• Canada: CBS: Professional education events (6 in Feb. 2023)
• Canada:CSTM 2023 Conference, Montréal (25-28 May, 2023)
• Canada: CSMLS LabCon 2023 (Whistler, BC May 26-28, 2023)
• Canada: International symposium on individualized behavioural deferral criteria: 20 Apr. 2023 (Héma-Québec & Canadian Blood Services webinar)
• Canada: CBS/ORBCoN Technical Dry Workshop: Fear and Loathing in the blood bank (26 Apr. 2023)
• Canada: ORBCoN and CBS 18th Annual Transfusion Medicine Educational Web Conference Symposium (27 Apr. 2023)
• ISBT: 33rd Regional ISBT Congress in Gothenburg, Sweden (17-21 June 2023)
• No gains in transfusion efficacy with C1-INH treatment for CAD (17 Mar. 2023) | Related:
  • De Boer ECW, Jalink M, Delvasto-Nuñez L, et al. C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia. Blood Adv. 2023 Mar 15:bloodadvances.2022009402. Epub ahead of print.
• Industry news (USA): Sophia Genetics and Agilent collaborate on cancer analysis solution (15 Mar. 2023)
• First transfusion of lab-grown blood cells: Why wouldn’t you do it? (15 Mar. 2023)
• UPMC explores machine learning’s potential to personalize HIV testing (14 Mar. 2023) | Related:
  • HIV testing
  • Branson BM, Handsfield HH, Lampe MA, et al.; Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4. (Free full text) | PubMed abstract
• Industry news: Hikma's bortezomib regimen yields notable efficacy in Waldenström macroglobulinemia (14 Mar. 2023) | Related:
  • Buske C, Dimopoulos MA, Grunenberg A, et al. Bortezomib-dexamethasone, rituximab, and cyclophosphamide as first-line treatment for Waldenström's macroglobulinemia: A prospectively randomized trial of the European Consortium for Waldenström's macroglobulinemia. J Clin Oncol. 2023 Feb 10:JCO2201805.
• All exercise is beneficial but for cell health, train longer (13 Mar. 2023) | Related:
  • Demaria M, Bertozzi B, Veronese N, et al. Long-term intensive endurance exercise training is associated to reduced markers of cellular senescence in the colon mucosa of older adults. npj Aging 9, 3 (2023). (Open access)
• Fatty acid-binding proteins may be potential target for myeloma (13 Mar. 2023) | Related:
  • Farrell M, Fairfield H, Karam M, et al. Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signalin. Elife. 2023 Mar 7;12:e81184. (Free full text) | PubMed abstract
• Communication strategies can help clinicians address cancer-related misinformation (10 Mar. 2023)
• Industry news: Qiagen partners with Servier to develop new test for AML drug (10 Mar. 2023)
• Magnetic soft-robotic chains that can be reconfigured into programmable shapes show potential applications in improving minimally invasive surgery (10 Mar. 2023) | Related:
  • Gu H, Möckli M, Ehmke C, et al. Self-folding soft-robotic chains with reconfigurable shapes and functionalities. Nat Commun. 2023 Mar 7;14(1):1263. (Open access) | PubMed abstract
• Mercury and urinary arsenobetaine in blood are strong biomarkers for seafood consumption among pregnant women (10 Mar. 2023) | Related:
  • Stråvik M, Gustin K, Barman M, et al. Biomarkers of seafood intake during pregnancy - Pollutants versus fatty acids and micronutrients. Environ Res. 2023 Mar 4:115576. Epub ahead of print. (open access) | PubMed abstract
• Invasive aspergillosis linked with risk of death in acute myeloid leukemia or High-risk myelodysplastic syndrome (9 Mar. 2023)
• New approach to improve clinical trial enrollment and diversity (9 Mar. 2023) | Related:
  • Pittman T, Bell L, Jones S, et al. Enhancing study recruitment through implementation of an opt-out, cold contact process with consideration for autonomy, beneficence and justice. Journal of Clinical and Translational Science, 7(1), E63. Revised 26 Jan. 2023 (Open access)
• World’s most comprehensive study on COVID-19 mental health news (8 Mar. 2023) | Related:
  • Sun Y, Wu Y, Fan S, et al. Comparison of mental health symptoms before and during the covid-19 pandemic: evidence from a systematic review and meta-analysis of 134 cohorts. BMJ. 2023 Mar 8;380:e074224. (Free full text) | PubMed abstract
• Confronting anti-vaccine activism with counter narratives (8 Mar. 2023) | Related
  • Carpiano RM, Callaghan T, DiResta R, et al. Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era. Lancet. 2023 Mar 2:S0140-6736(23)00136-8. Epub ahead of print. (Free full text) | PubMed abstract
• Industry news (USA): US FDA approves Shorla’s oncology drug for T-cell leukaemia (8 Mar. 2023)
• Blood test identifies acute myeloid leukemia patients at greater risk of relapse (8 Mar. 2023) | Related:
  • Dillon LW, Gui G, Page KM, et al. DNA sequencing to detect residual disease in adults with acute myeloid leukemia prior to hematopoietic cell transplant. JAMA. 2023 Mar 7;329(9):745-55.
• People with sickle cell disease seldom receive newer pain medications (8 Mar. 2023)
• Cancer will cost the world $25 trillion over next 30 years (7 Mar. 2023) | Related:
  • Chen S, Cao Z, Prettner K, et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023 Feb 23:e227826. Epub ahead of print. (Free full text) | PubMed abstract
• Biodegradable health sensors outperform conventional synthetic sensors (7 Mar. 2023) | Related:
  • Adel A K, Aljarid, Doty KL, et al. Food-inspired, high-sensitivity piezoresistive graphene hydrogels. ACS Sustainable Chem. Eng 2023. Epub 25 Jan. 2023. (Free full text)
• Canada: Sublingual vaccine for urinary tract infections is awaiting approval by Health Canada (7 Mar. 2023) | Related:
  • Nickel JC, Saz-Leal P, Doiron RC. Could sublingual vaccination be a viable option for the prevention of recurrent urinary tract infection in Canada? A systematic review of the current literature and plans for the future. Can Urol Assoc J. 2020 Aug;14(8):281-7. (Free full text) | PubMed abstract
• New artificial intelligence-based app detects mpox rashes (7 Mar. 2023) | Related:
  • Thieme AH, Zheng Y, Machiraju G, et al. A deep-learning algorithm to classify skin lesions from mpox virus infection. Nat Med. 2023 Mar 2. Epub ahead of print. (Open access) | PubMed abstract
• Custom tool sharply reduces errors in stem cell transplant engraftment reporting (7 Mar. 2023)
• Industry news: BioLineRx's motixafortide for stem cell mobilization to be tested in SCD (7 Mar. 2023)
• WHO countries begin negotiations on global pandemic preparedness agreement (6 Mar. 2023)
• Bacterial co-infections cause twofold increase in mortality in COVID patients: study (6 Mar. 2023) | Related:
  • Shah MM, Patel K, Milucky J, et al.; CDC COVID NET Surveillance Team. Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020-April 2022. Influenza Other Respir Viruses. 2023 Mar 2;17(3):e13107. (Open access) | PubMed abstract
• Screening protocols during early phase of COVID-19 improved outcomes in MM (6 Mar. 2023) | Related:
  • Ehsan H, Britt A, Voorhees PM, et al. Retrospective review of outcomes of multiple myeloma (MM) patients with COVID-19 infection (Two-Center Study). Clin Lymphoma Myeloma Leuk. 2023 Jan 18:S2152-2650(23)00018-6. Epub ahead of print. (Free full text) | PubMed abstract
• Frozen cells reveal a clue for a vaccine to block the deadly TB bug (6 Mar. 2023) | Related:
  • Musvosvi M, Huang H, Wang C, et al.; Adolescent Cohort Study team; GC6-74 Consortium. T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection. Nat Med. 2023 Jan;29(1):258-69. Epub 2023 Jan 5. (Open access) | PubMed abstract
• Experimental vaccine reprograms cancer to launch immunotherapy attack (5 Mar. 2023) | Related:
  • Linde MH, Fan AC, Kohnke T, et al. Reprogramming cancer into antigen presenting cells as a novel immunotherapy. Cancer Discov. 2023 Mar 1:CD-21-0502. Epub ahead of print.
• Long Covid is associated with significantly increased risk of death, heart and lung problems, study finds (3 Mar. 2023) | Related:
  • DeVries A, Shambhu S, Sloop S, Overhage JM. One-year adverse outcomes among US adults with post-COVID-19 condition vs those without COVID-19 in a large commercial insurance database. JAMA Health Forum. 2023 Mar 3;4(3):e230010. (Free full text) | PubMed abstract
• Industry news: BioNTech and Weizmann Institute to collaborate at company’s new mRNA centre in Israel (3 Mar. 2023)
• Red cell transfusion supports bone marrow health in patients with sickle cell disease (3 Mar. 2023)
• Blood or marrow transplant survivors at high risk for malignant neoplasms in the GI tract (3 Mar. 2023) | Related:
  • McDonald A, Dai C, Meng Q, et al. Malignant neoplasms of the gastrointestinal tract after blood or marrow transplant. JAMA Oncol. 2023 Jan 19:e226569. Epub ahead of print.
• Moving CAR T-cell treatment to outpatient setting: A real-world case study (3 Mar. 2023) | Related:
  • Moving the cars: Transitioning chimeric antigen receptor T cell therapy from inpatient to outpatient Tandem Meetings 2023. February 15-19, 2023. Abstract 107.
• AI predicts cancer patient survival by reading doctor’s notes (2 Mar. 2023) | Related:
  • Nunez JJ, Leung B, Ho C, et al. Predicting the survival of patients with cancer from their initial oncology consultation document using natural language processing JAMA Netw Open. 2023 Feb 1;6(2):e230813. (Free full text) | PubMed abstract
• Taking the measure of cancer, genomically (2 Mar. 2023)
• Industry news: Janssen's siltuximab shows promising efficacy against CRS and ICANS (1 Mar. 2023) | Related:
  • Interim analysis of investigator-initiated phase 2 trial of siltuximab in treatment of cytokine release syndrome and immune effector cell associated neurotoxicity related to CAR T-cell therapy Tandem Meetings 2023. February 15-19, 2023. Abstract 165.
• Cancer patients reported symptoms of PTSD during first year of COVID-19 pandemic (1 Mar. 2023) | Related:
  • Bastien E, Lefèvre-Arbogast S, Lequesne J, et al. Posttraumatic stress symptoms in patients with cancer during the COVID-19 pandemic: A one-year longitudinal study. J Natl Compr Canc Netw. 2023 Feb 22:1-8. Epub ahead of print. (Full access) | PubMed abstract
• Delayed immune recovery predictive of worse overall survival in adults following Allo-HCT (1 Mar. 2023) | Related:
  • Delayed CD4+ T cell recovery after allogeneic hematopoietic cell transplantation is associated with decreased overall survival in adult but not pediatric recipients Tandem Meetings 2023. February 15-19, 2023. Abstract 409.
• Industry news: Novel robotic system can 3D print cells onto organs inside the body (28 Feb. 2023) | Related:
  • Thai MT, Phan PT, Tran HA, et al. Advanced soft robotic system for in situ 3D bioprinting and endoscopic surgery. Adv Sci (Weinh). 2023 Feb 19:e2205656. Epub ahead of print. (Open access) | PubMed abstract
• Industry news: GC Biopharma acquires Catalyst Biosciences' orphan hematology disorder pipeline (28 Feb. 2023)
• CAR-T Survival outcomes unrelated to household poverty and neighborhood opportunity in ALL (28 Feb. 2023) | Related:
  • Newman H, Li Y, Liu H, et al. Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy. Blood. 2023 Feb 9;141(6):609-19. (Free full text) | PubMed abstract
• Industry news (USA): Big sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report (28 Feb. 2023)
• CAR-T safe, effective for adults with multiple myeloma and renal insufficiency (28 Feb. 2023)
• How patient monitoring is poised to revolutionize healthcare (27 Feb. 2023)
• Healthy diet may improve side effects for lymphoma survivor (27 Feb. 2023)
• ‘Dusseldorf patient’ cured of HIV following stem cell transplant (27 Feb. 2023) | Related:
  • Jensen BO, Knops E, Cords L, et al. In-depth virological and immunological characterization of HIV-1 cure after CCR5 32/ 32 allogeneic hematopoietic stem cell transplantation. Nat Med. 2023 Feb 20. Epub ahead of print. (Open access) | PubMed abstract
• Gene therapies reduce bleeding in hemophilia A and B (27 Feb. 2023) | Related:
  • Mahlangu J, Kaczmarek R, von Drygalski A, et al.; GENEr8-1 Trial Group. Two-year outcomes of valoctocogene roxaparvovec therapy for hemophilia A. N Engl J Med. 2023 Feb 23;388(8):694-705.
  • Pipe SW, Leebeek FWG, Recht M, et al. Gene therapy with etranacogene dezaparvovec for hemophilia B. N Engl J Med. 2023 Feb 23;388(8):706-18.
• Stem cell therapy may reduce risk of heart attack and stroke in certain heart failure patients, study shows (27 Feb. 2023) | Related:
  • Perin EC, Borow KM, Henry TD, et al. Randomized trial of targeted transendocardial mesenchymal precursor cell therapy in patients with heart failure. J Am Coll Cardiol. 2023 Mar 7;81(9):849-63. (Open access) | PubMed abstract
• Industry news (USA): The paid plasma industry literally wants to suck the blood of the poor (25 Feb. 2023) | Related:
  • FDA warns: Don’t give these companies your ‘young blood’ (22 Feb. 2019)
• Several demographic groups underrepresented in clinical trials of blood donation, blood transfusion (24 Feb. 2023) | Related:
  • Muir R, Jacobs JW, Flores LE, et al. Examining participant representation by sex, race, ethnicity and age in United States blood donation and blood transfusion clinical trials. Transfus Apher Sci. 2023 Feb 10:103653. Epub ahead of print.
• Industry news: Sanofi, Sobi score FDA nod for second hemophilia A treatment (24 Feb. 2023)
• Industry news: PharmaEssentia's new Besremi campaign focuses on what counts (24 Feb. 2023)
• Chronic opioid use after stem cell transplant may affect myeloma outcomes (23 Feb. 2023)
• Industry news: Sickle cell pipeline narrows as gene therapy developers rethink research plans (23 Feb. 2023)
• Gut microbiome data can predict response to CAR-T for multiple myeloma (23 Feb. 2023) | Related:
  • Plant-based diet may improve outcomes for patients with multiple myeloma (23 Feb. 2023)
• The patient point of view (22 Feb. 2023) | Related:
  • Bandini A, Dousty M, Hitzig SL, et al. Measuring hand use in the home after cervical spinal cord injury using egocentric video. J Neurotrauma. 2022 Dec;39(23-24):1697-1707. Epub 2022 Jul 21.
• Being physically active at any time in adulthood linked to later life cognitive performance (22 Feb. 2023) | Related:
  • James SN, Chiou YJ, Fatih N, et al. Timing of physical activity across adulthood on later-life cognition: 30 years follow-up in the 1946 British birth cohort. J Neurol Neurosurg Psychiatry. 2023 Feb 21:jnnp-2022-329955. Epub ahead of print. (Free full text) | PubMed abstract
• Industry news: AstraZeneca's acalabrutinib tablet formulation approved in Europe for chronic lymphocytic leukemia (22 Feb. 2023) | Related:
  • Sharma S, Pepin X, Burri H, et al. Bioequivalence and relative bioavailability studies to assess a new acalabrutinib formulation that enables coadministration with proton-pump inhibitors. Clin Pharmacol Drug Dev. 2022 Nov;11(11):1294-1307. Epub 2022 Aug 27. (Open access) | PubMed abstract
• Pano/GBM plus ASCT deemed safe and effective in high-risk or relapsed/refractory MM (22 Feb. 2023) | Related:
  • Nieto Y, Yang Z, Kundu S, et al. Safety and efficacy of a new high-dose chemotherapy regimen of panobinostat, gemcitabine, busulfan and melphalan (Pano/GBM) with autologous stem cell transplant (ASCT) for patients with high-risk or refractory/relapsed myeloma ­ Matched pair comparisons with a concurrent control cohort. Tandem Meetings 2023. February 15-19, 2023. Abstract 38.
• Liquid biopsy predicts response to CAR-T for multiple myeloma (21 Feb. 2023) | Related:
  • Shah NN, Maziarz RT, Ghosh M, et al. Interim analysis of a phase II study of administered fresh bispecific anti-CD20/anti-CD19 CAR T-cell therapy - Zamtocabtagene autoleucel (zamto-cel) for relapsed/refractory (R/R) DLBCL (DALY II USA NCT04792489). Tandem Meetings 2023. February 15-19, 2023. Abstract 16.
• Industry news: Three months after receiving US green light, CSL's Hemagix has become the first gene therapy to gain EU approval for hemophilia B (21 Feb. 2023)
• Case studies expose deadly risk of mpox to people with untreated HIV (21 Feb. 2023) | Related:
  • Mitjà O, Alemany A, Marks M, et al. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023. Epub 21 Feb. 2023. (Free full text)
• AGA guideline recommends blood and stool tests for ulcerative colitis (21 Feb. 2023) | Related:
  • Singh S, Ananthakrishnan AN, Nguyen NH, etal.; AGA Clinical Guidelines Committee. AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis. Gastroenterology. 2023 Mar;164(3):344-72. (Free full text) | PubMed abstract
• Researchers identify transfusion threshold that confers lower mortality risk in VV ECMO (21 Feb. 2023) | Related:
  • Mortality on ECMO higher in second wave of patients with COVID-19 (17 Feb. 2023)
  • Dognon N, Gaudet A, Parmentier-Decrucq E, et al., Lille Intensive Care Covid-Group. Extracorporeal Membrane Oxygenation for COVID 2019-Acute Respiratory Distress Syndrome: Comparison between First and Second Waves (Stage 2). J Clin Med. 2021 Oct 21;10(21):4839. (Open access) | PubMed abstract
• Industry news (USA): Maternova and MedMira sign rapid diagnostics distribution deal (21 Feb. 2023)
• Gene linked to leukemia found to decrease insulin production in diabetics (21 Feb. 2023) | Related:
  • Bacos K, Perfilyev A, Karagiannopoulos A, et al. Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets. J Clin Invest. 2023 Feb 15;133(4):e163612. (Open access) | PubMed abstract
• Industry news: With $135M in fresh funds, Hemab aims to leapfrog drug development for neglected blood disorders (21 Feb. 2023)
• 10 years on, stem cell transplant may have cured patient of HIV (20 Feb. 2023) | Related:
  • Lisziewicz J, Rosenberg E, Lieberman J, et al. Control of HIV despite the discontinuation of antiretroviral therapy. (Letter to the editor) N Engl J Med. 1999 May 27;340(21):1683-4. (Free full text)
  • Has a second person with HIV been cured? (4 Mar. 2019)
• Industry news (USA): FDA approves Terumo’s platelet pooling set for seven-day storage (20 Feb. 2023) | Related:
  • Terumo blood and cell technologies’ IMUGARD platelet pooling set cleared by FDA (14 Feb. 2023)
• ‘Bond villain’ DNA could transform cancer treatment, scientists say (18 Feb. 2023)
• History: Nineteenth-Century doctors used milk for blood transfusions (17 Feb. 2023)
• Covid-19 infection offers strong protection against reinfection for about 10 months, study finds (16 Feb. 2023) | Related:
  • COVID-19 Forecasting Team. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. The Lancet. Epub 16 Feb. 2023. (Open access)
  • COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022 Apr 16;399(10334):1513-36. Epub 2022 Mar 10. Erratum in: Lancet. 2022 Apr16;399(10334):1468. (Open access) | PubMed abstract
• Oral bacteria may slightly increase heart disease risk (16 Feb. 2023) | Related:
  • Hodel F, Xu ZM, Thorball CW, et al. Associations of genetic and infectious risk factors with coronary heart disease. Elife. 2023 Feb 14;12:e79742. (Free full text) | PubMed abstract
• Breast cancer risk models may incorrectly classify many women (16 Feb. 2023) | Related:
  • Paige JS, Lee CI, Wang PC, et al. Variability among breast cancer risk classification models when applied at the level of the individual woman. J Gen Intern Med. 2023 Feb 7. Epub ahead of print. (Open access) | PubMed abstract
• Industry news: Grifols announces 400-million-euro cost-saving initiative (16 Feb. 2023)
• MRD detection provides prognostic value in patients with ALL undergoing HCT (16 Feb. 2023)
• Industry news (USA): Terumo Blood and Cell Technologies' IMUGARD platelet pooling set cleared by FDA (16 Feb. 2023)
• Industry news (USA): FDA grants fast track and RMAT designations to IASO Biotherapeutics' CAR T product for R/R myeloma (15 Feb. 2023) | Related:
  • U.S. FDA grants orphan drug designation to BCMA CAR-T cell therapy co-developed by IASO Bio and Innovent (14 Feb. 2023)
• Long COVID now looks like a neurological disease, helping doctors to focus treatments (14 Feb. 2023)
• Automated feeding platform to study mosquito disease transmission (14 Feb. 2023) | Related:
  • Janson KD, Carter BH, Jameson SB, et al. Development of an automated biomaterial platform to study mosquito feeding behavior. Front Bioeng Biotechnol. 2023. Epub 9 Feb. 2023. (Free full text) 
• CAR T-cell recipients receive more psychological support, fear cancer progression less (14 Feb. 2023)
• “Severe4” predicts outcomes of CAR T-cell therapy in relapsed/refractory DLBCL (14 Feb. 2023) | Related:
  • Shouse G, Kaempf A, Gordon MJ, et al. A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B cell lymphoma.Blood Adv. 2023 Feb 3:bloodadvances.2022009309. Epub ahead of print. (Free full text as .pdf) | PubMed abstract
• Cases of SCC-related hospitalizations increasing among patients with multiple myeloma (14 Feb. 2023) | Related:
  • Al Hadidi S, Dongarwar D, Schinke C, et al. Racial differences in spinal cord compression related hospitalizations in patients with multiple myeloma. Clin Hematol Int. 2023 Feb 3. Epub ahead of print. (Open access) | PubMed abstract
• AABB, Canadian Blood Services announce partnership to help US blood collectors prepare for individual risk assessment (13 Feb. 2023) | Related:
  • Individual Risk Assessment (AABB, 14 Feb. 2023)
• Industry news: AstraZeneca, SOPHiA team up to use AI, machine learning in cancer drugs development (13 Feb. 2023)
• IV iron for chemo-induced anaemia: Ready for primetime? (13 Feb. 2023)
• Industry news: Biotech funding roundup: 7 startups raise more than $200M in capital (12 Feb. 2023)
• New, highly sensitive diagnostic test for infectious diseases (10 Feb. 2023) | Related:
  • Gupta R, Gupta P, Wang S, et al. Ultrasensitive lateral-flow assays via plasmonically active antibody-conjugated fluorescent nanoparticles. Nat Biomed Eng. 2023 Feb 2. Epub ahead of print. (Free full text) | PubMed abstract
• Industry news: GSK's momelotinib may be ‘no. 1 choice’ for second-line myelofibrosis, anemia (10 Feb. 2023) | Related:
  • Verstovsek S, Gerds AT, Vannucchi AM,et al.; MOMENTUM Study Investigators. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Lancet. 2023 Jan 28;401(10373):269-280.
• Modifiable chronic health conditions linked to late mortality in pediatric cancer survivors (10 Feb. 2023) | Related:
  • Ehrhardt MJ, Liu Q, Dixon SB, et al. Association of modifiable health conditions and social determinants of health with late mortality in survivors of childhood cancer. JAMA Netw Open. 2023 Feb 1;6(2):e2255395. (Free full text) | PubMed abstract
• Industry news (USA): Celgene Pharma's enasidenib improves some outcomes, but not overall survival, in relapsed/refractory acute myeloid leukemia (10 Feb. 2023) | Related:
  • de Botton S, Montesinos P, Schuh AC, et al. Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial. Blood. 2023 Jan 12;141(2):156-67. (Free full text) | PubMed abstract
• Industry news: AstraZeneca goes for growth with new drugs as COVID sales wane (9 Feb. 2023)
• Remote dietary intervention reduces fatigue in cancer survivors (9 Feb. 2023) | Related:
  • Weinhold KR, Light S, Bittoni AM, et al. A remote whole food dietary intervention to reduce fatigue and improve diet quality in lymphoma survivors: Results of a feasibility pilot study. Nutr Cancer. 2023 Feb 8:1-11. Epub ahead of print. (Open access) | PubMed abstract
• Clinicians call for accurate characterization of heart muscle disorders (9 Feb. 2023) | Related:
  • Petersen SE, Jensen B, Aung N, et al. Excessive trabeculation of the left ventricle: JACC: Cardiovascular imaging expert panel paper. JACC Cardiovasc Imaging. 2023 Feb 6:S1936-878X(23)00031-1. Epub ahead of print. (Free full text) | PubMed abstract
• ACS NSQIP data provide insight on blood product use (8 Feb. 2023)
• Daily physical activity has positive impact on immune stimulation in MM (8 Feb. 2023) | Related:
  • Wang J, Sheng L, Lai Y, et al. Effects of physical activity on clinical and inflammatory markers in diagnosing multiple myeloma patients. Front Physiol. 2023 Jan 4;13:1094470. (Free full text) | PubMed abstract
• Clonal hematopoiesis more prevalent, distinct among pediatric cancer survivors (8 Feb. 2023) | Related:
  • Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population (8 Feb. 2023)
  • Hagiwara K, Natarajan S, Wang Z, et al. Dynamics of age- versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer. Cancer Discov. 2023 Feb 8:CD-22-0956. Epub ahead of print. (Free to read as .pdf) | PubMed abstract
• Study reveals serious cancer research gaps for Black Canadians (7 Feb. 2023) | Related
  • Cénat JM, Dromer É, Darius WP, et al. Incidence, factors, and disparities related to cancer among Black individuals in Canada: A scoping review. Cancer. 2023 Feb 1;129(3):335-55. Epub 2022 Nov 27. (Free full text) | PubMed abstract
• USA: Survey: Nearly 40% of U.S. households hit by 'tripledemic' (7 Feb. 2023) | Related:
  • KFF COVID-19 vaccine monitor: January 2023 (7 Feb. 2023)
• Multidimensional rehabilitation appears feasible/safe in blood cancer (7 Feb. 2023) | Related:
  • Accogli MA, Denti M, Costi S, Fugazzaro S. Therapeutic education and physical activity are feasible and safe in hematologic cancer patients referred to chemotherapy: results of a randomized controlled trial. Support Care Cancer. 2022 Dec 19;31(1):61. (Open access) | PubMed abstract
• Does alcohol consumption increase dementia risk? (7 Feb. 2023) | Related:
  • Jeon KH, Han K, Jeong SM, et al. Changes in alcohol consumption and risk of dementia in a nationwide cohort in South Korea. JAMA Netw Open. 2023 Feb 1;6(2):e2254771. (Free full text) | PubMed abstract
• At-home medication errors may be common for children with leukemia, lymphoma (7 Feb. 2023) | Related:
  • Wong CI, Vannatta K, Gilleland Marchak J, et al. Preventable harm because of outpatient medication errors among children with leukemia and lymphoma: A multisite longitudinal assessment. Cancer. 2023 Jan 27. Epub ahead of print.
• Bone marrow transplants may lower risk of stroke in patients with sickle cell disease (7 Feb. 2023) | Related:
  • Bone marrow transplant may halt brain blood vessel disease in adults with sickle cell disease (2 Feb. 2023)
• Industry news: Taiwan-based Lotus Pharma launches drug for multiple myeloma in Brazilian market (6 Feb. 2023)
• 'Young blood' transfusions found to reverse aging in mice (6 Feb. 2023) | Related:
  • Ho TT, Dellorusso PV, Verovskaya EV, et al. Aged hematopoietic stem cells are refractory to bloodborne systemic rejuvenation interventions. J Exp Med. 2021 Jul 5;218(7):e20210223. Epub 2021 May 25. (Free full text) | PubMed abstract
• Industry news (USA): FDA oks study of Gracell Therapeutics novel CAR-T cell therapy for myeloma (6 Feb. 2023)
• CH.1.1 ‘Orthrus’: How concerning is this new Covid-19 subvariant? (4 Feb. 2023)
• Vaccines: Unvaccinated donors block transfusions (4 Feb. 2023) | The movement spins anti-vaccine narratives.
• Alberta-made Linac-MR machine combining MRI and radiation could revolutionize cancer treatments (3 Feb. 2023)
• Researchers investigate whether the perception of time changes with age (3 Feb. 2023) | Related:
  • Stoji S, Topi V, Nadasdy Z. Children and adults rely on different heuristics for estimation of durations. Sci Rep. 2023 Jan 19;13(1):1077. (Open access) | PubMed abstract
• New, targeted test for colistin-resistant enterobacter species (3 Feb. 2023) | Related:
  • Doijad SP, Gisch N, Frantz R, et al. Resolving colistin resistance and heteroresistance in Enterobacter species. Nat Commun. 2023 Jan 10;14(1):140. (Open access) | PubMed abstract
• Innovative transfusion saving lives, new study finds (2 Feb. 2023) | Related:
  • Tucker H, Brohi K, Tan J, et al. Association of red blood cells and plasma transfusion versus red blood cell transfusion only with survival for treatment of major traumatic hemorrhage in prehospital setting in England: a multicenter study. Crit Care. 2023 Jan 17;27(1):25. (Open access) | PubMed abstract
• National study shows Indigenous patients with autoimmune liver disease face worse symptoms and outcomes (2 Feb. 2023) | Related:
  • Roberts SB, Hirschfield GM, Worobetz LJ, et al.; Canadian Network for Autoimmune Liver Disease (CaNAL). Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis. Hepatology. 2022 Aug;76(2):303-16. Epub 2022 Mar 15.
• Industry news (USA): GSK's daprodustat receives FDA approval for anemia caused by CKD on dialysis (1 Feb. 2023)
• Industry news: Mesoblast gives allogeneic cell therapy a 2nd try with FDA—but without a new trial (1 Feb. 2023)
• Risk for adverse CVD events elevated following sepsis survival (1 Feb. 2023) | Related:
  • Jentzer JC, Lawler PR, Van Houten HK, et al. Cardiovascular events among survivors of sepsis hospitalization: A retrospective cohort analysis. J Am Heart Assoc. 2023 Feb 1:e027813. Epub ahead of print. (Open access) | PubMed abstract
• WHO: COVID still an emergency but nearing ‘inflection’ point (30 Jan. 2023)
• Worse prognosis found for obese, underweight myeloma patients (30 Jan. 2023) | Related:
  • Shah UA, Whiting K, Devlin S, et al. Extreme body mass index and survival in newly diagnosed multiple myeloma patients. Blood Cancer J. 2023 Jan 12;13(1):13. (Open access)
• Multidisciplinary SCD-pulmonary care associated with improved outcomes (30 Jan. 2023) | Related:
  • Zeno RN, Stanek J, Pugh C, et al. Outcomes before and after providing interdisciplinary hematology and pulmonary care for children with sickle cell disease. Blood Adv. 2022 Dec 28:bloodadvances.2022009079. Epub ahead of print.
• Bottlebrush-shaped molecules carry drug combos to combat cancer (29 Jan. 2023) | Related:
  • Detappe A, Nguyen HV, Jiang Y, et al. Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma. Nat Nanotechnol. 2023 Jan 26. Epub ahead of print.
• Baltimore researchers say AI could help reduce disparities, improve access to health care (29 Jan. 2023)
• Industry news (USA): CDC urges people with weak immune systems to take extra precautions after Covid subvariants knock out AstraZeneca's Evusheld (27 Jan. 2023)
• Blood type may predict risk of venous thromboembolism among patients with cancer (26 Jan. 2023) | Related:
  • Englisch C, Moik F, Nopp S, et al. ABO blood group type and risk of venous thromboembolism in patients with cancer. Blood Adv. 2022 Dec 27;6(24):6274-81. (Free full text) | PubMed abstract
• Study shows low enoxaparin VTE prophylaxis adherence for patients with sickle cell disease during hospitalization (26 Jan. 2023) | Related:
  • Sakon C, Nikirk M, O'Brien ARW. Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease. Expert Rev Hematol. 2022 Dec 28:1-4. Epub ahead of print.
• Caregivers of older adults with AML may have extra burdens, special needs (25 Jan. 2023) | Related:
  • Tan KR, Chan YN, Iadonisi K, et al. Perspectives of caregivers of older adults with acute myeloid leukemia during initial hypomethylating agents and venetoclax chemotherapy. Support Care Cancer. 2023 Jan 4;31(1):95. (Free full text) | PubMed abstract
• Efficacy and safety of Ide-Cel confirmed in real-world multiple myeloma population (31 Jan. 2023) | Related:
  • Hansen DK, Sidana S, Peres LC, et al. Idecabtagene vicleucel for relapsed/refractory multiple myeloma: Real-world experience from the myeloma CAR T consortium. J Clin Oncol. 2023 Jan 9:JCO2201365. Epub ahead of print.
• Industry news: European Medicines Agency (EMA) committee recommends approval of Bristol Myers Squibb’s Reblozyl to treat anaemia-associated, NTD beta thalassemia (30 Jan. 2023)
• Disruption of the blood-brain barrier due to long COVID (27 Jan. 2023)
• Industry news: Syros Pharmaceuticals stock rises as tamibarotene gets FDA fast track status for rare blood cancer (26 Jan. 2023)
• Using artificial human skin to block invasive growth in a skin cancer model (26 Jan. 2023) | Related:
  • Ye Z, Kilic G, Dabelsteen S, Marinova IN, et al. Characterization of TGF- signaling in a human organotypic skin model reveals that loss of TGF- RII induces invasive tissue growth. Sci Signal. 2022 Nov 22;15(761):eabo2206. Epub 2022 Nov 22.
• Industry news: GenKOre signs pacts worth up to $350M biobucks for gene editing tech (26 Jan. 2023)
• Industry news: EPFL startup HemostOD develops system for producing blood platelets on demand (26 Jan. 2023)
• Vaccine misinformation spawns 'pure blood' movement (25 Jan. 2023)
• Training physicians to improve blood transfusion safety and pertinence: a successful strategy (25 Jan. 2023) | Related:
  • Lee TC, Almeida N, Pelletier P, McDonald EG. Comparison of blood transfusion rates before and after implementation of a quality improvement initiative for transfusion safety and appropriateness. (Research letter) JAMA Netw Open. 2023 Jan 3;6(1):e2252253. (Free full text)
• Diagnosis, treatment of hepatitis C using point-of-care assays (25 Jan. 2023) | Related:
  • Trickey A, Fajardo E, Alemu D, et al. Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023 Jan 24:S2468-1253(22)00346-6. Epub ahead of print. (Free full text) | PubMed abstract
• KRd Improves PFS as maintenance therapy in transplant-eligible multiple myeloma (25 Jan. 2023) | Related:
  • Dytfeld D, Wróbel T, Jamroziak K, et al. Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial. Lancet Oncol. 2023 Feb;24(2):139-50. Epub 2023 Jan 12. | Onyx Pharmaceuticals makes Carfilzomib, Teva Pharmaceuticals makes lenalidomide.
• Scientists illuminate how blood cancer treatments can lead to therapy-related myeloid neoplasms (25 Jan. 2023) | Related:
  • Diamond BT, Ziccheddu B, Maclachlan KH, et al. Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures. Blood. 2023 Jan 10:blood.2022018244. Epub ahead of print.
• World Health Organization launches $2.54bn emergency health appeal (24 Jan. 2023)
• Industry news: Geneseeq Technology nabs CE Marks for minimal residual disease, early cancer detection tests (24 Jan. 2023) | Related:
  • Geneseeq receives CE Marks for MRD and MCED tests (24 Jan. 2023)
• VEXAS Syndrome: What to know about this newly identified autoimmune disease (24 Jan. 2023) | Related:
  • Newly discovered disease may affect over 15,000 Americans (24 Jan. 2023)
  • Beck DB, Bodian DL, Shah V, et al. Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population. JAMA. 2023 Jan 24;329(4):318-324.
• How do cell & gene therapy requirements differ between FDA & EMA? (24 Jan. 2023)
• Health improves after stem cell transplant, but challenges remain (24 Jan. 2023) | Related:
  • Dovern E, Nijland SJAM, van Muilekom MM, et al. Physical, mental, and social health of adult patients with sickle cell disease after allogeneic hematopoietic stem cell transplantation: A mixed-methods study. Transplant Cell Ther. 2023 Jan 9:S2666-6367(23)00002-7. Epub ahead of print. (Free full text) | PubMed abstract
• New insights into mechanisms of taste perception (24 Jan. 2023) | Related:
  • Lang R, Lang T, Dunkel A, et al. Overlapping activation pattern of bitter taste receptors affect sensory adaptation and food perception. Front Nutr. 2022 Dec 19;9:1082698. (Free full text) | PubMed abstract
• Industry news (USA): Cadrenal Therapeutics novel oral anticoagulant fast tracked for patients with ESRD and atrial fibrillation (23 Jan. 2023)
• Women on ART with high HIV viral load at increased risk of non-AIDS comorbidities (22 Jan. 2023)
• General industry news: Bizarre and sinister world of the commercial blood industry (21 Jan. 2023) | Related:
  • Blood Money: The Story of Life, Death, and Profit Inside America's Blood Industry Hardcover ­ February 28, 2023
• Study: Telehealth use linked to lower cancer care costs (20 Jan. 2023) | Related:
  • Patel KB, Turner K, Alishahi Tabriz A, et al. Estimated indirect cost savings of using telehealth among nonelderly patients with cancer. JAMA Netw Open. 2023 Jan 3;6(1):e2250211. (Free full text) | PubMed abstract
• A CAR-T cell gel kills residual cancer cells left over from surgery (20 Jan. 2023)
| Related:
• Uslu U, Da T, Assenmacher CA, et al. Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma. Sci Adv. 2023 Jan 13;9(2):eade2526. Epub 2023 Jan 11. (Free full text) | PubMed abstract
• Blood transfusions with CAD, AIHAs require special care: Study (20 Jan. 2023) | Related:
  • Johnson ST, Puca KE. Evaluating patients with autoimmune hemolytic anemia in the transfusion service and immunohematology reference laboratory: pretransfusion testing challenges and best transfusion-management strategies. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):96-104. (Free full text) | PubMed abstract
• Scientists developing early Alzheimer’s disease detection sensor (19 Jan. 2023) | Related:
  • De Silva T, Fawzy M, Hasani A, et al. Ultrasensitive rapid cytokine sensors based on asymmetric geometry two-dimensional MoS₂ diodes. Nat Commun. 2022 Dec 19;13(1):7593. (Open access) | PubMed abstract
• Researchers combine new technologies to examine blood proteins in COVID-19 patients (No date given) | Related:
  • Iosef C, Martin CM, Slessarev M, et al. COVID-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high-precision disease management. J Cell Mol Med. 2023 Jan;27(1):141-57. Epub 2022 Dec 19. (Open access) | PubMed abstract
• Global burden of non-Hodgkin lymphoma estimated to increase 1.5-fold by 2040 (19 Jan. 2023)
• Inequities seen in cancer treatment delay in patients with SARS-CoV-2 (19 Jan. 2023) | Related:
  • Llanos AAM, Ashrafi A, Ghosh N, et al. Evaluation of inequities in cancer treatment delay or discontinuation following SARS-CoV-2 infection. JAMA Netw Open. 2023 Jan 3;6(1):e2251165. (Free full text) | PubMed abstract
• Industry news: CEO of Novartis says Covid likely to become endemic, urges investment in pandemic preparedness (19 Jan. 2023)
• Researchers identify a specific neural mechanism behind remembering emotional events (19 Jan. 2023) | Related:
  • Qasim SE, Mohan UR, Stein JM, Jacobs J. Neuronal activity in the human amygdala and hippocampus enhances emotional memory encoding. Nat Hum Behav. 2023 Jan 16. Epub ahead of print.
• Industry news: NICE recommends all-oral treatment for multiple myeloma, including 2 drugs made by Takeda Pharma (19 Jan. 2023)
• Close BP monitoring important before, during and after cancer therapy (19 Jan. 2023)
• Industry news: BeiGene's Brukinsa gains approval for two additional types of leukemia (19 Jan. 2023)
• Higher mortality and worse overall survival in younger black patients with DLBCL (19 Jan. 2023)
• International Council for Commonality in Blood Banking Automation (ICCBBA) publishes a new ISBT 128 Standard for the Chain of Identity (CoI) Identifier (18 Jan. 2023) | Related:
  • List of ISBT 128 Standards
• WHO analysis: hybrid immunity offers high protection against COVID-19 (18 Jan. 2023) | Related:
  • Bobrovitz N, Ware H, Ma X, et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis. 2023. Epub 18 Jan. 2023. (Open access)
• Canada: Ontario considered lifting ban on paid blood donation according to political staff e-mails (18 Jan. 2023)
• Inflammation linked to inferior outcomes in leukemia (18 Jan. 2023) | Related:
  • Lasry A, Nadorp B, Fornerod M, et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat Cancer. 2022 Dec 29. Epub ahead of print.
• Industry news: Blood transfusion market to see huge growth by 2027 (18 Jan. 2023)
• World Health Organization releases latest set of COVID-19 guidelines (17 Jan. 2023) | Related:
  • WHO updates COVID-19 guidelines on masks, treatments and patient care (13 Jan. 2023)
• UCalgary study offers new insight into deadly fungal invasion of the lungs (17 Jan. 2023) | Related:
  • Sarden N, Sinha S, Potts KG, et al. A B1a-natural IgG-neutrophil axis is impaired in viral- and steroid-associated aspergillosis. Sci Transl Med. 2022 Dec 7;14(674):eabq6682. Epub 2022 Dec 7.
• Convalescent COVID-19 plasma beneficial for immunocompromised (17 Jan. 2023) | Related:
  • Senefeld JW, Franchini M, Mengoli C, et al. COVID-19 convalescent plasma for the treatment of immunocompromised patients: A systematic review and meta-analysis. JAMA Netw Open. 2023 Jan 3;6(1):e2250647. (Free full text) | PubMed abstract
• Challenges of treating patients with cytopenias in myelofibrosis (17 Jan. 2023)
• COVID long-haulers face stigma as well as lingering symptoms, study shows (16 Jan. 2023) | Related:
  • Damant RW, Rourke L, Cui Y, et al. Reliability and validity of the post COVID-19 condition stigma questionnaire: A prospective cohort study. EClinicalMedicine. 2022 Nov 25;55:101755. (Open access) | PubMed abstract
• COVID-19 convalescent plasma transfusions significantly reduced mortality rates among hospitalized SARS-CoV-2 patients (16 Jan. 2023) | Related:
  • Senefeld JW, Gorman EK, Johnson PW, et al. Mortality rates among hospitalized patients with COVID-19 treated with convalescent plasma. A systematic review and meta-analysis. medRxiv. 2023 Jan. Epub 12 Jan. 2023. Preprint. (Free full text)
• Industry news (USA): Janssen Biotech's daratumumab, Teva Pharmaceuticals' lenalidomide, dexamethasone improves OS in relapsed/refractory multiple myeloma (16 Jan. 2023) | Related:
  • Dimopoulos MA, Oriol A, Nahi H, et al. Overall survival with daratumumab, lenalidomide, and dexamethasone in previously treated multiple myeloma (POLLUX): A randomized, open-label, Phase III trial. J Clin Oncol. 2023 Jan 4:JCO2200940. Epub ahead of print. (Free full text) | PubMed abstract
• Child mortality from trauma and sudden death rising in England, study shows (16 Jan. 2023) | Related:
  • Odd D, Stoianova S, Williams T, et al. Child mortality in England during the first 2 years of the COVID-19 pandemic. JAMA Netw Open. 2023 Jan 3;6(1):e2249191. (Free full text) | PubMed abstract
• cfDNA may help risk-stratify patients with ALL (14 Jan. 2023) | Related:
  • Sampathi S, Chernyavskaya Y, Haney MG, et al. Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemia. Front Oncol. 2022 Dec 14;12:958673. (Free full text) | PubMed abstract
• Clinical laboratory technician shares personal journey and experience with burnout during the COVID-19 pandemic (13 Jan. 2023) | Related:
  • Taking action against clinician burnout: A systems approach to professional well-being (National Academies of Medicine, Oct. 2019)
• Caterpillars could replace some mammals in the study of disease (13 Jan. 2023) | Related:
  • Windfelder AG, Müller FHH, Mc Larney B, et al. High-throughput screening of caterpillars as a platform to study host-microbe interactions and enteric immunity. Nat Commun. 2022 Nov 24;13(1):7216. (Open access) | PubMed abstract
• Industry news (USA): AstraZeneca's injection treatment for rare leukemia subtype to be discontinued in the U.S. (13 Jan. 2023) | Related:
  • FDA approves new agent for hairy cell leukemia (13 Sept. 2018)
• Medicines to increase foetal haemoglobin levels and reduce the need for blood transfusion in people with non-transfusion-dependent thalassaemia (13 Jan. 2023) | Related:
  • Foong WC, Loh CK, Ho JJ, Lau DS. Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias. Cochrane Database Syst Rev. 2023 Jan 13;1:CD013767. (Free full text) | PubMed abstract
• The impact of early life microbial colonization and respiratory diseases on the respiratory microbiome (13 Jan. 2023) | Related:
  • Di Simone SK, Rudloff I, Nold-Petry CA, et al. Understanding respiratory microbiome-immune system interactions in health and disease. Sci Transl Med. 2023 Jan 11;15(678):eabq5126. Epub 2023 Jan 11. (Free full text) | PubMed abstract
• Brain structures could predict an person's predisposition to accidental awareness under anesthesia (12 Jan. 2023) | Related:
  • Deng F, Taylor N, Owen AM, Cusack R, Naci L. Responsiveness variability during anaesthesia relates to inherent differences in brain structure and function of the frontoparietal networks. Hum Brain Mapp. 2023 Jan 8. Epub ahead of print. (Open access) | PubMed abstract
• Industry news (USA): FDA grants orphan drug designation for Jubilant Pharmova 's JBI-802 in SCLC and AML (12 Jan. 2023)
• DNA fragments in blood promise cheap, easy test for cancer (12 Jan. 2023) | Related:
  • Budhraja KK, McDonald BR, Stephens MD, et al. Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer. Sci Transl Med. 2023 Jan 11;15(678):eabm6863.
• Omicron XBB.1.5 does not have mutations known to make people sicker, WHO says (11 Jan. 2023) | Related:
  • WHO: XBB.1.5 Rapid risk assessment (11 Jan. 2023)
• Did people use mental health services more during the COVID-19 pandemic? (11 Jan. 2023) | Related:
  • McBain RK, Cantor J, Pera MF, et al. Mental health service utilization rates among commercially insured adults in the US during the first year of the COVID-19 pandemic. JAMA Health Forum. 2023 Jan 6;4(1):e224936. (Free full text) | PubMed abstract
• Improving treatment for hairy cell leukemia (11 Jan. 2023) | Related:
  • Handa S, Lee JO, Derkach A, et al. Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy. Blood. 2022 Dec 22;140(25):2663-71.
• Canada: Canadian Blood Services needs more Black donors: expert (11 Jan. 2023)
• Who invented blood transfusions? A comprehensive exploration (11 Jan. 2023)
• Investigational T-cell therapy for viral infections after allogeneic stem cell transplant showed 95% patient response (11 Jan. 2023)
• Canada: World first - Sunnybrook and SickKids clinical trial delivers chemotherapy to pediatric brain tumours using MRI-guided focused ultrasound (10 Jan. 2023) | Related:
  • Opening the blood-brain barrier to deliver a chemotherapy in Diffuse Intrinsic Pontine Gliomas (DIPG)
• WHO meeting to decide on COVID emergency set for Jan. 27 (10 Jan. 2023)
• Telehealth saves patients with cancer time and money (10 Jan. 2023)
• Blood sample 24 hours after start of chemotherapy predicts survival (10 Jan. 2023) | Related:
  • Tislevoll BS, Hellesøy M, Fagerholt OHE, et al. Early response evaluation by single cell signaling profiling in acute myeloid leukemia. Nat Commun. 2023 Jan 7;14(1):115. (Open access) | PubMed abstract
• A new way to monitor blood flow in the brain (10 Jan. 2023) | Related:
  • Saeed S, Nowacka K, Gerega A, et al. Continuous-wave parallel interferometric near-infrared spectroscopy (CW pNIRS) with a fast two-dimensional camera. Biomed. Opt. Express 13, 5753-74 (2022) (Open access)
• Industry news (USA): US FDA grants EUA for BD and CerTest’s PCR test to detect Mpox (10 Jan. 2023)
• Novel risk prediction tool may identify patients with multiple myeloma at a high risk of venous thromboembolism (10 Jan. 2023) | Related:
  • Chakraborty R, Rybicki L, Wei W, et al. Abnormal metaphase cytogenetics predicts venous thromboembolism in myeloma: derivation and validation of the PRISM score. Blood. 2022 Dec 8;140(23):2443-50.
• Industry news: BioNTech and UK government partner to accelerate mRNA cancer immunotherapies (9 Jan. 2023)
• Researchers address kinesiophobia in patients with hemophilia (9 Jan. 2023) | Related:
  • Feldberg G, Ricciardi JBS, Zorzi AR,et al. Chronic pain in patients with hemophilia: Influence of kinesiophobia and catastrophizing thoughts. Haemophilia. 2022 Nov 29. Epub ahead of print. (Free to read) | PubMed abstract
• Industry news: Janssen's talquetamab for advanced multiple myeloma up for approval in EU (9 Jan. 2023)
• New biomarker for early prediction of response to CAR-T cell therapy (9 Jan. 2023) | Related:
  • Worel N, Grabmeier-Pfistershammer K, Kratzer B, et al. The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma. Front. Immunol. 09 January 2023. (Free full text)
• Implantable "sponge" fights off cancer in striking mouse study (8 Jan. 2023) | Related:
  • Majedi FS, Hasani-Sadrabadi MM, Thauland TJ, et al. Systemic enhancement of antitumour immunity by peritumourally implanted immunomodulatory macroporous scaffolds. Nat Biomed Eng. 2022 Dec 22. Epub ahead of print.
• 3-dose malaria vaccine shows promise in African trial (6 Jan. 2023) | Related:
  • Sirima SB, Ouédraogo A, Tiono AB, et al. A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria. Sci Transl Med. 2022 Dec 7;14(674):eabj3776. Epub 2022 Dec 7.
• Long COVID stemmed from mild cases of COVID-19 in most people, according to a new multicountry study (5 Jan. 2023) | Related:
  • Global Burden of Disease Long COVID Collaborators; Wulf Hanson S, Abbafati C, Aerts JG, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters Following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022 Oct 25;328(16):1604-15. (Free full text) | PubMed abstract
• Industry news (USA): US FDA greenlights Precision BioLogic chromogenic assay to identify factor IX deficiency (5 Jan. 2023)
• Pharmacotyping of childhood leukemia provides a blueprint for 'true precision medicine' (5 Jan. 2023) | Related:
  • Lee SHR, Yang W, Gocho Y, et al. Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response. Nat Med. 2023 Jan 5. Epub ahead of print. (Open access) | PubMed abstract
• Novel machine-learning model may reduce misdiagnosis in heparin-induced thrombocytopenia (5 Jan. 2023) | Related:
  • Nilius H, Cuker A, Haug S, et al. A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study. EClinicalMedicine. 2022 Nov 24;55:101745. (Open access) | PubMed abstract
• Convalescent plasma (CCP) may improve survival rates among patients with severe COVID-19 and cancer (4 Jan. 2023) | Related:
  • Denkinger CM, Janssen M, Schäkel U, et al. Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial. Nat Cancer. 2022 Dec 29. Epub ahead of print. (Open access) | PubMed abstract
• UCalgary researchers build 3D-printed materials with liquids (4 Jan. 2023) | Related:
  • Bazazi P, Stone HA, Hejazi SH. Spongy all-in-liquid materials by in-situ formation of emulsions at oil-water interfaces. Nat Commun. 2022 Jul 18;13(1):4162. (Open access) | PubMed abstract
• Data analytics could prevent testing bottlenecks during future pandemics (4 Jan. 2023) | Related:
  • Sangal RB, Venkatesh AK, Cahill J, et al. Choice architecture to assist clinicians with appropriate COVID-19 test ordering. J Appl Lab Med. 2023 Jan 4;8(1):98-105. (Free full text) | PubMed abstract
• Industry news: GC Cell license out T-cell lymphoma treatment to US affiliate Artiva Biotherapeutics (4 Jan. 2023)
• Clinicians should limit intraoperative blood transfusion during radical cystectomy, expert says (4 Jan. 2023) | Related:
  • Myers A, Frank I, Shah PH, et al. Intraoperative blood transfusion is associated with increased risk of venous thromboembolism after radical cystectomy. J Urol. 2022 Nov 29:101097JU0000000000003094. Epub ahead of print.
• Industry news: Roche's glofitamab induces promising complete response rate in relapsed/refractory diffuse large B-cell lymphoma (4 Jan. 2023) | Related:
  • Dickinson MJ, Carlo-Stella C, Morschhauser F, et al. Glofitamab for relapsed or refractory diffuse large B-cell lymphoma. N Engl J Med. 2022 Dec 15;387(24):2220-2231. Epub 2022 Dec 11.
• Blood supply shortages common for patients with myelodysplastic syndromes (4 Jan. 2023) | Related:
  • Gupta S, Kulasekararaj AG, Costantino H, et al. Physicians' experience in blood supply shortages and the top factors that impact the clinical, economic, and humanistic outcomes of patients with myelodysplastic syndromes in 5 European countries. Curr Med Res Opin. 2022 Dec 7:1-9. Epub ahead of print. (Open access) | PubMed abstract
• CARMEN regimen shows promise in MYC-rearranged aggressive lymphoma (4 Jan. 2023) | Related:
  • Ferreri AJM, Angelillo P, Erbella F, et al. Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma. Blood Adv. 2022 Nov 22;6(22):5811-20. (Free full text) | PubMed abstract
• Industry news (USA): Janssen, American Cancer Society team up to help patients on their oncology journeys (3 Jan. 2023)
• Industry news: Progression-free survival increased with BeiGene's zanubrutinib in leukemia (3 Jan. 2023) | Related:
  • Brown JR, Eichhorst B, Hillmen P, et al. Zanubrutinib or ibrutinib in relapsed or refractory chronic lymphocytic leukemia. N Engl J Med. 2022 Dec 13. Epub ahead of print.
• Industry news (USA): Datar’s TriNetra-Glio receives FDA breakthrough designation (3 Jan. 2023) | Related:
  • US FDA grants breakthrough designation for blood test to help diagnose inaccessible brain tumors (2 Jan. 2023)
• 'Decoy' receptor protects CAR-T cells from antibody-driven destruction (3 Jan. 2023) | Related:
  • Gravina A, Tediashvili G, Rajalingam R, et al. Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression. Nat Biotechnol. 2023 Jan 2. Epub ahead of print. (Open access) | PubMed abstract
• Industry news (USA): Burning Rock wins FDA breakthrough nod for multi-cancer blood test (3 Jan. 2023)
• Adding omega-3 or vitamin D helps treat vaso-occlusive crises (VOCs) in children: cost analysis (3 Jan. 2023) | Related:
  • Abdelhalima SM, Murphy JE, Meabed MH, et al. Cost-effectiveness analysis of adding omega-3 or vitamin D supplementation to standard therapy in treating painful crises of pediatric sickle cell disease patients. Eur Rev Med Pharmacol Sci. 2022 Oct;26(20):7506-13. (Free as .pdf) | PubMed abstract
• Canada: Canadian Blood Services says there is an immediate need for donors (3 Jan. 2023)
• Canada: Canadian doctors pioneer medical procedure to treat inoperable brain tumor (1 Jan. 2023)
• ‘You’re improving the quality of life of somebody’: Diversifying blood and stem cell donations saves lives, experts say (31 Dec. 2022) Related:
  • Data & statistics on Sickle Cell Disease (US CDC)
  • Beck CE, Trottier ED, Kirby-Allen M, Pastore Y. Acute complications in children with sickle cell disease: Prevention and management. Paediatr Child Health. 2022 Mar 7;27(1):50-62. (Free full text) | PubMed abstract
• USA: Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly (30 Dec. 2022) | Related:
  • Wang Q, Iketani S, Li Z, et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 2022 Dec 14:S0092-8674(22)01531-8. Epub ahead of print. (Open access) | PubMed abstract
• ML model accurately predicts need for massive transfusion during surgery (29 Dec. 2022) | Related:
  • Lee SM, Lee G, Kim TK, et al. Development and validation of a prediction model for need for massive transfusion during surgery using intraoperative hemodynamic monitoring data. JAMA Netw Open. 2022 Dec 1;5(12):e2246637. (Free full text) | PubMed abstract
• Stem cell therapy may slow MS better than meds: Study (28 Dec. 2022)
• Canada: Canadian Blood Services needs blood, plasma donors after storm disruption (27 Dec. 2022)
• Reflecting on another year with sickle cell disease (23 Dec. 2022)
• USA: FDA approves Roche's Mosunetuzumab for relapsed/refractory follicular lymphoma (22 Dec. 2022) | Related:
  • Budde LE, Sehn LH, Matasar M, et al. Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study. Lancet Oncol. 2022 Aug;23(8):1055-65. Epub 2022 Jul 5.
• Patient-centered communication tool feasible for seniors with acute myeloid leukemia (22 Dec. 2022) | Related:
  • LoCastro M, Sanapala C, Wang Y, et al. Patient-centered communication tool for older patients with acute myeloid leukemia, their caregivers, and oncologists: A single-arm pilot study. Cancer Med. 2022 Dec 19. Epub ahead of print. (Open access) | PubMed abstract
• 610 Mosunetuzumab monotherapy demonstrates durable efficacy with a manageable safety profile in patients with relapsed/refractory follicular lymphoma who received =2 prior therapies: Updated results from a pivotalphase II study (Oral & poster abstracts at 64th ASH Annual Meeting)
• Industry news (USA): Janssen gets help from Hero Collective in reaching the Black community (22 Dec. 2022)
• Industry news: Roche's Actemra wins approval for hospitalized Covid patients (22 Dec. 2022)
• Infant gene therapy is a breakthrough for Artemis-SCID patients (21 Dec. 2022) | Related:
  • Cowan MJ, Yu J, Facchino J, et al. Lentiviral gene therapy for Artemis-deficient SCID. N Engl J Med. 2022 Dec 22;387(25):2344-55.
• Industry news: bioMérieux announces CE-marking of VIDAS^® KUBE^™, the next generation system in the VIDAS^® immunoassay portfolio (20 Dec. 2022)
• Researchers identify 28 early signs of CAR T-cell toxicity (20 Dec. 2022) | Related:
  • Spanjaart AM, Pennings ERA, Kos M, et al. Development of a core set of patient- and caregiver-reported signs and symptoms to facilitate early recognition of acute chimeric antigen receptor T-cell therapy toxicities. JCO Oncol Pract. 2022 Dec 12:OP2200501. Epub ahead of print. | PubMed abstract
• The slow roll-out of the world’s first malaria vaccine (19 Dec. 2022)
• Laser-pulsing skin patch goes deep to uncover signs of cancer (19 Dec. 2022) | Related:
  • Gao X, Chen X, Hu H, et al. A photoacoustic patch for three-dimensional imaging of hemoglobin and core temperature. Nat Commun. 2022 Dec 15;13(1):7757. (Open access) | PubMed abstract
• Industry news: SeekIn receives CE-IVD mark approval for PanCanSeek^® cancer mutation detection kit (19 Dec. 2022)
• Canada: 'Heading into toughest weeks': Blood donors urgently needed (17 Dec. 2022)
• Geriatric assessment in hematology scale predicts treatment tolerability in older patients with hematological malignancies (16 Dec. 2022) | Related:
  • de la Rubia J, González B, Cruz-Jentoft AJ, et al. Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study. J Geriatr Oncol. 2022 Nov 17:S1879-4068(22)00520-3. Epub ahead of print. (Open access) | PubMed abstract
• COVID-19 can spread from dead bodies, research suggests (16 Dec. 2022) | Related:
  • Saitoh H, Yuko Sakai-Tagawa Y, Nagasawa S, et al. High titers of infectious SARS-CoV-2 in COVID-19 corpses. medRxiv. 2022 Oct 13. Preprint. (Free full text)
• Low platelet counts linked with greater symptom burden in myelofibrosis (16 Dec. 2022) | Related:
  • Palmer JM, Gerds AT, Harrison C, et al. Differential impact of thrombocytopenia and anemia on myelofibrosis (MF) symptom burden. Blood. 2022;140(suppl 1):3938-40.
• Imaging method yields highly accurate and precise values of radionuclide organ uptake (16 Dec. 2022)
• Can stem cells improve shoulder surgery? (16 Dec. 2022) | Related:
  • Fang F, Xiao Y, Zelzer E, et al. A mineralizing pool of Gli1-expressing progenitors builds the tendon enthesis and demonstrates therapeutic potential. Cell Stem Cell. 2022 Dec 1;29(12):1669-1684.e6.
• Industry news: Judge grants final OK to $9.9M settlement to end fingerprint scan class action vs CSL Plasma (16 Dec. 2022)
• Changing heart cell programming can reverse the lasting damage caused by heart attacks (16 Dec. 2022) | Related:
  • Tani H, Sadahiro T, Yamada Y, et al. Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction. Circulation. 2022 Dec 12. Epub ahead of print. (Free access) | PubMed abstract
• Ebola vaccines spur lasting immunity in children and adults, trials show (15 Dec. 2022) | Related:
  • PREVAC Study Team, Kieh M, Richert L, et al. Randomized trial of vaccines for Zaire ebola virus disease. N Engl J Med. 2022 Dec 14. Epub ahead of print. (Free full text) | PubMed abstract
• National registry may reduce mortality among alloimmunized people with sickle cell disease (15 Dec. 2022)
• Industry news: Inceptor Bio becomes third company to join Ori’s LEAP program (15 Dec. 2022)
• Point-of-care biosensor rapidly detects oral cancer (14 Dec. 2022) | Related:
  • Minghan Xian M, Stephany JL, Chiu C-W, et al. High sensitivity CIP2A detection for oral cancer using a rapid transistor-based biosensor module. J Vac Sci Technol B 2022. Epub 13 Dec. 2022.
• Swiss naturopath launches international blood bank for the unvaccinated (14 Dec. 2022) | Related:
  • Canadian Blood Services: COVID-19 vaccines and blood donation | Blood from vaccinated donors is safe for patients
• Industry news: Novartis partners with Cancer Research UK for rare cancer trial (14 Dec. 2022)
• Canada: Canadian Blood Services needs donors as demand rises over holidays (14 Dec. 2022)
• Gene therapy confers durable benefits for patients with beta-thalassemia (14 Dec. 2022) | Related:
  • 3665 Long-term patient-reported outcomes following treatment with betibeglogene autotemcel in patients with transfusion-dependent ß-thalassemia (Oral & poster abstracts at 64th ASH Annual Meeting)
  • 2348 Long term outcomes of 63 patients with Ttransfusion-dependent ß-thalassemia (TDT) followed up to 7 years post-treatment with betibeglogene autotemcel (beti-cel) gene therapy and exploratory analysis of predictors of successful treatment outcomes in phase 3 trials (Oral & poster abstracts at 64th ASH Annual Meeting)
• WHO-commissioned study makes strong health and economic argument for investing in new TB vaccines (13 Dec. 2022)
• USA: Three data trends guiding cost-saving laboratory logistics strategies and benchmarks (13 Dec. 2022) | Related:
  • Report: U.S. hospitals face worst year financially since start of COVID-19 pandemic, jeopardizing access to patient care (15 Sept. 2022)
• Industry news: Positive Moderna, Merck cancer vaccine data advances mRNA promise, shares rise (13 Dec. 2022)
• Smartphone-connected device uses light to detect malaria ­ in 10 seconds (13 Dec. 2022) | Related:
  • Garcia GA, Kariyawasam TN, Lord AR, et al. Malaria absorption peaks acquired through the skin of patients with infrared light can detect patients with varying parasitemia. PNAS Nexus 2022 Dec. 7. Epub 7 Dec. (Free to read as .pdf)
• New episode of transfusion monthly podcast focuses on hemostatic function of cold-stored platelets (13 Dec. 2022) | Related:
  • Cold-stored platelets in a bleeding model (Monthly podcast)
  • Nogawa M, Watanabe N, Koike T, et al. Hemostatic function of cold-stored platelets in a thrombocytopenic rabbit bleeding model. Transfusion. 2022 Nov;62(11):2304-13. Epub 2022 Sep 30.
• Pediatric hodgkin lymphoma survivors experience accelerated epigenetic aging (13 Dec. 2022) |Related:
  • 902 Epigenetic age acceleration and neurocognitive function among long-term survivors of pediatric hodgkin lymphoma: A report from the St. Jude Lifetime Cohort (Oral & poster abstracts at 64th ASH Annual Meeting)
• Cancer patients unruffled by whole-body MRI per se (13 Dec. 2022) | Related:
  • Mazzocco K, Busacchio D, Summers PE, et al. Is whole-body magnetic resonance imaging a source of anxiety in oncological patients? Cancer Rep (Hoboken). 2022 Dec 9:e1737. Epub ahead of print. (Open access) | PubMed abstract
• WHO member states commit to producing a pandemic accord in 2023 (12 Dec. 2022) | Related:
  • WHO Member States agree to develop zero draft of legally binding pandemic accord in early 2023 (7 Dec. 2022; WHO news release)
• Team undertakes study of two-dimensional transition metal chalcogenides (12 Dec. 2022) | Related:
  • Wang K, Xu W, Zhang W, et al. Bio-inspired water-driven electricity generators: From fundamental mechanisms to practical applications. Nano Research Energy, 2022. Epub 30 Nov. 2022. (Open access)
• Industry news: Merck officially commences $1.36B Imago Biosciences buyout (12 Dec. 2022)
• Experimental CAR-T safe, ‘highly effective’ for certain patients with T-cell malignancies (12 Dec. 2022) | Related:
  • 980 Analysis of 53 patients with relapsed or refractory (R/R) T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) treated with CD7-targeted CAR-T cell therapy (Oral & poster abstracts at 64th ASH Annual Meeting)
• Industry news: Teva Pharmaceutical's low-dose lenalidomide reduces risk of transfusion dependency, provides clonal response and safety benefits in MDS (12 Dec. 2022) | Related:
  • Cadenas FL, Lumbreras E, Gonzalez T, et al. Evaluation of lenalidomide (len) vs placebo in non-transfusion dependent low risk del(5q) MDS patients. final results of Sintra-REV phase III international multicenter clinical trial. Blood. 2022;140(suppl 1):1109­1111.
• Gene therapy may be equitable therapeutic option for sickle cell disease in US (11 Dec. 2022)
• Meet MEDi: a robot designed to help children in hospital manage pain, anxiety (11 Dec. 2022) | Related:
  • Gates M, Hartling L, Shulhan-Kilroy J, et al. Digital technology distraction for acute pain in children: A meta-analysis. Pediatrics. 2020 Feb;145(2):e20191139. Epub 2020 Jan 22. (Free full text) | PubMed abstract
• Gene therapy may be equitable therapeutic option for sickle cell disease in US (11 Dec. 2022)
• Industry news: A cheap new blood test by Elypta can detect 14 types of cancer before they spread (10 Dec. 2022) | Related:
  • Bratulic S, Limeta A, Dabestani S, et al. Noninvasive detection of any-stage cancer using free glycosaminoglycans. Proc Natl Acad Sci U S A. 2022 Dec 13;119(50):e2115328119. Epub 2022 Dec 5. (Free full text) | PubMed abstract
• Industry news: Novartis' Tisa-Cel improves outcomes vs usual care in relapsed or refractory follicular lymphoma (8 Dec. 2022) | Related:
  • Salles G, Schuster SJ, Dreyling M, et al. Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma. Blood Adv. 2022 Nov 22;6(22):5835-43. (Free full text) | PubMed abstract
• Industry news: The Native Antigen Company expands infectious disease portfolio to include Sudan ebolavirus Boniface 1976 Glycoprotein (8 Dec. 2022)
• USA: CDC report shows how infectious mpox is and how important vaccination was in stemming outbreak (8 Dec. 2022) | Related:
  • Payne AB, Ray LC, Cole MM, et al. Reduced risk for Mpox after receipt of 1 or 2 doses of Bavarian Nordic's JYNNEOS vaccine compared with risk among unvaccinated persons - 43 U.S. jurisdictions, July 31-October 1, 2022. MMWR Morb Mortal Wkly Rep. 2022 Dec 9;71(49):1560-64. (Free full text) | PubMed abstract
• Pokey patch painlessly monitors drug levels in patients' bloodstreams (8 Dec. 2022) | Related:
  • Lin S, Cheng X, Zhu J, et al. Wearable microneedle-based electrochemical aptamer biosensing for precision dosing of drugs with narrow therapeutic windows. Sci Adv. 2022 Sep 23;8(38):eabq4539. Epub 2022 Sep 23. (Free full text) | PubMed abstract
• Industry news: Novartis' iptacopan meets PhIII test in fight against rare blood disease, PNH (8 Dec. 2022) | Related:
  • Novartis investigational iptacopan provides clinically meaningful increases in hemoglobin levels in complement-inhibitor-naïve patients with PNH (8 Dec. 2022)
• E-Selectin levels associated with vasculopathy and retinopathy in sickle cell disease (7 Dec. 2022) | Related:
  • Agouti I, Masson E, Loundou A, et al. Plasma levels of E-selectin are associated with retinopathy in sickle cell disease. Eur J Haematol. 2022 Nov 21. Epub ahead of print. (Open access) | PubMed abstract
• USA: FDA seeks to withdraw Oncopeptides AB's melphalan flufenamide for relapsed/refractory multiple myeloma (7 Dec. 2022)
• Extreme obesity may increase relapse risk during maintenance therapy in children with leukemia subtype (6 Dec. 2022)
• Sarcopenia predicts negative outcomes in newly diagnosed myeloma (6 Dec. 2022) | Related:
  • Nandakumar B, Baffour F, Abdallah NH, et al. Sarcopenia identified by computed tomography imaging using a deep learning-based segmentation approach impacts survival in patients with newly diagnosed multiple myeloma. Cancer. 2022 Nov 22. Epub ahead of print.
• Encouraging findings in first-in-human clinical trial evaluating HIV vaccine (5 Dec. 2022) | Related:
  • Leggat DJ, Cohen KW, Willis JR, et al. Vaccination induces HIV broadly neutralizing antibody precursors in humans. Science. 2022 Dec 2;378(6623):eadd6502. Epub 2022 Dec 2.
• Lung scarring occurs in up to 11% of patients recovered from COVID, regardless of infection severity (5 Dec. 2022)
• Singapore: National University of Singapore developed a new cancer testing that makes regular monitoring affordable (5 Dec. 2022)
• Industry news: Device for early diagnosis of blood clots receives £500k Innovate UK grant (5 Dec. 2022)
• USA: Syndax receives breakthrough therapy tag for revumenib to treat acute leukemia (5 Dec. 2022)
• When are packed red blood cell transfusions during ECMO beneficial to survival? (5 Dec. 2022) | Related:
  • Martucci G, Schmidt M, Agerstrand C, et al.; International ECMO Network (ECMONet). Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study. Lancet Respir Med. 2022 Oct 11:S2213-2600(22)00353-8. Epub ahead of print.
• Checking blood pressure in a heartbeat, using artificial intelligence and a camera (5 Dec. 2022) | Related:
  • Al-Naji A, Fakhri AB, Mahmood MF, Chahl J. Contactless blood pressure estimation system using a computer vision system. Inventions, 2022; 7 (3). (Open access)
• Researchers at Institute for Stem Cell Science and Regenerative Medicine report a novel technology to enhance the quality and shelf-life of stored blood. (2 Dec. 2022) | Related:
  • Pandey S, Mahato M, Srinath P, et al. Intermittent scavenging of storage lesion from stored red blood cells by electrospun nanofibrous sheets enhances their quality and shelf-life. Nat Commun. 2022 Dec 1;13(1):7394. (Open access) | PubMed abstract
• UK: World-first trial launches in UK to assess stem cell transplants as first-line MS treatment (2 Dec. 2022) | Related:
  • University of Sheffield StarMS Trial
  • Brittain G, Coles AJ, Giovannoni G, et al. Autologous haematopoietic stem cell transplantation for immune-mediated neurological diseases: what, how, who and why? Pract Neurol. 2022 Sep 26:pn-2022-003531. Epub ahead of print.
• The incidence of antimicrobial resistance among urinary E. coli isolates is increasing in both hospital and community settings in Australia (1 Dec. 2022) | Related:
  • Keighley C, van Oijen AM, Brentnall SJ, et al. Multi-year antimicrobial-resistance trends in urine Escherichia coli isolates from both community-based and hospital-based laboratories of an Australian local health district. J Glob Antimicrob Resist. 2022 Nov 24:S2213-7165(22)00251-X. Epub ahead of print. (Free full text) | PubMed abstract
• CDC will test sewage for polio outside New York to see if it’s circulating elsewhere in nation (30 Nov. 2022)
• Study reveals wasteosomes as markers of chronic glymphatic system insufficiency (30 Nov. 2022) | Related:
  • Riba M, Del Valle J, Molina-Porcel L, et al. Wasteosomes (corpora amylacea) as a hallmark of chronic glymphatic insufficiency. Proc Natl Acad Sci U S A. 2022 Nov 29;119(48):e2211326119. Epub 2022 Nov 21. (Free full text) | PubMed abstract
• CATCR-T cell therapy may aid in antiphospholipid syndrome through selective B-cell depletion (30 Nov. 2022)
• New prospective study finds that Masimo SpHb^® noninvasive and continuous hemoglobin monitoring can help provide effective blood management in patients undergoing major surgery (30 Nov. 2022) | Related:
  • Akdag S, Zengin SU, Cakmak G, et al. Targeted bleeding management guided by non-invasive haemoglobin measurement in surgical patients. J Coll Physicians Surg Pak. 2022 Oct;32(10):1242-8. (Open access) | PubMed abstract
• Real-world data supports use of hypomethylating drugs in elderly patients with acute myeloid leukemia (30 Nov. 2022) | Related:
  • Molica M, Mazzone C, Niscola P, et al. Identification of predictive factors for overall survival and response during hypomethylating treatment in very elderly ( 75 years) acute myeloid leukemia patients: A multicenter real-life experience. Cancers (Basel). 2022 Oct 6;14(19):4897. (Free full text) | PubMed abstract
• Coping strategies linked to distress, quality of life in caregivers of stem cell recipients (29 Nov. 2022) | Related:
  • Amonoo HL, Johnson PC, Nelson AM, et al. Coping in caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. Blood Adv. 2022 Nov 18:bloodadvances.2022008281. Epub ahead of print. (Free as .pdf) | PubMed abstract
• Episode 11B: The effect of trilaciclib in patients receiving chemotherapy for extensive-stage small cell lung cancer treatment (29 Nov. 2022)
• WHO recommends new name for monkeypox disease - “mpox” (28 Nov. 2022)
• Benefits of 'bloodless medicine' boost surgery without transfusions (28 Nov. 2022)
• Researchers in US and Israel detect fungal DNA in most cancer types found in the human body (28 Nov. 2022) | Related:
  • Dohlman AB, Klug J, Mesko M, et al. A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell. 2022 Sep 29;185(20):3807-3822.e12.
• Fighting aggressive blood cancer ages and exhausts immune cells, study suggests (27 Nov. 2022)
• ‘I never had no Nobel dreams’ (25 Nov. 2022) | News item from University of Cape Town: Nobel Prize winners Dr. Harvey Alter & Dr Richard Henderson address a packed auditorium at the Faculty of Health Sciences on their research journeys to the ultimate award in science.
• New CRISPR gene-editing system can "drag-and-drop" DNA in bulk (24 Nov. 2022) | Related:
  • Yarnall MTN, Ioannidi EI, Schmitt-Ulms C, et al. Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases. Nat Biotechnol. 2022 Nov 24. Epub ahead of print.
• Novel ways to measure glucose levels without drawing blood (23 Nov. 2022) | Related:
  • Kim S, Malik J, Seo JM, et al. Subcutaneously implantable electromagnetic biosensor system for continuous glucose monitoring. Sci Rep. 2022 Oct 17;12(1):17395. (Open access) | PubMed abstract
• Study challenges “good” cholesterol’s role in predicting heart disease risk (22 Nov. 2022) | Related:
  • Zakai NA, Minnier J, Safford MM, et al. Race-dependent association of high-density lipoprotein cholesterol levels with incident coronary artery disease. J Am Coll Cardiol. 2022 Nov 29;80(22):2104-15. (Free full text) | PubMed abstract
• Thalassemia patients in Turbat (24 Nov. 2022) | Note: Balochistan region is split between 3 nations: Iran, Afghanistan, Pakistan & Turbat is in Pakistan.
• Significant treatment attrition rate seen in multiple myeloma (22 Nov. 2022) | Related:
  • Jimenez-Zepeda VH, Chen G, Shaw E, et al. Real-world treatment patterns for patients with newly diagnosed multiple myeloma in Alberta, Canada. Leuk Lymphoma. 2022 Nov;63(11):2557-64. Epub 2022 Jul 5.
• Industry news: Genmab & AbbVie announce U.S. FDA accepts for priority review Biologics License Application for Epcoritamab (DuoBody®-CD3xCD20) for the treatment of relapsed/refractory large B-cell lymphoma (21 Nov. 2022) | Related:
  • Hutchings M, Mous R, Clausen MR, et al. Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study. Lancet. 2021 Sep 25;398(10306):1157-69. Epub 2021 Sep 8.
• USA: Johns Hopkins finds new AI blood test detects liver cancer in study (21 Nov. 2022) | Related:
  • Foda ZH, Annapragada AV, Boyapati K, et al. Detecting liver cancer using cell-free DNA fragmentomes. Cancer Discov. 2022 Nov 18:CD-22-0659. Epub ahead of print. (Free full text as .pdf) | PubMed abstract
• Industry news: MIF invests in KAHR Medical to explore lead immunotherapy drug for multiple myeloma (18 Nov. 2022)
• Genes to potentially diagnose long-term lyme disease identified (18 Nov. 2022) | Related:
  • Clarke DJB, Rebman AW, Fan J, et al. Gene set predictor for post-treatment Lyme disease. Cell Rep Med. 2022 Nov 15;3(11):100816. (Open access) | PubMed abstract
• CAR-T destined for earlier lines of therapy in blood cancers, experts say (18 Nov. 2022)
• Industry news: Sanofi’s Enjaymo for hemolytic anemia given marketing authorization by EC (18 Nov. 2022)
• Achieving Event-free survival (EFS) after 2 years shows signs of promising OS in MCL (18 Nov. 2022) | Related:
  • Wang Y, Larson MC, Maurer MJ, et al. MCL-027 prognostic role of event-free survival at 24 months (EFS24) in newly diagnosed mantle cell lymphoma (MCL). Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S394.
• Industry news: EdiGene announces completion of last patient dosing in Phase I clinical trial of ET-01, its investigational gene-editing hematopoietic stem cell therapy for transfusion dependent ß-thalassemia (18 Nov. 2022)
• Study uncovers new rules for lineage progression (17 Nov. 2022) | Related:
  • Shi X, Zhuang Y, Chen Z, et al. Hierarchical deployment of Tbx3 dictates the identity of hypothalamic KNDy neurons to control puberty onset. Sci Adv. 2022 Nov 18;8(46):eabq2987. Epub 2022 Nov 16. (Free full text) | PubMed abstract
• Industry news: Ponatinib produces higher rates of minimal residual disease-negative complete remission in Ph+ ALL (17 Nov. 2022) | Related:
  • Phase 3 trial of ICLUSIG® (ponatinib) met primary endpoint in newly-diagnosed Ph+ ALL, a setting with no targeted treatments approved in the US. (Takeda News release, 16 Nov. 2022)
• WHO, Uganda plan to test three candidate Ebola vaccines in outbreak (16 Nov. 2022)
• Dried blood sample testing found acceptable for hepatitis B virus screenings (16 Nov. 2022)
• WHO, WIPO, WTO to hold technical symposium on response, preparedness to future pandemics (15 Nov. 2022) | Related:
  • WHO, WIPO, WTO to hold technical symposium on response, preparedness to future pandemics (10 Nov. 2022)
• How COVID-19 causes neurological damage (15 Nov. 2022) | Related:
  • Etter MM, Martins TA, Kulsvehagen L, et al. Severe neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat Commun. 2022 Nov 9;13(1):6777. (Open access) | PubMed abstract
• Researchers create mini ‘bone marrow in a dish’ to boost anti-cancer treatments (15 Nov. 2022) | Related:
  • Khan AO, Rodriguez-Romera A, Reyat JS, et al. Human bone marrow organoids for disease modelling, discovery and validation of therapeutic targets in hematological malignancies. Cancer Discov. 2022 Nov 9:CD-22-0199. Epub ahead of print.
• Are fungal mycelium skin-derived MycelioTronics an environmentally friendly substitute for electronics? (15 Nov. 2022) | Related:
  • Danninger D, Pruckner R, Holzinger L, et al. MycelioTronics: Fungal mycelium skin for sustainable electronics. Sci Adv. 2022 Nov 11;8(45):eadd7118. Epub 2022 Nov 11. (Free full text) | PubMed abstract
• Best uses of transplantation for patients with peripheral T-cell lymphoma (15 Nov. 2022) | Related:
  • Foley NC, Mehta-Shah N. Management of peripheral T-celllymphomas and the role of transplant. Curr Oncol Rep. 2022 Nov;24(11):1489-99. Epub 2022 Aug 10.
• USA: Medtech startup 410 Medical lands new cash transfusion: $6.3 million (15 Nov. 2022)
• Lipid nanoparticles: from little league to the majors (15 Nov. 2022)
• Industry news: Priothera’s Mocravimod improves survival for patients with hematological malignancies (14 Nov. 2022)
• EHR data show MM treatment burden higher than chronic lymphoid leukemia (14 Nov. 2022) | Related:
  • Bennink C, van der Klift M, Sonneveld P, et al. Measuring hospital-related burden of treatment in multiple myeloma using electronic health records’-reimbursement data. Health Policy Technol. Epub Nov. 11, 2022:100695. (Open access)
• USA: FDA to review aphexda in the transplant setting for patients with multiple myeloma (13 Nov. 2022) | Related:
  • BioLineRx Ltd. announces U.S. FDA acceptance of new drug application for aphexda® (motixafortide) in stem cell mobilization (10 Nov. 2022)
• WHO reports 90% drop in global COVID-19 deaths since February (11 Nov. 2022)
• Repeat COVID-19 infections increase risk of organ failure, death (10 Nov. 2022) | Related:
  • Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022 Nov 10. Epub ahead of print. (Open access) | PubMed abstract
• USA: Experimental cancer vaccine shows promise in animal studies (US NIH press release, 10 Nov. 2022) | Related:
  • Baharom F, Ramirez-Valdez RA, Khalilnezhad A, et al. Systemic vaccination induces CD8⁺ T cells and remodels the tumor microenvironment. Cell. 2022 Nov 10;185(23):4317-4332.e15. Epub 2022 Oct 26.
• Industry news: Real-world study of Pfizer's voxelotor for sickle cell disease shows safety, efficacy similar to clinical trials (11 Nov. 2022)
• CRISPR cancer trial success paves the way for personalized treatments (10 Nov. 2022) | Related:
  • Foy SP, Jacoby K, Bota DA, et al. Non-viral precision T cell receptor replacement for personalized cell therapy. Nature. 2022 Nov 10. Epub ahead of print.
• USA: Cedars-Sinai study: Biomarkers that predict preeclampsia risk (9 Nov. 2022)
• Industry news: Collaboration to develop CAR-T cell therapy for cutaneous T-cell lymphoma (8 Nov. 2022) | The Peter MacCallum Cancer Centre & Cartherics Pty Ltd have entered into a collaborative development program agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy for the treatment of cutaneous T-cell lymphoma.
• Lab-grown blood given to people in world-first clinical trial (7 Nov. 2022)
• Could “Choosing Wisely” help fight health worker burnout? (7 Nov. 2022) | Related:
  • Kerr EA, Friese CR, Conroy JM. Enhancing the value of clinical Work—Choosing Wisely to preserve the clinician workforce. JAMA Health Forum. 2022 Nov 4;3(11):e224018. (Free full text)
• USA: Monkeypox in kids, teens is rare and seldom severe: CDC (3 Nov. 2022) | Related:
  • Hennessee I, Shelus V, McArdle CE, et al.; California Department of Public Health Monkeypox Pediatric Working Group; CDC Monkeypox Pediatric Working Group. Epidemiologic and clinical features of children and adolescents aged <18 years with monkeypox - United States, May 17-September 24, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 4;71(44). (Free full text)
• Lymphoma-specific questionnaire addresses unmet patient needs (7 Oct. 2022) | Related:
  • CN58 - Mapping the measurement of lymphoma survivors’ unmet needs and quality of life outcomes: Evidence for a lymphoma-specific questionnaire (ESMO Congress abstract, 10 Sept. 2022)
• Industry news: Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant (4 Nov. 2022)
• Black patients have greater risk of all-cause mortality from diabetes, stroke (3 Nov. 2022) | Related:
  • Joseph JJ, Rajwani A, Roper D, et al. Associations of cardiometabolic multimorbidity with all-cause and coronary heart disease mortality among black adults in the Jackson Heart Study. JAMA Netw Open. 2022 Oct 3;5(10):e2238361. (Free full text) | PubMed abstract
• Industry news: Collaboration to develop CAR-T cell therapy for cutaneous T-cell lymphoma (8 Nov. 2022) | The Peter MacCallum Cancer Centre & Cartherics Pty Ltd have entered into a collaborative development program agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy for the treatment of cutaneous T-cell lymphoma.
• Modified blood cells deliver antibiotics to kill dangerous bacteria (3 Nov. 2022) | Related:
  • Krivić H, Himbert S, Sun R, et al. Erythro-PmBs: A selective polymyxin B delivery system using antibody-conjugated hybrid erythrocyte liposomes. ACS Infect Dis. 2022 Oct 14;8(10):2059-72. Epub 2022 Sep 29.
• Industry news: Enzyre raises funds for haemophilia diagnostic platform development (3 Nov. 2022)
• Initiation of antiretroviral therapy reduces number of active HIV-infected cells (2 Nov. 2022) | Related:
  • Gunst JD, Pahus MH, Rosás-Umbert M, et al. Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial. Nat Med. 2022 Oct 17. Epub ahead of print. (Free full text) | PubMed abstract
• Monkeypox may spread before symptoms start, study suggests (2 Nov. 2022) | Related:
  • Ward T, Christie R, Paton RS, et al. Transmission dynamics of monkeypox in the United Kingdom: contact tracing study. BMJ. 2022 Nov 2;379:e073153. (Open access) | PubMed abstract
• Could DNA nanotransporters treat cancer? (2 Nov. 2022) | Related:
  • Desrosiers A, Derbali RM, Hassine S, et al. Programmable self-regulated molecular buffers for precise sustained drug delivery. Nat Commun. 2022 Nov 2;13(1):6504. (Open access) | PubMed abstract
• Physical activity and fitness appears lower among patients with moderate to severe hemophilia (2 Nov. 2022) | Related:
  • Kennedy M, Roche S, McGowan M, et al.; iPATH study group. Physical activity, physical fitness and cardiometabolic risk amongst adults with moderate and severe haemophilia. Haemophilia. 2022 Oct 4. Epub ahead of print. (Open access) | PubMed abstract
• Ongoing study evaluates diagnosis of myelodysplastic syndrome with peripheral blood samples (2 Nov. 2022) | Related:
  • Raskovalova T, Scheffen L, Jacob MC, et al. Flow cytometry lyophilised-reagent tube for quantifying peripheral blood neutrophil myeloperoxidase expression in myelodysplastic syndromes (MPO-MDS-Develop): protocol for a diagnostic accuracy study. BMJ Open. 2022 Oct 7;12(10):e065850. (Free full text) | PubMed abstract
• New malaria antibody drug prevents infection in adults for 6 months (1 Nov. 2022) | Related:
  • Kayentao K, Ongoiba A, Preston AC, et al.; Mali Malaria mAb Trial Team. Safety and efficacy of a monoclonal antibody against malaria in Mali. N Engl J Med. 2022 Oct 31. Epub ahead of print.
• SCD patients at higher risk of death from kidney disease, study finds (1 Nov. 2022) | Related:
  • Winer JC, Yee ME, Ataga KI, et al. Patients with sickle cell disease who develop end-stage kidney disease continue to experience poor survival - A 19-year United States Renal Data System study. Br J Haematol. 2022 Oct 3. Epub ahead of print. (Free access)
• BCMA and CD3 T-cell­engaging bispecific antibody shows promise in R/R multiple myeloma (1 Nov. 2022) | Related:
  • D'Souza A, Shah N, Rodriguez C, et al. A phase I first-in-human study of ABBV-383, a B-cell maturation antigen × CD3 bispecific T-cell redirecting antibody, in patients with relapsed/refractory multiple myeloma. J Clin Oncol. 2022 Nov 1;40(31):3576-86. Epub 2022 Aug 27. (Free full text) | PubMed abstract
• Industry news: Roche to launch infectious diseases testing system cobas 5800 in US (1 Nov. 2022)
• Fetal care and treatment center performs successful first laser ablation procedure for twin-to-twin transfusion syndrome (1 Nov. 2022)
• Heart disease-related deaths increased due to COVID-19, undoing a decade of progress (31 Oct. 2022) | Related:
  • Woodruff RC, Campbell AP, Taylor CA, et al. Risk factors for severe COVID-19 in children. Pediatrics. 2022 Jan 1;149(1):e2021053418. Epub 2021 Dec 22. (Free full text) | PubMed abstract
• Machine learning shows promise in therapeutic decision-making for patients with acute myeloid leukemia (31 Oct. 2022) | Related:
  • Islam N, Reuben JS, Dale J, et al. Machine learning-based exploratory clinical decision support for newly diagnosed patients with acute myeloid leukemia treated with 7 + 3 type chemotherapy or venetoclax/azacitidine. JCO Clin Cancer Inform. 2022 Sep;6:e2200030. (Free full text) | PubMed abstract
• WHO guideline on fluid management of acutely ill children (28 Oct. 2022)
• Omicron subvariants resistant to key antibody treatments are increasing every week in the U.S. (28 Oct. 2022)
• Industry news: Industry's interleukin-2 (IL-2) struggles continue as Sanofi drops program (28 Oct. 2022)
• T-cell immunity may impact outcomes in patients with acute lymphoblastic leukemia (28 Oct. 2022) | Related:
  • Li Y, Yang X, Sun Y, et al. Impact of T-cell immunity on chemotherapy response in childhood acute lymphoblastic leukemia. Blood 2022 Sep 29;140(13):1507- 21.
• Industry news: Novartis’ iptacopan meets 2 endpoints for paroxysmal nocturnal hemoglobinuria treatment (27 Oct. 2022) | Related:
  • Novartis investigational oral monotherapy iptacopan demonstrates clinically meaningful superiority over anti-C5 treatment in Phase III APPLY-PNH study. (News release, 24 Oct. 2022)
• USA: FDA advisory committee returns mixed vote on GSK’s CKD drug - updated (27 Oct. 2022)
• Updated Covid-19 vaccines boost protection, but may not beat original formula against BA.4 and BA.5, early studies suggest (26 Oct. 2022) | Related:
  • Wang Q, Bowen A, Valdez R, et al. Antibody responses to Omicron BA.4/BA.5 bivalent mRNA vaccine booster shot. doi.org/10.1101/2022.10.22.513349 Preprint. Epub 24 Oct. 2022 (Free full text)
  • Collier AY, Miller J, Hachmann NP, et al. Immunogenicity of the BA.5 bivalent mRNA vaccine boosters doi.org/10.1101/2022.10.24.513619 Preprint. Epub 25 Oct. 2022 (Free full text)
• Industry news: Eisai Pharmaceutical responds to claims linking patient death to lecanemab - Updated (28 Oct. 2022)
• Aggressive warming during noncardiac surgery unnecessary (26 Oct. 2022)
• Industry news: Merck to donate Sudan Ebola virus vaccine to international AIDS vaccine initiative (26 Oct. 2022)
• Next-generation approaches to overcoming drug resistance in therapies multiple myeloma (26 Oct. 2022) | Related:
  • Solimando AG, Malerba E, Leone P, et al. Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche. Front Oncol. 2022 Sep 21;12:973836. (Free full text) | PubMed abstract
• Industry news (USA): US FDA grants approval for Janssen’s tecvayli to treat multiple myeloma (26 Oct. 2022)
• Interim FDG-PET/CT may have positive prognostic value for Hodgkin’s lymphoma (26 Oct. 2022) | Related:
  • Al-Ibraheem A, Anwer F, Juweid ME, et al. Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's lymphoma. Sci Rep. 2022 Oct 21;12(1):17702. (Open access) | PubMed abstract
• COVID cases will increase in coming months, but at a slower pace, analysis says (25 Oct. 2022)
• People who caught mild Covid had increased risk of blood clots, British study finds (25 Oct. 2022) | Related:
  • Raisi-Estabragh Z, Cooper J, Salih A, et al. Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank. Heart. 2022 Oct 24:heartjnl-2022-321492. Epub ahead of print. (Open access) | PubMed abstract
• Industry news: OpGen signs agreement with Bioversys for Unyvero platform for rapid diagnostics (25 Oct. 2022) | Related:
  • OpGen subsidiary Curetis and BioVersys sign collaboration agreement for clinical trial support (25 Oct. 2022)
• The great pandemic hand-washing blooper (24 Oct. 2022) | Related:
  • Dick EC, Jennings LC, Mink KA, et al. Aerosol transmission of rhinovirus colds. J Infect Dis. 1987 Sep;156(3):442-8.
• Industry news (USA): Daiichi Sankyo's quizartinib gets FDA priority review to treat blood cancer subtype (24 Oct. 2022)
• Research finds that life-saving intervention is not risk-free in pediatric patients (24 Oct. 2022) | Related:
  • Acker SN, Nolan MM, Prendergast C, et al. Blood transfusion is associated with adverse outcomes in pediatric solid tumor oncology patients following tumor resection. J Pediatr Hematol Oncol. 2022 Aug 22.Epub ahead of print.
• Hematopoietic stem cell transplantation shows positive efficacy for inborn errors of immunity (24 Oct. 2022) | Related:
  • Albert MH, Sirait T, Eikema DJ, et al. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study. Blood. 2022 Oct 6;140(14):1635-1649.
• Industry news: Novartis's paroxysmal nocturnal hemoglobinuria drug candidate demonstrates superiority to anti-C5 therapies (24 Oct. 2022)
• The main COVID symptoms have changed, research shows (23 Oct. 2022)
• Identifying ASCT-ineligible patients who could benefit from CAR T-cell treatment (22 Oct. 2022) | Related:
  • Vic S, Lemoine J, Armand P, et al. Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant population. Eur J Cancer. 2022 Nov;175:246-53. Epub 2022 Sep 24.
• Study - Adherence to PrEP increases prevention of HIV (21 Oct. 2022) | Related:
  • Hempel A, Biondi MJ, Baril JG, Tan DHS. Pre-exposure prophylaxis for HIV: effective and underused. CMAJ. 2022 Sep 6;194(34):E1164-E1170. (Free full text)
• UK: Library resources (NHS, 21 Oct. 2022):
  • Clinical commissioning policy: Treatment of iron overload for transfused and non-transfused patients with chronic inherited anaemias (all ages)
  • Clinical panel report: Treatment of iron overload for transfused and non-transfused patients with chronic inherited anaemias (all ages)
  • Clinical priorities advisory group summary report: Treatment of iron overload for transfused and non-transfused patients with chronic inherited anaemias (all ages)
  • Evidence review: Treatment of iron overload for transfused and non-transfused patients with chronic inherited anaemias (all ages)
  • Engagement report: Treatment of iron overload for transfused and non-transfused patients with chronic inherited anaemias (all ages)
  • Equality and Health Inequalities Impact Assessment (EHIA): Treatment of iron overload for transfused and non-transfused patients with chronic inherited anaemias (all ages)
• WHO: 500M at risk without more physical activity (20 Oct. 2022)
• UK hospital study explores whether monkeypox can be transmitted through aerosolized droplets and fomites (20 Oct. 2022) | Related:
  • Gould S, Atkinson B, Onianwa O, et al.; NHS England Airborne High Consequence Infectious Diseases Network. Air and surface sampling for monkeypox virus in a UK hospital: an observational study. Lancet Microbe. 2022 Oct 7:S2666-5247(22)00257-9. Epub ahead of print. (Open access) | PubMed abstract
• Swansea University develops diagnostic tool to deliver quick health test results (20 Oct. 2022) | Related:
  • New diagnostic tool could deliver health test results in two minutes
  • Del Giudice F, Barnes C. Rapid temperature-dependent rheological measurements of non-Newtonian solutions using a machine-learning aided microfluidic rheometer. Anal Chem. 2022 Mar 1;94(8):3617-28. Epub 2022 Feb 15. (Free access) | PubMed abstract
• Industry news: MDIC and Horizon partner to improve accuracy of NGS-based cancer tests (20 Oct. 2022)
• Blood pressure disorder in pregnancy linked to heightened risk of death (20 Oct. 2022) | Related:
  • Huang C, Wei K, Lee PMY, et al. Maternal hypertensive disorder of pregnancy and mortality in offspring from birth to young adulthood: national population based cohort study. BMJ. 2022 Oct 19;379:e072157. (Open access) | PubMed abstract
• Industry news: Novartis signs world's first licensing deal for high-priced cancer drug (20 Oct. 2022)
• Industry news: Eltrombopag & azacitidine in high-risk myelodysplastic syndromes patients (20 Oct. 2022) | Related:
  • Sternberg A, Boucher R, Coulthard HC, et al. Phase Ib study of eltrombopag and azacitidine in patients with high-risk myelodysplastic syndromes and related disorders (the ELASTIC study). Br J Haematol. 2022 Oct;199(2):222-9.
• Ancient viral remnants in the human genome are active in normal tissues (19 Oct. 2022) | Related:
  • Burn A, Roy F, Freeman M, Coffin JM. Widespread expression of the ancient HERV-K (HML-2) provirus group in normal human tissues. PLoS Biol. 2022 Oct 18;20(10):e3001826. (Open access) | PubMed abstract
• Why do some people attract mosquitoes more than others? (19 Oct. 2022) | Related:
  • De Obaldia ME, Morita T, Dedmon LC, et al. Differential mosquito attraction to humans is associated with skin-derived carboxylic acid levels. Cell. 2022 Oct 17:S0092-8674(22)01253-3. Epub ahead of print. (Free full text) | PubMed abstract
• Low blood phosphate levels may be linked to neurological side effects from CAR T-cell therapy (19 Oct. 2022) | Related:
  • Tang JP, Peters CW, Quiros C, et al. Hypophosphatemiadue to increased effector cell metabolic activity Is associated with neurotoxicity symptoms in CD19-targeted CAR T-cell therapy. Cancer Immunol Res. 2022 Oct 19:OF1-OF8. Epub ahead of print. (Full text as a .pdf) | PubMed abstract
• New platform matches patients to precision oncology trials (19 Oct. 2022) | Related:
  • Klein H, Mazor T, Siegel E, et al. MatchMiner: an open-source platform for cancer precision medicine. NPJ Precis Oncol. 2022 Oct 6;6(1):69. (Open access) | PubMed abstract
• Hypoxic storage of red blood cells mitigates storage lesion (18 Oct. 2022) | Related:
  • Rabcuka J, Blonski S, Meli A, et al. Metabolic reprogramming under hypoxic storage preserves faster oxygen unloading from stored red blood cells. Blood Adv. 2022 Sep 27;6(18):5415-28. (Free full text) | PubMed abstract
• Among people with hemophilia, HCV prevention is working, but eradication remains elusive (17 Oct. 2022) | Related:
  • Spanoudaki A, Papadopoulos N, Trifylli EM, et al. Hepatitis C virus infections in patients with hemophilia: Links, risks and management. J Multidiscip Healthc. 2022 Oct 10;15:2301-09. (Free full text) | PubMed abstract
• Study shows school-aged children can successfully swab themselves for COVID-19 tests, but is this something that can help short-staffed medical laboratories? (17 Oct. 2022) | Related:
  • Waggoner JJ, Vos MB, Tyburski EA, et al. Concordance of SARS-CoV-2 results in self-collected nasal swabs vs swabs collected by health care workers in children and adolescents. JAMA. 2022 Sep 13;328(10):935-40. (Free full text) | PubMed abstract
• Hemostasis biomarkers & bleeding-related outcomes in cirrhosis children (17 Oct. 2022) | Related:
  • Jarasvaraparn C, Rusch C, Nadler M, et al. Characterization of biomarkers of hemostasis and bleeding-related outcomes in children with cirrhosis. J Pediatr Gastroenterol Nutr. 2022 Oct 1;75(4):506-13. Epub 2022 Jul 7.
• Review underscores potential and obstacles of universal CAR T-cell therapy (15 Oct. 2022) | Related:
  • Sun W, Jiang Z, Jiang W, Yang R. Universal chimeric antigen receptor T cell therapy - The future of cell therapy: A review providing clinical evidence. Cancer Treat Res Commun. 2022 Sep 22:100638. Epub ahead of print. (Open access) | PubMed abstract
• Manual cleaning of medical instruments exposes staff to contaminated fluids (14 Oct. 2022) | Related:
  • Ofstead CL, Hopkins KM, Daniels FE, et al. Splash generation and droplet dispersal in a well-designed, centralized high-level disinfection unit. Am J Infect Control. 2022 Sep 15:S0196-6553(22)00629-0. Epub ahead of print. (Open access) | PubMed abstract
• Applications, future directions of BTK inhibitors in blood cancers and autoimmune disorders (14 Oct. 2022) | Related:
  • Alu A, Lei H, Han X, et al. BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies. J Hematol Oncol. 2022 Oct 1;15(1):138. (Free full text) | PubMed abstract
• COVID-19 pandemic impacted blood supply in Africa: WHO (13 Oct. 2022) | Related:
  • WHO African region status report on blood availability, safety and quality (Brazzaville - 2022)
• WHO & ECDC say that Europe has entered another COVID wave (13 Oct. 2022)
• Lifetime of stress tied to big rise in cancer risk (13 Oct. 2022) | Related:
  • Moore JX, Andrzejak SE, Bevel MS, et al. Exploring racial disparities on the association between allostatic load and cancer mortality: A retrospective cohort analysis of NHANES, 1988 through 2019. SSM Popul Health. 2022 Jul 31;19:101185. (Open access) | PubMed abstract
• It's in the blood: Researchers discover new way to diagnose long-COVID (13 Oct. 2022) | Related:
  • Patel MA, Knauer MJ, Nicholson M, et al. Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol Med. 2022 Oct 10;28(1):122. (Open access) | PubMed abstract
• Pre-transplant nutritional risk index shows a lack of predictive accuracy in AML (13 Oct. 2022) | Related:
  • Orvain C, Byelykh M, Othus M, et al. Relationship between pre-transplant nutritional status and outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation. Transplant Cell Ther. 2022 Sep 27:S2666-6367(22)01658-X. Epub ahead of print.
• Canada: Doctors seeing resistance to blood transfusions over unfounded COVID vaccine concerns (13 Oct. 2022)
• WHO chief urges immediate action to tackle ‘devastating’ long Covid (12 Oct. 2022)
• Children with HIV at greater risk for impaired neurological development (12 Oct. 2022) Related:
  • Patil G, Mbewe EG, Kabundula PP, et al. Longitudinal cognitive outcomes in children with HIV in Zambia: 2-year outcomes from the HIV-associated neurocognitive disorders in Zambia (HANDZ) study. J Acquir Immune Defic Syndr. 2022 Oct 1;91(2):217-25.
• Worldwide monkeypox cases surpass 70,000, WHO says (12 Oct. 2022)
• Industry news: BeiGene heaps more pressure on AbbVie, J&J with new Brukinsa head-to-head win over Imbruvica (12 Oct. 2022)
• 63% of long covid patients are women, study says (11 Oct. 2022) | Related:
  • Global Burden of Disease Long COVID Collaborators, Wulf Hanson S, Abbafati C, et al. Estimated globalproportions ofindividuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022 Oct 10. Epub ahead of print. (Free full text) | PubMed abstract
• USA - AABB:
  • Mark T. Friedman, DO. How do I use clinical decision support for patient blood management? (October 2022)
  • Shaughn Nalezinski, MS, MLS(ASCP) SBB. How do I select evidence-based transfusion thresholds for platelets, plasma and cryoprecipitate? (July 2022)
• Risk of TA-TMA elevated in children with sickle cell disease (11 Oct. 2022) | Related:
  • Schoettler M, Stenger EO, Spencer K, et al. Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children. Blood Adv. 2022 Sep 8:bloodadvances.2022008058. Epub ahead of print.
• Nobel Prize in Physiology and Medicine awarded to Svante Pääbo (10 Oct. 2022) | Related:
  • Press release: The Nobel Prize in Physiology or Medicine 2022
  • Ancient DNA pioneer Svante Pääbo wins Nobel Prize in Physiology or Medicine (3 Oct. 2022)
• First patient with B-NHL or CLL treated with Mustang Bio's MB-106 in phase 1/2 study (10 Oct. 2022) | Related:
  • Study to assess safety, tolerability and efficacy of MB-106 in patients with relapsed or refractory B-cell NHL or CLL
• Study highlights sex differences in lymphoma incidence and mortality (10 Oct. 2022) | Related:
  • Radkiewicz C, Bruchfeld JB, Weibull CE, et al. Sex differences in lymphoma incidence and mortality by subtype: A population-based study. Am J Hematol. 2022 Sep 30. Epub ahead of print. (Open access) | PubMed abstract
• USA: Omicron BA.4.6 subvariant makes up nearly 14% of COVID variants in U.S. - CDC (9 Oct. 2022)
• Leukemia treatment breakthrough for babies (7 Oct. 2022) | Related:
  • Ragusa D, Cicirò Y, Federico C, et al. Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles. Oncogenesis. 2022 Sep 3;11(1):50. (Open access) | PubMed abstract
• Can you diagnose a bloodstream infection in 2.5 hours? (7 Oct. 2022) | Related:
  • Ganguli A, Lim J, Mostafa A, et al. A culture-free biphasic approach for sensitive and rapid detection of pathogens in dried whole-blood matrix. Proc Natl Acad Sci U S A. 2022 Oct 4;119(40):e2209607119. Epub 2022 Sep 26.
• Discovery broadens scope of use of CRISPR gene editing (7 Oct. 2022) | Related:
  • Huang C, Han Z, Evangelopoulos M, Mirkin CA. CRISPR spherical nucleic acids. J Am Chem Soc. 2022 Oct 6. Epub ahead of print.
• Red blood cell transfusions impact survival outcomes in endometrial cancer (7 Oct. 2022) | Related:
  • Anic K, Schmidt MW, Schmidt M, et al. Impact of perioperative red blood cell transfusion, anemia of cancer and global health status on the prognosis of elderly patients with endometrial and ovarian cancer. Front Oncol. 2022 Sep 16;12:967421. (Free full text) | PubMed abstract
• USA: ‘We just lost two years.’ How COVID-19 disrupted the fight against HIV (6 Oct. 2022) | Related:
  • Moitra E, Tao J, Olsen J, et al. Impact of the COVID-19 pandemic on HIV testing rates across four geographically diverse urban centres in the United States: An observational study. Lancet Reg Health Am. 2022 Mar;7:100159. Epub 2021 Dec 23. (Open access) | PubMed abstract
  • DiNenno EA, Delaney KP, Pitasi MA, et al. HIV testing before and during the COVID-19 pandemic - United States, 2019-2020. MMWR Morb Mortal Wkly Rep. 2022 Jun 24;71(25):820-4. (Free full text) | PubMed abstract
• Comparative study on retracted publications explores whether COVID-19-related research is subject to a higher degree of scrutiny (6 Oct. 2022) | Related:
  • Shi X, Abritis A, Patel RP, et al. Characteristics of retracted research articles about COVID-19 vs other topics. JAMA Netw Open. 2022 Oct 3;5(10):e2234585. (Free full text)
• USA: Call it data liberation day: Patients can now access all their health records digitally (6 Oct. 2022)
• Diagnosis of previously unsolved IHA cases: Next-generation sequencing (6 Oct. 2022) | Related:
  • Songdej D, Kadegasem P, Tangbubpha N, et al. Whole-exome sequencing uncovered genetic diagnosis of severe inherited haemolytic anaemia: Correlation with clinical phenotypes. Br J Haematol. 2022 Sep;198(6):1051-64. Epub 2022 Jul 12.
• Immune responses to SARS-CoV-2 mRNA vaccines vary among patients with hematologic malignancies (5 Oct. 2022) | Related:
  • Greenberger LM, Saltzman LA, Gruenbaum LM, et al. Anti-spike T cell and antibody responses to SARS-CoV-2 mRNA vaccines in patients with hematologic malignancies. Blood Cancer Discov. 2022 Sep 8:BCD-22-0077. (Free text as .pdf) | PubMed abstract
• Industry news: Lumen Bioscience data show needle free spirulina-produced vaccination protects against malaria (4 Oct. 2022) | Related:
  • Saveria T, Parthiban C, Seilie AM, et al. Needle-free, spirulina-produced Plasmodium falciparum circumsporozoite vaccination provides sterile protection against pre-erythrocytic malaria in mice. NPJ Vaccines. 2022 Oct 4;7(1):113. (Open access) | PubMed abstract
• DMT for sickle cell anemia started in childhood may prevent myocardial fibrosis (4 Oct. 2022)
• USA: FDA approves Theratechnologies trogarzo for 30-second IV push, simplifying HIV treatment for heavily treatment-experienced people (4 Oct. 2022)
• Industry news: Immucor and Pirche announce multi-year partnership (4 Oct. 2022 press release)
• 2-year nonrecurrence linked with improved long-term survival with haplo-SCT (3 Oct. 2022) | Related:
  • Saengboon S, Ramdial J, Saini N, et al. AML-528 long-term outcomes after haploidentical stem cell transplantation (haplo-SCT) for hematologic malignancies. Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S259-S260.
• Review: More research on treatment for extramedullary hematopoiesis in transfusion-dependent beta thalassemia is needed (1 Oct. 2022) | Related:
  • Subahi EA, Ata F, Choudry H, et al. Extramedullary haematopoiesis in patients with transfusion dependent -thalassaemia (TDT): a systematic review. Ann Med. 2022 Dec;54(1):764-74. (Open access) | PubMed abstract
• USA - AABB:
  • Mark T. Friedman, DO. How do I use clinical decision support for patient blood management? (October 2022)
  • Shaughn Nalezinski, MS, MLS(ASCP) SBB. How do I select evidence-based transfusion thresholds for platelets, plasma and cryoprecipitate? (July 2022)
• Ethics not only allow but demand placebo in some HIV cure trials (30 Sept. 2022) | Related:
  • Magalhaes M, Kuritzkes DR, Eyal N. The ethical case for placebo control in HIV-cure-related studies with ART interruption. J Virus Erad. 2022 Aug 28;8(3):100084. (Open access) | PubMed abstract
• Discovery of antibody that neutralizes all known variants of SARS-CoV-2 could lead to new vaccines and clinical laboratory treatments for COVID-19 (30 Sept. 2022) | Related:
  • Luo S, Zhang J, Kreutzberger AJB, et al. An antibody from single human V_H-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion. Sci Immunol. 2022 Aug 11:eadd5446. Epub ahead of print. (Free full text) | PubMed abstract
• USA: Disparities in multiple myeloma diagnosis and outcomes identified in Hispanic patients (30 Sept. 2022)
• Israeli nanotech may be able to reduce side-effects of chemotherapy, scientists say (30 Sept. 2022) | Related:
  • Harris Y, Sason H, Niezni D, Shamay Y. Automated discovery of nanomaterials via drug aggregation induced emission. Biomaterials. 2022 Oct;289:121800. Epub 2022 Sep 16.
• Allogeneic CAR T recognized for cutaneous T-cell lymphomas (29 Sept. 2022) | Related:
  • CRISPR Therapeutics announces FDA regenerative medicine advanced therapy (RMAT) designation granted to CTX130^TM for the treatment of cutaneous T-cell lymphomas (28 Sept. 2022)
• 'Breakthrough' infections after COVID vaccine can help prevent future illness (28 Sept. 2022) | Related:
  • Curlin ME, Bates TA, Guzman G, et al. Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection. medRxiv [Preprint]. 2022 Apr 12:2022.04.11.22273694. (Free full text) | PubMed abstract
• USA: A single dose of monkeypox vaccine provides some protection against infection, CDC says (28 Sept. 2022)
• Promising approach to mitigate complications of leukemia treatment (27 Sept. 2022) | Related:
  • Mo F, Watanabe N, Ingersoll Omdahl K, et al. Engineering T cells to suppress acute GvHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 2022 Aug 31:blood.2022016052. Epub ahead of print.
• Industry news: Sanofi and Scribe Therapeutics ink $1B CRISPR cell therapy deal (27 Sept. 2022)
• New stem cell transplant strategy appears promising for Fanconi anemia (27 Sept. 2022)
• Ferriprox safe, effective over long term at lowering patients’ iron load (27 Sept. 2022) | Related:
  • Elalfy MS, Hamdy M, El Beshlawy A, et al. Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years. Blood Adv. 2022 Aug 26:bloodadvances.2021006778. Epub ahead of print. (Free as a .pdf) | PubMed abstract
• Industry news: Daiichi Sankyo bags an industry first with Japanese nod for blood cancer drug Ezharmia (26 Sept. 2022)
• Octreotide improves control of anemia related to gastrointestinal angiodysplasia (26 Sept. 2022) | Related:
  • Goltstein LCMJ, Grooteman KV, Rocco A, et al. Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis. Lancet Gastroenterol Hepatol. 2021 Nov;6(11):922-32. Epub 2021 Sep 9.
• Industry news: BD, CerTest launch monkeypox diagnostic for lab research in U.S. (26 Sept. 2022)
• Industry news: Why this expert has a ‘positive long-term view’ on the CSL share price (26 Sept. 2022)
• Discovery of Er blood group system (24 Sept. 2022, University of Bristol press release)
• USA: What to know about the BA.4.6, BF.7 and BA.2.75 variants now growing nationwide (23 Sept. 2022)
• Integrating genetic testing in electronic health records saves time (22 Sept. 2022) | Related:
  • Lau-Min KS, McKenna D, Asher SB, et al. Impact of integrating genomic data into the electronic health record on genetics care delivery. Genet Med. 2022 Sep 15:S1098-3600(22)00900-5. Epub ahead of print.
• WHO warns ability to identify new Covid variants is diminishing as testing declines (22 Sept. 2022) | WHO is “deeply concerned” that it is evolving at a time when there is no longer robust testing in place to help rapidly identify new variants, Maria Van Kerkhove, WHO's Covid-19 technical lead said.
• Most long COVID patients recover within year, says study (22 Sept. 2022) | Related:
  • Son K, Jamil R, Chowdhury A, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms. Eur Respir J. 2022 Sep 22:2200970. Epub ahead of print.
• Stanford Medicine study: SARS-CoV-2 infects fat tissue, creates inflammatory storm cloud (22 Sept. 2022) | Related:
  • Martínez-Colón GJ, Ratnasiri K, Chen H, et al. SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages. Sci Transl Med. 2022 Sep 22:eabm9151. Epub ahead of print. (Free full text) | PubMed abstract
• New studies show telemedicine Is effective, doesn’t reduce access to care (22 Sept. 2022) | Related:
  • Busting three myths about the impact of telemedicine parity. NEJM Catalyst 2022 Oct;3(10). Epub 21 Sept. 2022 | Article preview
• The predictive power of blood: Metabolomic profiling reveals risk of multiple diseases all at once (22 Sept. 2022) | Related:
  • Buergel T, Steinfeldt J, Ruyoga G, et al. Metabolomic profiles predict individual multidisease outcomes. Nat Med. 2022 Sep 22. Epub ahead of print. (Open access) | PubMed abstract
• Industry news: CARsgen Therapeutics' Zevor-cel elicits 100% ORR in heavily pretreated relapsed/refractory myeloma (22 Sept. 2022) ORR = 'objective response rate' | Related:
  • CARsgen presents North America phase 2 updates for zevor-cel BCMA CAR T at the 7th Annual CAR-TCR Summit (21 Sept. 2022) | BCMA = B.C. Muslim Association
• Most global deaths are from preventable noncommunicable diseases (21 Sept. 2022)
• HIV, hepatitis C combination boosts heart attack risk as people age (21 Sept. 2022) | Related:
  • Lang R, Humes E, Hogan B, et al. Evaluating the cardiovascular risk in an aging population of people with HIV: The impact of hepatitis C virus coinfection. J Am Heart Assoc. 2022 Sep 21:e026473. Epub ahead of print. (Open access) | PubMed abstract
• Industry news: Virax Biolabs introduces monkeypox antigen rapid test kit (20 Sept. 2022)
• No difference in patient outcomes following pathogen-reduced platelet, low-yield pr platelet transfusion (20 Sept. 2022) | Related:
  • Tang MS, Shu E, Sussman H, et al. Transfusion outcomes between regular and low yield pathogen reduced platelets across different patient populations in a single institution. Transfusion. 2022 Aug 4. Epub ahead of print.
• Industry news: Bioreactor platform launched by Terumo BCT to support process development for cell and gene therapy (20 Sept. 2022)
• Lasting lung damage seen in children and teens after COVID (20 Sept. 2022) | Related:
  • Heiss R, Tan L, Schmidt S, et al. Pulmonary dysfunction after pediatric COVID-19. Radiology. 2022 Sep 20:221250. Epub ahead of print. (Free access) | PubMed abstract
• Canada: Health Coalitions denounce for-profit deal by Canadian Blood Services that endangers Canada's blood supply (20 Sept. 2022)
• Industry news: BeiGene keeps its Brukinsa momentum going by winning NICE nod for rare lymphoma (20 Sept. 2022)
• Blood clot risk remains elevated nearly a year after COVID-19 (19 Sept. 2022)
• New NCCN patient guidelines for marginal zone lymphoma helps patients, caregivers understand rare form of blood cancer (19 Sept. 2022) | Related:
  • NCCN’s new patient guidelines for marginal zone lymphoma helps patients and caregivers better understand a rare form of blood cancer (12 Sept. 2022)
• Results from promising new therapy shows it may drive lupus into remission (19 Sept. 2022) | Related:
  • Mackensen A, Müller F, Mougiakakos D, et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat Med. 2022 Sep 15. Epub ahead of print.
• YouGov survey shows global health systems ‘unfit to cope’ with another pandemic (16 Sept. 2022) | YouGov
• First it was health monitoring devices on wrists, now it’s health monitoring on fingers (16 Sept. 2022)
• Canada: Ontario and B.C. decline to endorse Canadian Blood Services’ view that private firm can circumvent collection ban (16 Sept. 2022)
• Industry news: Astrazeneca pulls ahead in haemoglobinuria (16 Sept. 2022) | Related:
  • Danicopan (ALXN2040) add-on to Ultomiris or Soliris met primary endpoint in ALPHA Phase III trial for patients with paroxysmal nocturnal haemoglobinuria who experience clinically significant extravascular haemolysis (16 Sept. 2022)
• USA: Pet medicine is looking a lot more like human medicine — down to the need for doggie blood donors (16 Sept. 2022)
• Industry news: Pfizer's Xalkori gets EMA panel nod for expanded use in blood cancer subtypes (15 Sept. 2022)
• USA: Cutaneous T-cell lymphoma incidence on the rise in the United States (15 Sept. 2022) | Related:
  • Cai ZR, Chen ML, Weinstock MA, et al. Incidence trends of primary cutaneous T-cell lymphoma in the US From 2000 to 2018: A SEER population data analysis. JAMA Oncol. 2022 Sep 1:e223236. Epub ahead of print. (Free full text) | PubMed abstract
• WHO announces new global fund for pandemic prevention and preparedness (14 Sept. 2022) | Over $1.4bn in financial commitments have already been announced and more are expected in the coming months
• Artificial embryo heart system grows blood stem cells on demand (14 Sept. 2022) | Related:
  • Li J, Lao O, Bruveris FF, et al. Mimicry of embryonic circulation enhances the hoxa hemogenic niche and human blood development. Cell Rep. 2022 Sep 13;40(11):111339. (Open access) | PubMed abstract
• AABB is announces the recipients of its 2022 Awards (14 Sept. 2022)
• Researchers discover compound that could treat Chagas disease (14 Sept. 2022) | Related:
  • Padilla AM, Wang W, Akama T, et al. Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates. Nat Microbiol. 2022 Sep 5. Epub ahead of print. (Open access) | PubMed abstract
• At least 17 million people in the WHO European Region experienced long COVID in the first two years of the pandemic; millions may have to live with it for years to come (13 Sept. 2022) | WHO/Europe urges countries to take post COVID-19 condition seriously by urgently investing in research, recovery, and rehabilitation
• Astatine-211 targets blood-borne cancers in Seattle clinical trials (13 Sept. 2022) | Related:
  • Exploring a new cancer treatment option in radioactive isotope astatine-211 (22 Aug. 2022)
• HSCT normalizes brain hemodynamics in children with sickle cell disease (12 Sept. 2022)
• Translational research unlocks new understanding of causes of acute kidney injury (12 Sept. 2022) | Related:
  • Vourc'h M, Roquilly A, Foucher A, et al. Transfusion-related renal dysfunction after cardiac surgery: The role of myeloid-related protein_14 in neutrophil-mediated tubular damage. JACC Basic Transl Sci. 2022 Jun 1;7(7):627-38. (Free full text) | PubMed abstract
  • Gupta R. Red blood cell transfusion and cardiac surgery-associated acute kidney injury. (Editorial) JACC Basic Transl Sci. 2022 Jul 25;7(7):639-41. (Free full text)
• Go slow before switching HIV meds due to metabolic effects (9 Sept. 2022) | Related:
  • O'Halloran JA, Sahrmann J, Parra-Rodriguez L, et al. Integrase strand transfer inhibitors are associated with incident diabetes mellitus in people with HIV. Clin Infect Dis. 2022 May 6:ciac355. Epub ahead of print.
• Standards update: AABB issues interim standards to the 33rd edition of Standards for Blood Banks and Transfusion Services (9 Sept. 2022)
• Enjaymo reduces anemia, fatigue in phase 3 CADENZA trial (9 Sept. 2022) | Related:
  • Röth A, Berentsen S, Barcellini W, et al. Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial. Blood. 2022 Sep 1;140(9):980-91. (Free full text) | PubMed abstract
• What makes faecal microbiota for transplant so ground-breaking? (9 Sept. 2022) | Related:
  • Gebrayel P, Nicco C, Al Khodor S, et al. Microbiota medicine: towards clinical revolution. J Transl Med. 2022 Mar 7;20(1):111. (Open access) | PubMed abstract
• A key to long Covid is virus lingering in the body, scientists say (8 Sept. 2022) | Related:
  • Swank Z, Senussi Y, Manickas-Hill Z, et al. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin Infect Dis. 2022 Sep 2:ciac722. Epub ahead of print. (Free full text: available as .pdf) | PubMed abstract
• How a key brain network responds to seasonal shifts in day length (8 Sept. 2022) | Related:
  • Porcu A, Nilsson A, Booreddy S, et al. Seasonal changes in day length induce multisynaptic neurotransmitter switching to regulate hypothalamic network activity and behavior. Sci Adv. 2022 Sep 2;8(35):eabn9867. Epub 2022 Sep 2. (Free full text) | PubMed abstract
• SARS-CoV-2 RNA from pre-symptomatic donor plasma not infectious in models (7 Sept. 2022) | Related:
  • Saá P, Fink RV, Bakkour S, et al.; NHLBI Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P). Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma. J Clin Invest. 2022 Sep 1;132(17):e159876. (Open access) | PubMed abstract
• Plasma viral antigen linked to baseline severity of COVID-19 (7 Sept. 2022) | Related:
  • ACTIV-3/TICO Study Group. The association of baseline plasma SARS-CoV-2 nucleocapsid antigen level and outcomes in patients hospitalized with COVID-19. Ann Intern Med. 2022 Aug 30:M22-0924. Epub ahead of print. (Free full text) | PubMed abstract
• Transition to hemlibra safe, effective in children with hemophilia A (7 Sept. 2022) | Related:
  • Glonnegger H, Andresen F, Kapp F, et al. Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab. BMC Pediatr. 2022 Aug 15;22(1):487. (Open access) | PubMed abstract
• USA: First U.S. patient receives autologous stem cell therapy to treat macular degeneration (7 Sept. 2022) | Related:
  • Autologous transplantation of induced pluripotent stem cell-derived retinal pigment epithelium for geographic atrophy associated with age-related macular degeneration
• Canada: McMaster researchers discover unusual bacteria-killing toxin (6 Sept. 2022) | Related:
  • Bullen NP, Sychantha D, Thang SS, et al. An ADP-ribosyltransferase toxin kills bacterial cells by modifying structured non-coding RNAs. Mol Cell. 2022 Aug 31:S1097-2765(22)00804-8. Epub ahead of print.
• Canada: Health Canada authorizes Héma-Québec submission to move to sexual behaviour-based screening criteria for all blood donors (6 Sept. 2022) | Related:
  • Starting Dec. 4 - All types of blood donation will be more inclusive (Héma-Québec press release, 6 Sept. 2022)
• Cell therapy could improve bone marrow transplant safety (6 Sept. 2022) | Related:
  • Li YR, Zeng S, Dunn ZS, et al. Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers. iScience. 2022 Aug 6;25(9):104859. (Open access) | PubMed abstract
• Industry news: First patient with peripheral T cell lymphoma dosed with Yingli Pharma’s linperlisib (5 Sept. 2022)
• Blood type may have a role in the risk of having a stroke before age 60 (2 Sept. 2022) | Related:
  • UM School of Medicine researchers find blood type linked to risk of stroke before age 60 (31 Aug. 2022, Press release, University of Maryland)
• Majority of underrepresented early career scientists experience mental distress (2 Sept. 2022) | Related:
  • Gretchen E White GE, Proulx CN, Rubio DM, et al. The impact of social unrest due to systemic racism on underrepresented post-doctoral fellows and early-career faculty. J Clin Transl Sci.2022. (Preproof available as free .pdf)
• 2 warming techniques useful when transfusing CAD blood: study (2 Sept. 2022) | Related:
  • Krull A, Thompson T, Strasburg D, et al. How do I warm HPC(A) products to maximize cell viability in the setting of cold agglutinin disease? Transfusion. 2022 Aug 10. Epub ahead of print.
• Long-term multicenter study underscores role of 1L cladribine in hairy cell leukemia (2 Sept. 2022) | Related:
  • Broccoli A, Argnani L, Cross M, et al. A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia. Blood Adv. 2022 Jul 26;6(14):4224-7. (Free full text) | PubMed abstract
• Industry news: Novo Nordisk ponies up $1.1B for Forma in effort to shape up sickle cell disease market (1 Sept. 2022)
• NfL IDs patients predisposed to neurotoxic complications (1 Sept. 2022) | Related:
  • Butt OH, Zhou AY, Caimi PF, et al. Assessment of pretreatment and posttreatment evolution of neurofilament light chain levels in patients who develop immune effector cell-associated neurotoxicity syndrome. JAMA Oncol. 2022 Sep 1. Epub ahead of print. (Free full text) | PubMed abstract
• USA: Treatment in the COVID era (31 Aug. 2022)
• A breakthrough for fast, efficient production of human immune cells (31 Aug. 2021) | Related:
  • Michaels YS, Edgar JM, Major MC, et al. DLL4 and VCAM1 enhance the emergence of T cell-competent hematopoietic progenitors from human pluripotent stem cells. Sci Adv. 2022 Aug 26;8(34):eabn5522. Epub 2022 Aug 24. (Free full text) | PubMed abstract
• Combined blockade of C3 and C5 may reduce breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria (31 Aug. 2022)
• My son needed a blood transfusion, but a miracle happened (31 Aug. 2022, Sickle Cell Disease News item)
• Invigorating T cells by crippling a gene to improve immunotherapies for blood and solid cancers (29 Aug. 2022) | Related:
  • Carnevale J, Shifrut E, Kale N, et al. RASA2 ablation in T cells boosts antigen sensitivity and long-term function. Nature. 2022 Aug 24. Epub ahead of print. (Open access) | PubMed abstract
• Industry news: Genomadix, Mayo Clinic collaborate on point-of-care PCR (29 Aug. 2022)
• Swedish researchers developing new treatment for chronic hepatitis B and D infections (26 Aug. 2022) | Related:
  • Burm R, Maravelia P, Ahlen G, et al. Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections. Gut. 2022 Aug 17:gutjnl-2022-327216. Epub ahead of print.
• Canada (CBS): Better support for families of organ donors – 20 suggestions for improvement (Blog, 23 Aug. 2022) | Related:
  • Pryzdial ELG, Leatherdale A, Conway EM. Coagulation and complement: Key innate defense participants in a seamless web. Front Immunol. 2022 Aug 9;13:918775. (Free full text) | PubMed abstract
• Industry news: Moderna suing Pfizer, BioNTech for patent infringement in development of COVID-19 vaccine (26 Aug. 2022)
• Looking at the CAR-T therapy landscape (26 Aug. 2022) | Related:
  • Sun Y, Hendrix A, Muluneh B, Ozawa S. Online pharmacy accessibility of imatinib, an oral chemotherapy medication. J Natl Compr Canc Netw. 2022 Jul;20(7):808-14. (Free full text) | PubMed abstract
• Industry news: FibroGen announces completion of patient enrollment in MATTERHORN, a phase 3 clinical study of roxadustat for the treatment of anemia in patients with lower risk transfusion-dependent myelodysplastic syndromes (26 Aug.2022)
• Industry news: BioMarin Pharma's Roctavian okay sets up another gene therapy test for Europe (26 Aug. 2022)
• Many types of leisure time activities may lower risk of death for older adults (25 Aug. 2022) | Related:
  • Watts EL, Matthews CE, Freeman JR, et al. Association of leisure time physical activity types and risks of all-cause, cardiovascular, and cancer mortality among older adults. JAMA Netw Open. 2022 Aug 1;5(8):e2228510. (Free full text) | PubMed abstract
• New class of drug could treat leukemia with fewer side effects (25 Aug. 2022) | Related:
  • Sandoval JE, Ramabadran R, Stillson N, et al. First-in-class allosteric inhibitors of DNMT3A disrupt protein-protein interactions and induce acute myeloid leukemia cell differentiation. J Med Chem. 2022 Aug 11;65(15):10554-66.
• Industry news: Canada's Liminal BioSciences announces termination of legacy CDMO contract (25 Aug. 2022) | Termination results in anticipated cash savings of $33.1 million
• What are the effects of non-nutritive sweeteners on the human gut microbiome? (24 Aug. 2022) | Related:
  • Suez J, Cohen Y, Valdés-Mas R, et al. Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell. 2022 Aug 17:S0092-8674(22)00919-9. Epub ahead of print. (Free full text) | PubMed abstract
• Industry news: Quotient Limited expands MosaiQ Innovator’s Circle to empower patient care and laboratory efficiencies (24 Aug. 2022)
• Industry news: Roche introduces Digital LightCycler System for disease detection (24 Aug. 2022)
• Industry news: Blood plasma derivatives market to garner US$ 59.8 billion, globally by 2027 at 6.40% CAGR: IMARC Group (23 Aug. 2022)
• Proximity to fracking sites may be associated with risk of pediatric leukemia (23 Aug. 2022) | Related:
  • Clark CJ, Johnson NP, Soriano M Jr, et al. Unconventional oil and gas development exposure and risk of childhood acute lymphoblastic leukemia: A case-control study in Pennsylvania, 2009-2017. Environ Health Perspect. 2022 Aug;130(8):87001. Epub 2022 Aug 17. (Free full text) | PubMed abstract
• Canada: Canadian Blood Services on the verge of privatizing plasma collection (CUPE, 23 Aug. 2022)
• Pre-cholecystectomy transfusion may be helpful in patients with sickle cell disease (23 Aug. 2022) | Related:
  • Rambaud E, Ranque B, Tsiakyroudi S, et al. Risks and benefits of prophylactic transfusion before cholecystectomy in sickle cell disease. J Clin Med. 2022 Jul 9;11(14):3986. (Open access) | PubMed abstract
• Canada: Kamloops, Kelowna air ambulance paramedics now equipped for life-saving transfusions (23 Aug. 2022)
• Industry news: Gilead Sciences’ long-acting HIV drug gets European Commission approval (22 Aug. 2022)
• Industry news: Relma-cel demonstrates durable activity in relapsed/refractory LBCL (22 Aug. 2022) | Related:
  • Ying Z, Yang H, Guo Y, et al. Relmacabtagene autoleucel (relma-cel) CD19 CAR-T therapy for adults with heavily pretreated relapsed/refractory large B-cell lymphoma in China. Cancer Med. 2021 Feb;10(3):999-1011. Epub 2020 Dec 31. (Open access) | PubMed abstract
• Canada: Canadian Blood Services looking at all options as donations continue to drop (21 Aug. 2022)
• WHO makes new recommendations for Ebola treatments, calls for improved access (19 Aug. 2022)
• Researchers discover SARS-CoV-2 makes us fat so it can invade our cells (19 Aug. 2022) | Related:
  • Farley SE, Kyle JE, Leier HC, et al. A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants. Nat Commun. 2022 Jun 17;13(1):3487. (Open access) | PubMed abstract
• Industry news: GSK awarded first-ever UNICEF contract for malaria vaccine in deal worth £170m (19 Aug. 2022)
• No one-size-fits-all artificial intelligence approach works (19 Aug. 2022) | Related:
  • Vadapalli S, Abdelhalim H, Zeeshan S, Ahmed Z. Artificial intelligence and machine learning approaches using gene expression and variant data for personalized medicine. Brief Bioinform. 2022 May 21:bbac191. Epub ahead of print.
• Investigators identify independent predictors of early mortality in newly diagnosed multiple myeloma (19 Aug. 2022) | Related:
  • McQuilten Z, Wellard C, Moore E, et al; Australian and New Zealand Myeloma and Related Diseases Registry. Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR). Br J Haematol. 2022 Sep;198(5):830-7. Epub 2022 Jul 11. (Open access) | PubMed abstract
• USA: $2.8m gene therapy treatment is America's most expensive drug ever (18 Aug. 2022) | Also see USA below
• Monkeypox cases jumped 20% in the last week to 35,000 across 92 countries, WHO says (17 Aug. 2022)
• Chinese scientists develop new ‘controllable and reversible’ gene-editing technique (17 Aug. 2022) | Related:
  • Tong H, Huang J, Xiao Q, et al. High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects. Nat Biotechnol. 2022 Aug 11. Epub ahead of print.
• T-cell-refreshing molecule could be key to preventing immune exhaustion (17 Aug. 2022) | Related:
  • Tsui C, Kretschmer L, Rapelius S, et al. MYB orchestrates T cell exhaustion and response to checkpoint inhibition. Nature (2022). Epub 17 Aug. 2022 (Open access)
• Industry news: Sanofi, Atomwise ink potential $1B+ R&D deal (17 Aug. 2022)
• Canada: Editorial: Keep blood donations voluntary (17 Aug. 2022)
• Industry news: CSL flags higher costs after FY profit dip (17 Aug. 2022)
• USA: Why fewer newborns will need jaundice treatment under new AAP guidelines (15 Aug. 2022) | Related:
  • American Academy of Pediatrics revises clinical guidelines for preventing, treating, and monitoring hyperbilirubinemia in newborns (5 Aug. 2022, news release)
  • Kemper AR, Newman TB, Slaughter JL, et al. Clinical practice guideline revision: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2022 Aug 5:e2022058859. Epub ahead of print. (Free full text)
• Industry news: Qiagen launches test to differentiate between monkeypox, other pathogens (15 Aug. 2022)
• Industry news: Roche launches COVID-19 test Elecsys (15 Aug. 2022)
• WHO plans to rename monkeypox over stigmatization concerns (12 Aug. 2022)
• Burned out in an understaffed lab? This survey says you’re not alone (12 Aug. 2022)
• Canada: Canadian wastewater surveillance expanding to new public health threats: Tam (12 Aug. 2022)
• Industry news: Two deaths after Novartis' Zolgensma put gene therapy’s liver safety in the spotlight once again (12 Aug. 2022)
• Canada: Canada not shifting to stretch supply of monkeypox vaccine yet (12 Aug. 2022)
• Canada: Private companies could help add to plasma supply, says Canadian Blood Services (11 Aug. 2022) | Related:
  • The sound of silence (More musings on paid plasma pros & cons)
• Industry news: Stem cell therapy to be used in treatment of long COVID by Panacell Biotech (10 Aug. 2022)
• Industry news: EU regulator begins review of Pfizer-BioNTech's variant-adapted Covid shot (9 Aug. 2022)
• Industry news: Epigenic Therapeutics raises $20M for gene editing technology (8 Aug. 2022)
• Mystery cells that create blood stem cells in mammals identified (8 Aug. 2022) | Related:
  • Chandrakanthan V, Rorimpandey P, Zanini F, et al. Mesoderm-derived PDGFRA ⁺ cells regulate the emergence of hematopoietic stem cells in the dorsal aorta. Nat Cell Biol. 2022 Aug;24(8):1211-25. Epub 2022 Jul 28. (Open access) | PubMed abstract
• Long-lasting HIV prevention drug could be game changer — but who will pay? (5 Aug. 2022) | Related:
  • Delany-Moretlwe S, Hughes JP, Bock P, et al.; HPTN 084 study group. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet. 2022 May 7;399(10337):1779-89. Epub 2022 Apr 1. Erratum in: Lancet. 2022 May 7;399(10337):1778. (Open access) | PubMed abstract
• American Academy of Pediatrics revises clinical guidelines for preventing, treating, and monitoring hyperbilirubinemia in newborns (5 Aug. 2022)
• Transfusing blood from an old mouse to a younger mouse causes ageing (5 Aug. 2022) | Related:
  • Jeon OH, Mehdipour M, Gil TH, et al. Systemic induction of senescence in young mice after single heterochronic blood exchange. Nat Metab. 2022 Jul 28. Epub ahead of print. (Free full text) | PubMed abstract
• Hospital facility blends capabilities (4 Aug. 2022) | Royal Australian Navy medical officer Commander Peter Smith: “We exercised our blood transfusion protocols to deliver large amounts of blood product to patients quickly, as well as demonstrating an ability to provide ongoing intensive care."
• Omicron better at invading young noses than other variants; smell loss may predict memory issues (2 Aug. 2022) | Related:
  • Zhu Y, Chew KY, Wu M, et al. Ancestral SARS-CoV-2, but not omicron, replicates less efficiently in primary pediatric nasal epithelial cells. PLoS Biol 2022 Aug1; 20(8): e3001728. (Open access)
• Global monkeypox vaccine race sparks fears that poorer nations will lose out (1 Aug. 2022)
• Baby boomer? You're at higher risk for hepatitis C (30 July 2022)
• Long COVID symptoms may include hair loss and sexual dysfunction, study shows (29 July 2022) | Related:
  • Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022 Jul 25. Epub ahead of print. (Open access) | PubMed abstract
• New smartphone clip-on can detect Zika virus in blood samples (29 July 2022) | Related:
  • Jankelow AM, Lee H, Wang W, Hoang TH, et al. Smartphone clip-on instrument and microfluidic processor for rapid sample-to-answer detection of Zika virus in whole blood using spatial RT-LAMP. Analyst. 2022 Jun 21. Epub ahead of print.
• Industry news: Belarusian-Dutch Pharmland produces plasma-based medications (29 July 2022)
• Early use of novel therapies in multiple myeloma could target bone marrow microenvironment (28 July 2022) | Related:
  • Neumeister P, Schulz E, Pansy K, et al. Targeting the microenvironment for treating multiple myeloma. Int J Mol Sci. 2022 Jul 10;23(14):7627. (Open access) | PubMed abstract
• Creating a microrobot to one day tackle cancer (27 July 2022) | Related:
  • Akolpoglu MB, Alapan Y, Dogan NO, et al. Magnetically steerable bacterial microrobots moving in 3D biological matrices for stimuli-responsive cargo delivery. Sci Adv. 2022 Jul 15;8(28):eabo6163. Epub 2022 Jul 15. (Full free text) | PubMed abstract
• Canada: CHEO helping conserve Canada’s national blood supply (27 July 2022) | CHEO has been awarded the Using Blood Wisely designation by Choosing Wisely Canada, a national campaign aimed at reducing the inappropriate use of red blood cells.
• 3D imaging reveals picture of T-cell activity to unlock solid tumor opportunity (26 July 2022) | Related:
  • Dekkers JF, Alieva M, Cleven A, et al. Uncovering the mode of action of engineered T cells in patient cancer organoids. Nat Biotechnol. 2022 Jul 25.Epub ahead of print. (Open access) | PubMed abstract
• Monkeypox outbreak spreading: WHO declares global health emergency (25 July 2022)
• Cardiovascular disease, not cancer, top cause of death among Hodgkin lymphoma survivors (25 July 2022) | Related:
  • Lu Z, Teng Y, Ning X, Wang H, et al. Long-term risk of cardiovascular disease mortality among classic Hodgkin lymphoma survivors. Cancer. 2022 Jul 25. Epub ahead of print. (Full access) | PubMed abstract
• Study supports capsaicin as potential pain treatment for patients with SCD (25 July 2022) | Related:
  • Glaros AK, Callaghan MU, Smith WR, et al. Targeting TRPV1 activity via high-dose capsaicin in patients with sickle cell disease. Epub 19 July 2022. (Open access)
• International study identifies risks for long COVID in children (22 July 2022) | Related:
  • Funk AL, Kuppermann N, Florin TA, et al. Post–COVID-19 conditions among children 90 days after SARS-CoV-2 infection. JAMANetwOpen. 2022; 5(7):e2223253. (Open access)
• Industry news: Consortium awarded €4M towards platform for personalized cell therapies (22 July 2022)
• WHO moves to roll out first malaria vaccine in Africa (21 July 2022)
• How to select the best combination of antibodies to treat HIV (21 July 2022) | Related:
  • LaMont C, Otwinowski J, Vanshylla K, et al. Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1. Elife. 2022 Jul 19;11:e76004. Epub ahead of print.
• Why Staph vaccines don’t work in humans (21 July 2022) | Related:
  • Tsai CM, Caldera JR, Hajam IA, et al. Non-protective immune imprint underlies failure of Staphylococcus aureus IsdB vaccine. Cell Host Microbe. 2022 Jun 30:S1931-3128(22)00311-0. Epub ahead of print. (Open acess) | PubMed abstract
• Many people with debilitating blood disorder hemophilia B may be cured within 3 years by new gene therapy, doctor said (21 July 2022) | Related:
  • Chowdary P, Shapiro S, Makris M, et al. Phase 1-2 trial of AAVS3 gene therapy in patients with hemophilia B. N Engl J Med. 2022 Jul 21;387(3):237-47.
• Psychological models may aid in improving ICT adherence in beta-thalassemia (20 July 2022) | Related:
  • Eziefula C, Shah FT, Anie KA. Promoting adherence to iron chelation treatment in beta-thalassemia patients. Patient Prefer Adherence. 2022 Jun 7;16:1423-37. (Free full text) | PubMed abstract
• Whole blood exchange being studied as a potential treatment for Alzheimer's disease (19 July 2022) | Related:
  • Urayama A, Moreno-Gonzalez I, Morales-Scheihing D, et al. Preventive and therapeutic reduction of amyloid deposition and behavioral impairments in a model of Alzheimer's disease by whole blood exchange. Mol Psychiatry. 2022 Jul 15. Epub ahead of print.
• High blood viscosity may predict mortality in COVID-19 hospitalization (18 July 2022)
• A new antibiotic can kill even drug-resistant bacteria (17 July 2022) | Related:
  • Wang Z, Koirala B, Hernandez Y, et al. Bioinformatic prospecting and synthesis of a bifunctional lipopeptide antibiotic that evades resistance. Science. 2022 May 27;376(6596):991-6. Epub 2022 May 26.
• Industry news: Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus (17 July 2022)
• Industry news: Animal blood plasma products and derivatives market size, top key players, types, applications & regional forecasts to 2030 (17 July 2022)
• USA: Walmart’s health and wellness chief discusses retail giant’s move to healthcare/telehealth provider, a step with implications for clinical laboratory testing (15 July 2022)
• New EU rules on blood, tissue, cells to be adapted to evolving science (15 July 2022)
• Industry news: Concizumab reduces treated bleeds in hemophilia A or B with inhibitors (15 July 2022)
• EU seeks to upgrade safety rules for blood, tissue, cell donations (14 July 2022)
• Blood test could predict future risk of leukaemia (14 July 2022) | Related:
  • Robertson NA, Latorre-Crespo E, Terradas-Terradas M, et al. Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects. Nat Med. 2022 Jul 4. Epub ahead of print. (Open access) | PubMed abstract
• Industry news: Pharma companies sue for the right to buy blood from Mexicans along border (14 July 2022)
• Canada: Telo Genomics launches clinical study of drug resistance test for multiple myeloma (14 July 2022)
• Industry news: GenScript and ACT partner to develop new CAR-T cell therapies (13 July 2022)
• Long COVID patients are seeking experimental 'blood washing' treatment abroad, investigation finds (12 July 2022)
• Industry news: Siga gets $28 mln antiviral drug orders as monkeypox spreads (12 July 2022)
• Secrecy: A demon of gene therapy’s past bedevils its future (11 July 2022)
• Is BA.5 the ‘Reinfection Wave’? (11 July 2022)
• Patients with blood cancers show immune response to COVID-19 vaccine boosters (11 July 2022)
• SNUH team finds a key cell that keeps top hematopoietic stem cells young (11 July 2022)
• Sickle cell disease could be treated with common plant, study finds (10 July 2022) | Related:
  • Adeniyi O, Baptista R, Bhowmick S, et al. Isolation and characterisation of quercitrin as a potent anti-sickle cell anaemia agent from Alchornea cordifolia. J Clin Med. 2022 Apr 13;11(8):2177. (Free full text) | PubMed abstract
• New paper examines transfusion utilization and appropriateness (8 July 2022) | Related:
  • Dawson J, Schwabl C, Pronovost P, et al. Transfusion utilization and appropriateness: Thinking differently at a tertiary academic medical center. Physician Leadersh J. 2022 July;9(4):18-23. (Abstract)
• An aggressive leukemia is much more lethal for black patients than whites - Why? (7 July 2022) | Related:
  • Larkin K, Nicolet D, Kelly BJ, et al. High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML. Blood Adv. 2022 Jul 5:bloodadvances.2022007544. Epub ahead of print. (Free full text) | PubMed abstract
• What health care supplies might we run out of next? (6 July 2022)
• Scientists uncover HIV’s sweet spot (5 July 2022) | Related:
  • Ma T, McGregor M, Giron L, et al. Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIV. Elife. 2022 Jul 5;11:e78870. (Free full text) | PubMed abstract
• Study shows HIV speeds up body’s aging processes soon after infection (30 June 2022) | Related:
  • Breen EC, Sehl ME, Shih R, et al. Accelerated aging with HIV begins at the time of initial HIV infection iScience 2022; 25(7):104488. eCollection 2022 Jul 15. (Open access)
• Canada: Héma-Québec needs more Black people to donate blood (30 June 2022)
• UK: Doctors treat first UK patient in Covid ‘super donor’ blood trial (30 June 2022) | Reopened trial to look at whether plasma with high levels of antibodies can help save lives of immunosuppressed
• Scientists prevent 'exhaustion' in cancer-fighting T cells (28 June 2022) | Related:
  • Belk JA, Yao W, Ly N, et al. Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence. Cancer Cell. 2022 Jun 17:S1535-6108(22)00231-8. Epub ahead of print.
• Factors associated with blood transfusion during hysterectomy are identified (28 June 2022) | Related:
  • Elfazari T, Nayak AL, Mallick R, et al. Surgical indication and approach are associated with transfusion in hysterectomy for benign disease. JSLS. 2022 Apr-Jun;26(2):e2022.00013. (Free full text) | PubMed abstract
• Case study: Improving outcomes after trauma and blood loss (28 June 2022)
• Related:
  • Brohi K, Eaglestone S. Traumatic coagulopathy and massive transfusion: improving outcomes and saving blood. Southampton (UK): NIHR Journals Library; 2017 Nov. (Free books & documents) | PubMed abstract
• Canada: 4-year-old Montreal girl desperately needs life-saving stem cell donation (28 June 2022) | 'Preparing for the worst, hoping for the best': Mother hopes Asian, mixed race donors step up.
• WHO: Monkeypox outbreak 'unusual' and worrying but not yet global emergency (27 June 2022)
• Diseases in the news: Chronic hepatitis B infections decreasing in recent years (24 June 2022) | Related:
  • GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022 Jun 20:S2468-1253(22)00124-8. Epub ahead of print. (Open access) | PubMed abstract
• Industry news: BioMarin's hemophilia gene therapy Roctavian wins conditional EU backing amid FDA delay (24 June 2022) | Related:
  • European Medicines Agency: First gene therapy to treat severe haemophilia A (24 June 2022)
• Industry news: Enjaymo led to hemoglobin gains, less need for blood transfusions (24 June 2022) | Related:
  • Gelbenegger G, Jaeger U, Fillitz M, et al. Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial. Br J Haematol. 2022 Jun 2. Epub ahead of print. (Free access)
• WHO considers declaring monkeypox a global health emergency (23 June 2022) | Experts question whether decision will exacerbate inequities between rich and poor countries;"It is a bit curious that WHO only called their experts when the disease showed up in white countries."
• Inhibitor harms leukemic stem cells while boosting normal ones (23 June 2022) | Related:
  • Grey W, Rio-Machin A, Casado P, et al. CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia. Sci Transl Med. 2022 Jun 22;14(650):eabn3248. Epub 2022 Jun 22.
• Clinical trial shows improved rare blood cancer treatment (23 June 2022) | Related:
  • Tremblay D, Mesa R. Momelotinib for the treatment of myelofibrosis with anemia. Future Oncol. 2022 Jun;18(20):2559-71. Epub 2022 May 23. (Free full text) | PubMed abstract
• Patient-reported outcomes and overall survival after allogeneic hematopoietic stem cell transplantation (22 June 2022) | Related:
  • Incorporating patient-reported outcome data into a hematopoietic cell transplant survival calculator (Poster at 2022 ASCO Annual Meeting)
• Study identifies proteins that allow blood vessels to grow (22 June 2022) | Related:
  • Ong YT, Andrade J, Armbruster M, et al. A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth. Nat Metab. 2022 Jun 20. Epub ahead of print. (Open access) | PubMed abstract
• Industry news: Novartis, Precision ink deal to develop potential sickle cell cure (22 June 2022)
• Data shows no increase in pediatric hepatitis, adenovirus 40/41 compared to pre-pandemic levels (21 June 2022) | Related:
  • Kambhampati AK, Burke RM, Dietz S, et al. Trends in acute hepatitis of unspecified etiology and adenovirus stool testing results in children - United States, 2017-2022. MMWR Morb Mortal Wkly Rep. 2022 Jun 17;71(24):797-802. (Free full text) | PubMed abstract
• Dual-target CAR-T ‘very promising’ for advanced multiple myeloma (21 June 2022)
• Industry news: Pfizer buys stake in Valneva to advance Lyme disease vaccine (20 June 2022)
• World Blood Donor Day: Poor funding, staff shortage worsen blood donation In Africa–WHO (19 June 2022)
• Global study identifies burden of SCD on provider, patient, caregiver (17 June 2022) | Related:
  • Sickle Cell Health Awareness, Perspectives and Experiences (SHAPE) survey: Findings on the burden of sickle cell disease and unmet needs as reported by patients and caregivers (Oral presentation at the Global Congress on Sickle Cell Disease, 2022)
• Transfusion-dependent patients with MDS vary in treatment experiences, preferences (17 June 2022) | Related:
  • Vijenthira A, Starkman R, Lin Y, et al. Multi-national survey of transfusion experiences and preferences of patients with myelodysplastic syndrome. Transfusion. 2022 Jun 10. Epub ahead of print.
• What to know about the newest, most contagious omicron subvariants,BA.4 and BA.5 (15 June 2022)
• WHO says it's investigating monkeypox DNA in semen (15 June 2022)
• Industry news: Jazz and Redx in milestone inhibitor agreement (15 June 2022)
• WHO convenes experts to decide if monkeypox is an emergency (14 June 2022)
• How strong is your Covid immunity? A blood test could offer some insight (14 June 2022) | Related:
  • Schwarz M, Torre D, Lozano-Ojalvo D, et al. Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR. Nat Biotechnol. 2022 Jun 13. Epub ahead of print. (Free full text) | PubMed abstract
• Canada: NUPGE supports World Blood Donor Day and calls for action in Canada on paid plasma clinics (14 June 2022)
• Industry news: Nanopore sequencing quickly and accurately diagnoses rare genetic disorders (14 June 2022) | Related:
  • Magini P, Mingrino A, Gega B, et al. Third-generation cytogenetic analysis: Diagnostic application of long-read sequencing. J Mol Diagn. 2022 May 5:S1525-1578(22)00107-6. Epub ahead of print. (Free full text) | PubMed abstract
• Groundbreaking treatment for HIV/AIDS developed by Israeli research team (13 June 2022) | Related:
  • Nahmad AD, Lazzarotto CR, Zelikson N, et al. In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice. Nat Biotechnol. 2022 Jun 9. Epub ahead of print.
• ISBT president urges for stronger Expert urges for stronger evidence base to improve blood transfusion outcomes (13 June 2022)
• WHO urges eligible people to make regular, voluntary, unpaid blood donations (13 June 2022)
• WHO Fact Sheet: Blood safety and availability | The median blood donation rate in high-income countries is 31.5 donations/1000 people vs 5/1000 in low-income countries.
• Electro-chemical bandages could be an effective alternative to antibiotics for managing wound infections (13 June 2022)
• Molecular imaging biomarker predicts response to CAR T cell therapy (12 June 2022)
• Industry news: Ten biotech companies were able to raise more than $500 million in combined financing in the past week (12 June 2022)
• When we’ll be able to 3D-print organs and who will be able to afford them (10 June 2022) | Related:
  • Wang X. Advanced polymers for three-dimensional (3D) organ bioprinting. Micromachines (Basel). 2019 Nov 25;10(12):814. (Open access) | PubMed abstract
• How an army captain invented blood banks during WWI (9 June 2022)
• Monkeypox outbreak tops 1,000 cases; WHO warns of 'real' risk (8 June 2022)
• Industry news: As monkeypox cases rise, BD pairs up with Spain-based CerTest for diagnostic (8 June 2022)
• Industry news: Roche's bispecific blood cancer drug Lunsumio treads on CAR-T's turf with first global approval (8 June 2022)
• Industry news: AstraZeneca’s Evusheld successfully prevents progression to severe COVID-19 (8 June 2022) | Related:
  • Montgomery H, Hobbs FDR, Padilla F, et al. Efficacy and safety of intramuscular administration of tixagevimab­cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Respir Med.2022. Epub 7 June. (Free full text)
• AABB: AABB accepting comments on proposed 4th edition of Standards for a Patient Blood Management Program until 28 June (8 June 2022)
• AABB: Comment period opens for proposed 6th Edition of Standards for Molecular Testing for Red Cell, Platelet and Neutrophil Antigens until 5 July (8 June 2022)
• Australia: This Australian entrepreneur delivered medical aid on a 2,500 kilometre journey across Ukraine (4 June 2022)
• Prior COVID won't shield kids From omicron, but vaccine might (2 June 2022) | Related:
  • Tang J, Novak T, Hecker J, et al. Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C. Nat Commun. 2022 May 27;13(1):2979. (Open access) | PubMed abstract
• Analysis: Inhaled vaccine for COVID-19 — The pandemic accelerated decades of research leading to jab-free vaccine now in human testing (2 June 2022)
• Age interacts with mutations, clonal growth and cancers of blood cells (2 June 2022) | Related:
  • Fabre MA, de Almeida JG, Fiorillo E, et al. The longitudinal dynamics and natural history of clonal haematopoiesis. Nature. 2022 Jun 1. Epub ahead of print. (Open access) | PubMed abstract
• How Is the menu of molecular diagnostics expanding after COVID-19? (1 June 2022)
• Canada: Despite some progress, Canadian women in STEM still face academic segregation (31 May 2022) | Related:
  • Persistence and representation of women in STEM programs (2 May 2022)
• Handheld device may help stop fatal blood loss (31 May 2022)
• Georgia Tech sees new details in 3-D images of organoids that could lead to medical advances (31 May 2022) | Related:
  • Liu W, Kim GR, Takayama S, Jia S. Fourier light-field imaging of human organoids with a hybrid point-spread function. Biosens Bioelectron. 2022 Jul 15;208:114201. Epub 2022 Mar 26.
• WHO can’t rule out monkeypox pandemic risk, says there’s a window of opportunity to stop outbreak (30 May 2022)
• Organic strawberries linked to hepatitis A outbreaks in U.S. and Canada (30 May 2022) | Related:
  • FDA: Outbreak investigation of hepatitis A virus: strawberries (28 May 2022)
• Genomic surveillance uncovers clusters of MRSA causing bloodstream infections (28 May 2022)
• Female Celebrity Cruises passenger sues after 'receiving HIV-infected blood from another traveler' during onboard emergency transfusion when she suffered hemorrhage (26 May 2022)
• Abstracts of ISBT, June 4-8, 2022: ISBT 2022 - Abstract Book (24 May 2022) | Related: Author index
• USA: CDC issues monkeypox warning advising travelers to 'practice enhanced precautions' (24 May 2022)
• USA: US in process of releasing monkeypox vaccine from national stockpile for ‘high-risk’ people, CDC says (24 May 2022)
• Repeat infections with COVID-19 may become the norm (23 May 2022)
• The evolution of blood group genotyping (20 May 2022) | Complementary to all via AABB Newsletter.
• Jamie Nash receives 28th Scott Murphy Memorial Award Lectureship (20 May 2022)
• Here’s how wars have changed modern medicine (19 May 2022)
• Epidemiological update issued 19 May 2022: hepatitis of unknown aetiology in children (European Centre for Disease Prevention and Control)
• USA: CDC, FDA consider expanding COVID-19 booster eligibility (19 May 2022)
• Journals: Ryan CT, Rosengart TK. Commentary: Culture trumps (transfusion) guidelines.J Thorac Cardiovasc Surg. 2022 Mar;163(3):1025-6. Epub 2020 May 11. (Free full text) | PubMed abstract
• Columbia University researchers say new high-speed 3D microscope could replace traditional biopsy, with implications for surgical pathology (18 May 2022) | Related:
  • Patel KB, Liang W, Casper MJ, et al. High-speed light-sheet microscopy for the in-situ acquisition of volumetric histological images of living tissue. Nat Biomed Eng. 2022 Mar 28. Epub ahead of print.
• Industry news: AstraZeneca boosts COVID portfolio with RQ Bio deal (17 May 2022)
• Smart pacifier developed to monitor infant health in hospitals (16 May 2022) | Related:
  • Lim HR, Lee SM, Park S, et al. Smart bioelectronic pacifier for real-time continuous monitoring of salivary electrolytes. Biosens Bioelectron. 2022 Aug 15;210:114329. Epub 2022 Apr 26.
• Addressing gaps in care for patients with thalassemia (13 May 2022)
• 'Human Cell Atlas' maps 1 million cell types in 33 organs (12 May 2022)
• UK: Hundreds of patient data breaches are left unpunished (12 May 2022)
• Industry news: CSL's $11.7B Vifor buy, 2021's biggest biopharma M&A deal, hits antitrust delay (12 May 2022)
• USA: Global license program to receive Covid-19 support from U.S. NIH (12 May 2002)
• USA: Rehospitalization and emergency department visits after CAR T-cell therapy in commercially insured patients with cancer (12 May 2022)
• Target trial emulation using real world data suggest older RBCs may increase mortality (11 May 2022) | Related:
  • Bruun-Rasmussen P, Andersen PK, Banasik K, et al. Intervening on the storage time of RBC units and its effects on adverse recipient outcomes using real-world data. Blood. 2022 Apr 28:blood.2022015892. Epub ahead of print. (Free full text) | PubMed abstract
• USA: Moderna completes FDA submission for use of COVID shot in adolescents, kids (11 May 2022)
• Growing share of Covid-19 deaths are among vaccinated people, but booster shots substantially lower the risk (11 May 2022)
• Industry news: BD, Babson set sights on bringing simple blood collection into the home (11 May 2022)
• In Memoriam: Morris “Moe” Blajchman, MD, FRCPC (10 May 2022)
• Canada: Saskatchewan 'close to a breaking point' with lab tech shortage (10 May 2022)
• Biomarkers in the blood can indicate the seriousness of head trauma (10 May 2022) | Related:
  • Thomas I, Dickens AM, Posti JP, et al.;CENTER-TBI Participants and Investigators. Serum metabolome associated with severity of acute traumatic brain injury. Nat Commun. 2022 May 10;13(1):2545. (Free full text) | PubMed abstract
• USA: Study finds ‘substantial’ underrepresentation of black patients in CAR-T clinical trials (10 May 2022) | Related:
  • Al Hadidi S, Schinke C, Thanendrarajan S, et al. Enrollment of black participants in pivotal clinical trials supporting US Food and Drug Administration approval of chimeric antigen receptor-T cell therapy for hematological malignant neoplasms. JAMA Netw Open. 2022 Apr 1;5(4):e228161. (Free full text) | PubMed abstract
• Pre-transfusion testing only necessary for select degenerative cervical spine surgery patients (10 May 2022) | Related:
  • Núñez JH, Bosch-García D, Escudero B, et al. Is routine blood typing and screening necessary for degenerative cervical spine surgery patients in specialty surgical hospitals? Transfusion. 2022 Apr 23. Epub ahead of print.
• Medication side effects tied to higher blood transfusion rates in those with Parkinson's disease (6 May 2022)
• USA: FDA limits use of J&J COVID vaccine due to blood clot risk (5 May 2022)
• Discovery provides critical clues to why many immunotherapies trigger dangerous side effects (5 May 2022) | Related:
  • Eschweiler S, Ramírez-Suástegui C, Li Y, et al. Intermittent PI3K inhibition sustains anti-tumour immunity and curbs irAEs. Nature. 2022 May 4. Epub ahead of print. (Open access) | PubMed abstract
• Stress in healthcare workers: a model to help us rethink challenges (3 May 2022)
• Canada: Blood test vial supplies stabilize, but concerns remain (3 May 2022)
• Researchers develop smartphone-powered microchip for at-home medical diagnostic testing (2 May 2022) | Related:
  • Ertsgaard CT, Yoo D, Christenson PR, et al. Open-channel microfluidics via resonant wireless power transfer. Nat Commun. 2022 Apr 6;13(1):1869. (Free full text) | PubMed abstract
• Hospitals can reduce antibiotic overuse by avoiding unnecessary blood draws in critically ill children, study shows (2 May 2022) | Related:
  • Woods-Hill CZ, Colantuoni EA, Koontz DW, et al. Association of diagnostic stewardship for blood cultures in critically ill children with culture rates, antibiotic use, and patient outcomes: Results of the Bright STAR Collaborative. JAMA Pediatr. 2022 May 2. Epub ahead of print.
• USA: CDC: Adenovirus should be considered in diagnosis of acute hepatitis in children (2 May 2022)
• Proven mRNA technologies embolden vaccine and drug makers (2 May 2022)
• Pfizer's oral COVID-19 antiviral Paxlovid falls short as preventive therapy, new data shows (2 May 2022)
• Global prevalence of long COVID ‘substantial,’ researchers say (1 May 2022) | Related:
  • Chen C, Haupert SR, Zimmermann L, et al. Global Prevalence of Post COVID-19 Condition or Long COVID: A meta-analysis and systematic review. J Infect Dis. 2022 Apr 16:jiac136. Epub ahead of print. (Free full text) | PubMed abstract
• Taking data visualization for blood management to the next level and beyond (April 2022)
• AABB: Proposed draft Standards for Perioperative Autologous Blood Collection and Administration, 10th edition, is available for public comment until May 18
• Artificial intelligence in digital pathology developments lean toward practical tools (29 Apr. 2022)
• Canada: Health Canada reviewing Moderna vaccine for kids under 6 (29 Apr. 2022)
• We’re facing a critical shortage of medical laboratory professionals (28 Apr. 2022)
• Hepatitis: Africa’s 2030 strategic elimination plan (28 Apr. 2022)
• Canada: Health Canada ends ban on blood donations from gay men (28 Apr. 2022) | Related:
  • Canadian Blood Services to remove eligibility criteria specific to men who have sex with men (28 Apr. 2022)
• Global vaccine rates need to be higher to fight new variants: Gavi, UNICEF (25 Apr. 2022)
• 1 death, 17 liver transplants in multi-country outbreak of hepatitis in children, WHO says (25 Apr. 2022) | Related:
  • WHO: Acute hepatitis of unknown aetiology ­ the United Kingdom of Great Britain and Northern Ireland (15 Apr. 2022)
• Industry news: Canada's Qvella secures CE mark for FAST System and FAST-PBC Prep Cartridge (25 Apr. 2022)
• A mighty kind movement brought to you by the Orgamites (22 Apr. 2022)
• USA: FDA could authorize Covid shots for children under 5 in June (21 Apr. 2022)
• Calcium in hemorrhagic trauma (21 Apr. 2022) | Reviewing the trauma lethal triad: hypothermia, acidosis and coagulopathy
• USA: Moderna to file for EUA of COVID-19 shot for very young kids by April end (20 Apr. 2022)
• UTD engineers’ new rapid virus test raises bar for detection (20 Apr. 2022) | Related:
  • Liu Y, Ye H, Huynh H, et al. Digital plasmonic nanobubble detection for rapid and ultrasensitive virus diagnostics. Nat Commun. 2022 Mar 30;13(1):1687. (Free full text) | PubMed abstract
• More than cost: The true impact of errors (20 Apr. 2022)
• USA: Emory researchers successfully use mRNA to activate genes (19 Apr. 2022) | Related:
  • Beyersdorf JP, Bawage S, Iglesias N, et al. Robust, durable gene activation in vivo via mRNA-encoded activators. ACS Nano. 2022 Mar 31. Epub ahead of print. (Free full text) | PubMed abstract
• Scientists create first map of human blood stem cell development (19 Apr. 2022)
• ‘Overriding adolescent refusals of treatment’ (University of Oxford blog, 19 Apr. 2022)
• Will mRNA technology companies spawn innovation ecosystems? (18 Apr. 2022)
• World Hemophilia Day (17 April)
• USA: Workplace a ‘major driver’ of COVID-19 among health care personnel (16 Apr. 2022) | Related:
  • Billock RM, Groenewold MR, Sweeney MH, et al. Reported exposure trends among healthcare personnel COVID-19 cases, USA, March 2020-March 2021. Am J Infect Control. 2022 Feb 22:S0196-6553(22)00043-8. Epub ahead of print. (Free full text) | PubMed abstract
• CEPI (Coalition for Epidemic Preparedness Innovations) moon shot: Developing pandemic vaccines in 100 days (13 Apr. 2022)
• Rilzabrutinib active, safe in immune thrombocytopenia (13 Apr. 2022)
• WHO: Despite decline in infections, deaths, COVID-19 pandemic still far from over (12 Apr. 2022) | While some of the high-income countries were rolling out fourth doses of the life-saving jabs, one third of the world’s population is yet to receive a single dose, including 83% of the population of Africa.
• New 3D printing technique: A game changer for medical testing devices (12 Apr. 2022)
• WHO monitoring 2 more Omicron sub-variants known as BA.4 and BA.5 (11 Apr. 2022)
• New evidence shows blood or plasma donations can reduce the PFAS ‘forever chemicals’ in our bodies (10 Apr. 2022)
• UN chief Antonio Guterres warns of large COVID outbreaks in Asia, says pandemic far from over (9 Apr. 2022)
• Historical: Medicine and Molière’s ‘imaginary patient’ (9 Apr. 2022)
• Current and prospective landscape of treatment options for rare anemias (8 Apr. 2022)
• Why we must reduce the demand for blood and not just increase donations (7 Apr. 2022) | Opinion piece by Carolyn Burns, MD:President for the Society for the Advancement of Patient Blood Management.
• Fact Check: It is unsafe to receive a blood transfusion from a vaccinated person (7 Apr. 2022) | False
• Gammon RR. How do I maintain an adequate inventory and avoid wastage during normal times and in a pandemic? (AABB PPM, April 2022)
• Medical and non-medical laboratories in UK and Europe hit by rising costs and supply shortages due to high demand for testing services (6 Apr. 2022)
• Researchers develop novel device to “cleanse” the blood of chemotherapeutic drugs (6 Apr. 2022) | Related:
  • Motamarry A, Wolfe AM, Ramajayam KK, et al. Extracorporeal removal of thermosensitive liposomal doxorubicin from systemic circulation after tumor delivery to reduce toxicities. Cancers (Basel). 2022 Mar 4;14(5):1322. (Free full text) | PubMed abstract
• What does Baghdad mean on 'Chicago Med'? Some viewers find it offensive (6 Apr. 2022)
• UK has detected a new Covid variant. Here’s what we know so far about omicron XE (6 Apr. 2022) | Related:
  • Omicron XE variant: 5 things to know (4 Apr. 2022) | Related:
• These steps may identify patients eligible for shorter DAA therapy for HCV (5 Apr. 2022)
• These steps may identify patients eligible for shorter DAA therapy for HCV (5 Apr. 2022)
• How sleep and mental health were affected in Sweden during the COVID-19 pandemic (4 Apr. 2022) | Related:
  • González-Hijón J, Anna K. Kähler AK, Frans EM, et al. Unravelling the link between sleep and mental health during the COVID-19 pandemic. medRxiv 2022 1 Apr. 2022. Preprint. (Free full text)
• Scientists engineer "universal donor" lungs (April 2022) | Related:
  • Wang A, Ribeiro RVP, Ali A, et al. Ex vivo enzymatic treatment converts blood type A donor lungs into universal blood type lungs. Sci Transl Med. 2022 Feb 16;14(632):eabm7190.
• Heart issues more common after Covid infection than vaccination, CDC reports (1 Apr. 2022) | Related:
  • Block JP, Boehmer TK, Forrest CB, et al. Cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination ­ PCORnet, United States, January 2021­January 2022. MMWR Morb Mortal Wkly Rep. ePub: 1 April 2022. (Free full text)
• Blood collection tube shortages continue - ‘routine’ labs should be limited (28 Mar. 2022)
• Canada (CBS): First-in-Canada approach for personalized hemophilia care gets national award (18 Mar. 2022) | Related:
  • "Pharmacist integration into the Hemophilia Treatment Centre: A Canadian pilot project to optimize treatment and improve cost-savings using pharmacokinetic assessments of hemophilia patients" (Includes abstract and 5:16 min. video)
• ISBT: Identify critical elements of a scientific manuscript review ( Dr. Ziggy Szczepiorkowski webinar: 47:58 min.)
• Catching the flu and COVID-19 at the same time doubles your risk of dying, new study finds (28 Mar. 2022) |
• Man turned away from British Airways flight dies after missing blood transfusion (25 Mar. 2022)
• New study reveals why HIV remains in human tissue even after antiretroviral therapy (25 Mar. 2022) | Related:
  • Shahbaz S, Okoye I, Blevins G, Elahi S. Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals. PLoS Pathog. Epub 24 March, 2022. (Free full text)
• Evidence grows that vaccines lower the risk of getting long COVID (24 Mar. 2022)
• Canada: Health Canada authorizes Héma-Québec submission to make source plasma donor screening criteria more inclusive for men who have sex with men (24 Mar. 2022)
• Internet of Things (IoT) becomes greater focus for pharma (23 Mar. 2022) | IoT defined: System of interrelated, internet-connected objects that are able to collect and transfer data over a wireless network without human intervention
• New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases (23 Mar. 2022) | Related:
  • Teplensky MH, Distler ME, Kusmierz CD, et al. Spherical nucleic acids as an infectious disease vaccine platform. Proc Natl Acad Sci U S A. 2022 Apr 5;119(14):e2119093119. Epub 2022 Mar 21. (Open access) | PubMed abstract
• USA: Biden administration eyeing 2nd booster shot recommendation for older Americans within weeks (23 Mar. 2022)
• WHO: BA.2, or ‘stealth omicron,’ takes over as dominant variant circulating worldwide (23 Mar. 2022) | Related:
  • WHO: Weekly epidemiological update on COVID-19 - 22 March 2022
• WHO blames rising Covid cases in Europe on curbs lifted too soon (22 Mar. 2022)
• USA: Johns Hopkins engineers build robot to perform surgery without a doctor (22 Mar. 2022)
• USA: ACC health policy statement outlines strategies to address bias, discrimination, bullying and harassment in the workplace (17 Mar. 2022)
• A gene therapy for hemophilia boosts levels of a crucial clotting protein (16 Mar. 2022) | Related:
  • Ozelo MC, Mahlangu J, Pasi KJ, et al.; GENEr8-1 Trial Group. Valoctocogene Roxaparvovec gene therapy for hemophilia A. N Engl J Med. 2022 Mar 17;386(11):1013-25.
• USA: Alleviating the stress that COVID-19 has placed on US health care (14 Mar. 2022)
• Pfizer CEO says new COVID variants might make four—or more—vaccine doses ‘necessary’ for returning to normal (14 Mar. 2022)
• The 13-step guide for conducting cell & gene therapy EHS risk assessments (14 Mar. 2022)
• WHO concerned about drop in COVID-19 testing (9 Mar. 2022)
• Researchers identify 'Deltacron' Covid variant that combines Delta and Omicron (9 Mar. 2022) | Related:
  • Colson P, Fournier P-E, Delerce J, et al. Culture and identification of a “Deltamicron” SARS-CoV-2 in a three cases cluster in southern France. medRxiv 2022 8 Feb. 2022. doi:10.1101/2022.03.03.22271812. Preprint. (Free full text)
• Study links shift work with poorer working memory and slower mental processing speed (9 Mar. 2022) | Related:
  • Vlasak T, Dujlovic T, Barth A. Neurocognitive impairment in night and shift workers: a meta-analysis of observational studies. Occup Environ Med. 2022 Mar 8:oemed-2021-107847. Epub ahead of print.
• USA: Pharma spars with US over ban on Mexican nationals donating paid blood plasma (9 Mar. 2022)
• Public health experts pitch their own path to the 'next' normal (8 Mar. 2022)
• Protein tweak makes CRISPR gene editing 4,000 times less error-prone (3 Mar. 2022) | Related:
  • Bravo JPK, Liu MS, Hibshman GN, et al. Structural basis for mismatch surveillance by CRISPR-Cas9. Nature. 2022 Mar 2. Epub ahead of print. (Open access) | PubMed abstract
• WHO recommends Merck COVID pill for non-severe, at-risk patients (3 Mar. 2022)
• This cool new imaging technique shows blood vessels like never before (3 Mar. 2022) | Related:
  • Bhargava A, Monteagudo B, Kushwaha P, et al. VascuViz: a multimodality and multiscale imaging and visualization pipeline for vascular systems biology. Nat Methods. 2022 Feb;19(2):242-54. Epub 2022 Feb 10.                 
• Canada: New CSTM blog - 'I will remember you: Astrid Maguire' | Well worth a read and includes many tips for all transfusion professionals.
• Canada: In memoriam - Dr. David Ferguson | Also see Dr. Ferguson's entry in a transfusion medicine blog
• Industry news: Novartis backs Epsilogen's bid to turn 'Cinderella antibody' into new class of cancer drug (2 Mar. 2022)
• Library resource: ISBT Code of Ethics (Available in 8 languages)
• Diseases in the news: Children with congenital Zika syndrome 11 times more likely to die, large study finds (24 Feb. 2022) | Related:
  • Paixao ES, Cardim LL, Costa MCN, et al. Mortality from congenital zika syndrome - nationwide cohort study in Brazil. N Engl J Med. 2022 Feb 24;386(8):757-67. (Free full text) | PubMed abstract
• Industry news: TargED Biopharmaceuticals will use €39m from a Series A financing to bring its thrombolytic treatment to patients (22 Feb. 2022)
• More free medical journals at PuBMed Central
• Free e-books on Internet:
  • Blood Groups and Red Cell Antigens (2005)
  • Transfusion chapters in StatPearls [Internet] (2022)
• What it’s like to specialize in pathology: Shadowing Dr. Koepsell (24 Feb. 2022) | Dr's specialty is pathology and laboratory medicine with a subspecialty in transfusion medicine and cellular therapy.
• New studies bring BA.2 variant into sharper focus (24 Feb. 2022) | Related:
  • Wolter N, Jassat W, DATCOV-Gen author group, von Gottberg A, Cohen C. Clinical severity of Omicron sub-lineage BA.2 compared to BA.1 in South Africa. medRxiv [Preprint]. Epub 19 Feb. 2022. (Free full text)
  • Stegger M, Edslev SM, Sieber RN, et al. Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfection. medRxiv [Preprint]. Epub 22 Feb. 2022. (Free full text)
• Q&A: How do we make the best use of blood banks in sub-Saharan Africa? (23 Feb. 2022)
• ß-thalassemia patients achieve transfusion independence with gene therapy (23 Feb. 2022)
• Industry news: Sanofi and GSK seek approval for Covid-19 vaccine (23 Feb. 2022)
• Big pharma tried to scuttle Africa bid to manufacture Covid-19 vaccines locally (19 Feb. 2022)
• Global cases are dropping, but the WHO is watching an Omicron subvariant (18 Feb. 2022)
• COVID-19: What you need to know about the coronavirus pandemic on Feb. 18 (18 Feb. 2022)
• WHO warns of COVID rise In eastern Europe amid lagging vaccination efforts (15 Feb. 2022)
• Diseases in the news: After more than 40 years, ‘HIV vaccine remains elusive’ (13 Feb. 2022)
• Smartphone app can vibrate a single drop of blood to determine how well it clots (11 Feb. 2022) | Related:
  • Chan J, Michaelsen K, Estergreen JK, et al. Micro-mechanical blood clot testing using smartphones. Nat Commun. 2022 Feb 11;13(1):831. (Open access) | PubMed abstract
• What runners should know about donating blood (11 Feb. 2022)
• In unvaccinated pregnant women, Covid can cause deadly harm to babies (10 Feb. 2022) | Related:
  • Schwartz DA, Avvad-Portari E, Babál P, et al. Placental tissue destruction and insufficiency from COVID-19 causes stillbirth and neonatal death from hypoxic-ischemic injury: a study of 68 cases with SARS-CoV-2 placentitis from 12 countries. Arch Pathol Lab Med. 2022 Feb 10. Epub ahead of print. (Open access) | PubMed abstract
• Novavax seeks to clear Covid shot for teens after successful trial (10 Feb. 2022) | Vaccine is 80% effective in adolescents
• WHO urges rich countries to pay up for Covid plan (9 Feb. 2022)
• Diseases in the news: Ebola lurking in brain fluid kills monkeys weeks after recovery (9 Feb. 2022)
• New CRISPR tool maps out routes to better immune cell therapies for cancer, autoimmune diseases (8 Feb. 2022) | Related:
  • Schmidt R, Steinhart Z, Layeghi M, et al. CRISPR activation and interference screens decode stimulation responses in primary human T cells. Science. 2022 Feb 4;375(6580):eabj4008. Epub 2022 Feb 4
• Plasma donor compensation still an ‘open wound’ in EU’s blood directive revision (7 Feb. 2022)
• AABB Newsletter (Feb. 2022) | Related: Preview for non-members
• Continuous monitoring of pooled international trials of convalescent plasma for COVID-19 hospitalized patients | Related:
  • Petkova E, Antman EM, Troxel AB. Pooling data from individual clinical trials in the COVID-19 era. (Viewpoint)vJAMA. 2020 Aug 11;324(6):543-5. (Free full text)
  • Statistical modeling proposal for continuous monitoring of pooled international trials of convalescent plasma for COVID-19 hospitalized patients: COMPILE (7 Aug. 2020)
• Industry news: Pfizer and BioNTech start trials of new omicron-specific jab (25 Jan. 2022)
• Industry news: As omicron spreads nationally, Octapharma’s fibryga® & Octaplas™ become increasingly important replacement therapies (24 Jan. 2022)
• New production method developed to freeze-dry COVID-19 vaccines (21 Jan. 2022)
• What is ‘Golden Blood, the incredibly rare blood type known as Rh null (20 Jan. 2022) | Related:
  • The man with the golden blood (20 Oct. 2014)
  • Dean L. Blood Groups and Red Cell Antigens [Internet]: Ch. 7 The Rh blood group
• USA: The omicron variant is deepening severe staffing shortages in medical laboratories across the US (19 Jan. 2022)
• Omicron won't be the last COVID-19 variant, WHO says (19 Jan. 2022)
• Considering the role of ESAs and blood transfusions in MDS management (17 Jan. 2022)
• WHO: HEV outbreak in Chad (17 Jan. 2022)
• Even mild COVID-19 cases can result in lingering heart issues (17 Jan. 2022)
• Canada: $10K bonuses for Nunavut nurses drove 5 of 8 Iqaluit lab technologists to resign (14 Jan. 2022)
• AABB: Value and accuracy of point-of-care testing (Jan. 2022)
• USA: U.S. averaging 700K new COVID-19 cases daily as deltacron revealed (10 Jan. 2022)
• Canada: Baby bobcat in New Brunswick saved by blood transfusion from cat (6 Jan. 2022)
• WHO chief ‘confident’ world can end pandemic in 2022, but only with global effort (2 Jan. 2022)
• Saliva in the spotlight for rapid SARS-CoV-2 detection (1 Jan. 2022)

International

Albania

• Albanian hospitals experience blood shortage, thalassemic children suffer (28 July 2022)

Argentina

• Health launched the transfusion medicine course with students from all over the country (9 Apr. 2022)

Australia / New Zealand (Down Under) &

• “Bloods” launch blood donor team to help save lives (15 Mar. 2023) | Australian Red Cross Lifeblood and the mighty Sydney Swans are partnering to launch a blood donor team for fans in the lead-up to the first blood donor centre opening in an Australian sporting complex at Sydney Swans HQ.
• Recognising women who give: The female pioneers of Lifeblood (8 Mar. 2023) | After WWII Dr Ruth Sanger moved to London, where she met her future husband & fellow researcher Robert Race. Together they published their findings in the influential book, Blood Groups in Man.
• Aishwarya’s father’s calls for WA health system royal commission renewed after another major hospital mishap (6 Mar. 2023)
• Jenny Kee’s latest iconic design a celebration of giving (6 Mar. 2023) | Inspired by International Women’s Day (8 March), Kee says the bold bandage, which is emblazoned with some of her signature motifs, including doves, hearts and waratahs, also pays tribute to the generous and giving women of Australia who change lives.
• Recognising women who give: how one mum gave hope by giving breast milk (Australian Red Cross, Lifeblood, 2 Mar. 2023)
• Potential blood donation changes for MSM (23 Feb. 2023) | Related:
  • HIV, viral hepatitis and sexually transmissible infections in Australia Annual surveillance report 2021
• Mater’s tiniest baby of 2022 has big brave heart (20 Feb. 2023) | During his stay in hospital, he required various forms of breathing support, received several blood transfusions, & continuously fought off the risk of infection.
• Discover how the blood you give helps haematologists fight cancer. (Australian Red Cross Lifeblood, 15 Feb. 2023)
• Call for blood donors to support cancer patients (1 Feb. 2023) | Related:
  • Camilla Franks designs must-have accessory to help boost blood donations (1 Feb. 2023)
  • Jase faced his cancer with an army of donors (30 Jan. 2023)
• Stillbirth autopsy funding to go to new coordinator roles to help guide families through process (23 Jan. 2023)
• Officers saving lives in a different way through Bleed4Blue in Far North Queensland (20 Jan. 2023)
• Does your donation have a use-by-date? (9 Jan. 2023) | Australian Red Cross Lifeblood^® 1:15min. video
• Canberra blood donor centres in urgent need of types A and O amid Christmas holiday shortage (25 Dec. 2022) | A mother whose children's lives were saved by blood donors is urging Australians to roll up their sleeves, to help avert a shortage.
• Blood donor centres open between Boxing Day and New Year (24 Dec. 2022)
• ‘Blood Blitz’ launched to curb Christmas and New Year shortage (20 Dec. 2022) | Australia needs more than 1,800 people a day to donate blood in the next two weeks to prevent a shortage of blood products needed by patients this festive season.
• New Zealand: Kiwi family moving to Australia to access treatment for son's rare disorder (20 Dec. 2022)
• Surgeon and scientist was an organ transplant pioneer (13 Dec. 2022) | Related:
  • Sir Peter Morris (Wikipedia entry)
•  Judge reserves decision in baby blood dispute case (6 Dec. 2022)
• Compromise needed for sick baby, not ‘vaccinated blood’ arguments outside court (1 Dec. 2022)
• New Zealand: Protesters gather outside Auckland High Court as Health NZ faces off with parents of sick baby over vaccinated blood donors (30 Nov. 2022)
• Health NZ seeks guardianship of baby whose parents are refusing vaccinated blood (30 Nov. 2022)
• Meet the man behind Blood Bikes Australia: Peter Davis (13 Nov. 2022)
• Saving lives in threes (11 Nov. 2022) | A group of Royal Australian Navy officers and sailors have united in South Australia this month, championing members donating blood for the first time.
• There are only 100 Anti-D plasma donors in Australia, but their antibodies save thousands of babies each year (23 Oct. 2022)
• A running passion for life (ARC Lifeblood story)
• Aussie plasma donors needed for ‘medical miracle’ (4 Oct. 2022)
• New major medical precinct for Melbourne (3 Oct. 2022)
• UK is A-OK (Australian Red Cross Lifeblood news story) | Related:
  • vCJD: a short history (25 July 2022)
• News stories from Australian Red Cross Lifeblood^®
  • Plasma gives Charlie life every week | Diagnosed with a rare genetic condition, Charlie relies on a regular infusion of immunoglobulin for protection against common viruses and bacteria.
  • Jacob’s second chance at life | Twelve years after a near-fatal car accident with a 5% chance of survival, Jacob is determined to make the most of his life.
  • Giving life beyond blood | How a generous organ donation gave little Maia the best chance at a normal life.
• How a Balinese community united to save Aussie man who arrived at hospital without a pulse (2 Sept. 2022)
• SA emergency services rescue winter blood supplies (9 Aug. 2022)
• Taking on the blood challenge to save lives (4 Aug. 2022)
• Grass becomes greener for Australian blood and plasma supplies as thousands of former UK residents step up to donate (3 Aug. 2022)
• Wagga baker Jenny Nixon is urging residents to donate their bone marrow (29 July 2022)
• Lifeblood welcomes first UK 'Mad Cow' blood donors (25 July 2022)
• How James Harrison, the "Man With The Golden Arm", saved nearly 2.5 Million babies' lives (22 July 2022)
• NZ: Eve van Grafhorst: The young girl who helped removed stigma people with HIV face in New Zealand (16 July 2022)
• Mum, I’ve got this. You don’t need to worry (14 July 2022)
• Misconceptions hindering blood donations (17 June 2022)
• Dog blood donors needed as blood supply levels for Queensland's pets drop (16 June 2022)
• Older Australians encouraged to give blood as supplies dwindle (13 June 2022)
• Australia's blood stocks plummet as donors off sick with flu and COVID, Red Cross Lifeblood says (30 May 2022)
• 'Transfusion confusion': Migrants turned away from donating blood in Australia (25 May 2022)
• Industry news: CSL staff shortages bite despite plasma bounce-back (3 May 2022)
• Mad cow disease ban for blood donations from UK residents lifted in Australia by TGA (28 Apr. 2022)
• NSW latest St George $385 million health precinct designs unveiled (29 Mar. 2022)
• Port Macquarie's Bruce de Graaf, a skateboarder, reaches his 600th blood donation (28 Mar. 2022)
• Industry news: Moderna’s Australian mRNA manufacturing facility set to become operational in 2024 (24 Mar. 2022)
• Blood donor services forced to reduce operating hours due to WA's labour crisis (22 Apr. 2022)
• Australia's blood types are becoming more positive, and that might change how some emergency transfusions are done (20 Mar. 2022) | Related:
  • Changing distribution of blood types in Australia linked to migrant diversity (21 Mar. 2022)
  • Hirani R, Weinert N, Irving DO. The distribution of ABO RhD blood groups in Australia, based on blood donor and blood sample pathology data. Med J Aust. 2022 Feb 16. Epub ahead of print. (Free access) | PubMed abstract
• New transfusion dataset a first step in nationally streamlined blood use (13 Apr. 2022, Monash University)
• ARC - Blood supply plunges to lowest point in a year (12 Apr. 2022)
• Doctors warn against unnecessary blood transfusions in Australian hospitals as donations decline (10 Mar. 2022) | Related:
  • “Use every drop wisely” – New push to reduce unnecessary blood transfusions (Royal Australasian College of Physicians, 11 Mar. 2022)
• Flooding and storms wreak havoc for Australian scientists (4 Mar. 2022)
• New Zealand: The 650-donation man: Meet New Zealand's most prolific blood and plasma donor (4 Mar. 2022)
• Monash University - Working towards treatments for rare diseases (28 Feb. 2022)
• New cell culture research to cut costs and improve tissue biomanufacturing (22 Feb. 2022)
• 'I have a rare blood disorder and one leg. And I'm a mum of three. Here's how I do it.' (12 Feb. 2022)
• Veterinary scene Down Under: Bolstering wildlife surveillance, plus veterinary transfusion equipment and more (2 Feb. 2022)
• Call to loosen restrictions for UK blood donors as Omicron takes donation toll (1 Feb. 2022)
• Australians with one of most aggressive forms of blood cancer have new PBS listed treatment option (1 Feb. 2022) | Pharmaceutical Benefits Scheme (PBS) is an Australian Government program that benefits all Australians by subsidising medicines to make them more affordable.
• Community of Howlong helps save Vietnam veteran's life amid ambulance delays (24 Jan. 2022)
• Red Cross to change rules to allow blood donations sooner after having COVID-19 (18 Jan. 2022)

Austria

• Austria to introduce individual donor risk assessment (23 May 2022)

Bangladesh

• Teen dies after transfusion with wrong blood type at DMCH (21 Oct. 2022)

Belarus

• Belarus President Administration joins blood donation campaign (29 Nov. 2022)
• Kochanova visits National Research Center for Transfusion Medicine and Medical Biotechnology (17 May 2022)

Belgium

• Belgium becomes first country to introduce mandatory monkeypox quarantine as global cases rise (23 May 2022)

Bermuda

• Blood donations not keeping pace with growing need for transfusions, warns BHB (9 June 2022)
• Rare blood: find out what life is like for people who deviate from the ABO standard (2 Oct. 2022) | For every thousand Brazilians, only 14 are regular blood donors in Brazil.
• Blood Center optimizes blood transfusion for hematological patients (28 Apr. 2022)

Borneo

• Sarawak cops donate blood to mark 216th police day (9 Mar. 2023)

Brunei

• Understanding thalassaemia (5 Oct. 2022) | Brunei has 55 thalassaemia patients depending on regular blood transfusions.

Burundi

• Giving blood in solidarity with Burundi, “a collective responsibility” (26 June 2022)

Cambodia

• Life Insurance PLC helps top up Kingdom’s blood bank (16 Jan. 2023)
• Banking sector, UYFC team up for blood drive (14 May 2022)
• SOS out for blood donors as centre needs 110,000 units of blood (3 Mar. 2022)
• ‘Blood slave’ kidnapped by Chinese crime gang in Cambodia drained for months and threatened with organ harvesting (17 Feb. 2022)

Cameroon

• Cameroon steps up COVID-19 vaccination efforts with support from WHO, UNICEF, WB and other partners (11 Dec. 2022)
• UN supports blood transfusion in Cameroon (15 June 2022)

China/Hong Kong

• China reports nearly 60,000 people with COVID-19 died since early December (14 Jan. 2023)
• Shanghai anti-COVID diary | Inside emergency department: transfusion room (8 Jan. 2023) | 3:57min. video
• China COVID wave could kill one million people, models predict (19 Dec. 2022) | Related:
  • Leung K, Leung GM, Wu JT. Modelling the adjustment of COVID-19 response and exit from dynamic zero-COVID in China. medRxiv. 2022 14 Dec. Preprint. (Free full text)
• Two persons with rarest ‘Golden Blood’ (Rh null) found in East China, raising global number to nearly 50 (30 Aug. 2022)

Croatia

• Valuable donation from Austria to Dubrovnik Hospital (24 Nov. 2022)
• Split to get €7.2m regional blood transfusion centre (7 Jan. 2022)

Democratic Republic of Congo

• Fresh Ebola outbreak in DRC likely to spread to neighboring countries: WHO (30 Apr. 2022)

Denmark

• Nation reports rise in syphilis despite COVID-19 restrictions (13 Feb. 2022)

Egypt

• Egypt to sign contract with private firm to process donated plasma (4 Aug. 2022)

Equatorial Guinea

• Death toll in Equatorial Guinea marburg outbreak rises to 11 (28 Feb. 2023)
• WHO officials gather for urgent meeting over outbreak of Marburg virus deemed among globe’s ‘deadliest disease’ that has no cure (20 Feb. 2023)
• WHO confirms Marburg virus outbreak in Equatorial Guinea: What to know about the viral disease (13 Feb. 2023)

France

• Statement on measures of security for human body products owing to a human case report of West Nile virus (WNV) infection in mainland France outside the seasonal alert period (18 Jan. 2023)
• French blood donor wins rights case over 'homosexual' data (8 Sept. 2022)
• British people can give blood in France - just not for transfusions (16 Mar. 2022)
• Industry news: Sanofi CEO Paul Hudson sketches a $1B-plus investment on its new mRNA center (8 Mar. 2022)
• Industry news: Sanofi has designs on creating Big Pharma's 'strongest' immunology franchise, CFO says (11 Jan. 2022)

Gambia

• Ministry Of Health disagrees with social media report indicating shortage of blood bags in health facilities (21 Feb. 2022)

Germany

• Transfusion law: Bundestag ends the exclusion of gays from donating blood (16 Mar. 2023)
• German Red Cross urgently calls for blood donation in Berlin (5 June 2022)

Ghana

• Ghana’s annual blood requirement is estimated at 350,000 units (16 Feb. 2023)
• Decision not to accept blood transfusion is not ethically, medically wrong - Health Experts (29 Dec. 2022)
• December edition of Luv FM blood donation collects 116 pints of blood for Komfo Anokye Teaching Hospital (KATH) blood bank (17 Dec. 2022)
• Vein-to-vein-to-value: how tech is enhancing life-saving blood transfusion value chain (18 Nov. 2022) | Related:
  • New technologies hold promise for transfusion medicine (15 May 2020)
• FDA, NBS launch haemovigilance documents to ensure safety of blood products (22 Oct. 2022)
• Voluntarily blood donation key to improving and saving lives ­ NIC Commissioner (10 Aug. 2022)
• Ghana confirms first cases of deadly Marburg virus (18 July 2022)
• Let’s save lives by donating blood–National Blood Service (19 June 2022)
• Calvary Charismatic Center donates over 2000 pints of blood to Komfo Anokye Teaching Hospital (6 June 2022)
• ‘Allow my foot to rot’ ­ blood transfusion war between patients and health workers in Ghana (1 Apr. 2022)
• Greater Accra Regional Hospital and the Princess Marie Louise Hospital receive 69 pints of blood from the Korean Foundation for International Healthcare (26 Feb. 2022)

Greece

• Greece removes ban on queer men donating blood (12 Jan. 2022)

Guyana

• Costly hepatitis C treatment could soon be free in Guyana–Health Minister (18 June 2022)

Honduras

• U.S. military, Honduran Red Cross save lives through local blood drives (16 May 2022)

Hungary

• Hungary sending blood transfusion bags to Ukraine (11 Mar. 2022)

Iceland

• Iceland to end indefinite donor deferral of gay, bisexual men replaced by 4-month deferral for all donors who engaged in “risky sex" (via AABB, 14 Sept. 2021)

India

• Blood donation camp PGIMER (14 Mar. 2023)
• Labrador donates blood to save pregnant canine (13 Mar. 2023)
• TSCS urges Telangana to make antenatal test mandatory for pregnant woman (12 Mar. 2023)
• ‘To instil confidence’: Centre on excluding transgender, gays from blood donation (9 Mar. 2023)
• Meet Trishla who has dedicated her life to kids with thalassemia (8 Mar. 2023)
• Udupi: Kasturba Hospital Blood Center holds international symposium, ‘Transfusion Medicine Update' (4 Mar. 2023)
• Blood transfusion saves baby diagnosed with severe foetal at 27 weeks in Pune (2 Mar. 2023)
• Top doctors of city attended two days conference on “Technologies Update in Transfusion Medicine” at LPU (19 Feb. 2023)
• Maharashtra private blood banks wary of new guidelines on bulk transfers (16 Feb. 2023)
• Young HIV-positive Indian boy beats inherited blood disorder (15 Feb. 2023) | Related:
  • The 7-year-old became the first successful high-risk bone marrow transplant in India (15 Feb. 2023)
• How 3 sickle cell disease survivors live with blood transfusion, hospital visits and yet help each other out (12 Feb. 2023)
• KGMU transfusion med dept, blood bank win NAAC praise (8 Feb. 2023)
• Pregnant women to be given free blood transfusion, no need for donor: U.P. govt (2 Feb. 2023)
• Nirankari Mission organizes blood donation camp (30 Jan. 2023)
• Manipal Hospital Old Airport Road performs first of its kind plasma filtration for a pregnant woman (25 Jan. 2023)
• Man dies of HIV after blood transfusion, hospital penalised Rs 10L (24 Jan. 2023) | 10 lakh is equivalent to $13,970 USD
• Mumbai: Blood banks send out SOS over extra units (20 Jan. 2023)
• Mumbai: Nurses boycott KEM 97th year celebrations (18 Jan. 2023) | The nurses protested with black bands tied to their arms, the lack of a safe structure to house and educate nursing students till the old one is repaired.
• Transfusion transmissible infections: A life-long fear for thalassemia patients (14 Jan. 2023)
• Ensure NAT-PCR in all blood banks in one year: Orissa HC (25 Dec. 2022)
• NTV journalist hospitalized, sends call to TBEN (23 Dec. 2022)
• Thalassemia patient's death: Guj family alleges hospital negligence (20 Dec. 2022)
•  TPAG, ASSOCHAM call for uniform law for safe blood transfusions (5 Dec. 2022)
• Blood bank soon in district civil hospital (5 Dec. 2022)
• Despite 82 existing blood banks, patients face crisis in Assam (3 Dec. 2022)
• Hyderabad-based Thalassemia Sickle Cell Society, President, Shri Chandrakant Agarwal recognized with the most prestigious H. D. Shourie Memorial National Award (3 Dec. 2022)
• Mangaluru: SAC organises Blood Donation Camp (25 Nov. 2022)
• Ayang organizes blood donation camp (25 Nov. 2022)
• All India Institute of Medical Sciences (AIIMS) doctor donates blood to save patient’s life (21 Nov. 2022)
• Without a blood bank, is Shireen Bagh a Super Specialty Hospital? (14 Nov. 2022)
• CPM blood donation camp set on fire, two injured in Tripura (13 Nov. 2022)
• We need to educate and encourage people for Voluntary blood donation: LG Sinha (11 Nov. 2022)
• Blood donations at pre-Covid levels, but surgeries up demand (7 Nov. 2022)
• Owner of UP hospital, where dengue patient died after platelet transfusion, held/arrested (5 Nov. 2022)
• Do all dengue fever patients require platelet transfusion? Health expert explains (4 Nov. 2022)
• Death of dengue patient in Prayagraj: HC lawyer files complaint with UP Human Rights Commission (31 Oct. 2022)
• Dengue patient’s death: Prayagraj CMO cancels registration of hospital (29 Oct. 2022)
• Access to safe and sustainable blood supply: Bedrock of health care (29 Oct. 2022)
• DNB immunohaematolgy and blood transfusion: Admission, medical colleges,fee, eligibilty criteria here (29 Oct. 2022) | Related:
  • DNB immunohaematolgy and blood transfusion in India: Check out NBE released curriculum (28 Oct. 2022)
• High Court stays order for demolition of building housing hospital in 'platelet-fruit juice' controversy (28 Oct. 2022)
• Focus on research papers & patents, Yogi Adityanath tells doctors (28 Oct. 2022)
• Organ transplant made easy in UP, says CM Yogi (27 Oct. 2022)
• Thinking of donating blood? Here are some important things you must keep in mind before and after donation (25 Oct. 2022)
• Dengue patient death: 10 arrested for selling fake platelets In Prayagraj (22 Oct. 2022)
• Bihar stares at platelets crisis as dengue cases surge (22 Oct. 2022)
• King George’s Medical University to adopt PRT to ensure safe blood for transfusion (21 Oct. 2022)
• Dengue patient dies after being transfused with ‘fake plasma’ in UP's Prayagraj; probe ordered (20 Oct. 2022)
• Ex-defence personnel says got HIV in blood transfusion, Supreme Court directs adequate treatment (20 Oct. 2022)
• Lack of safe blood: An ordeal for thalassemia patients (16 Oct. 2022)
• Soaring platelet demand after spike in dengue cases (14 Oct. 2022)
• TPAG, Thalassemics India call for voluntary blood donation (14 Oct. 2022)
• Strengthening India’s blood transfusion system requires a journey from awareness of voluntary blood donation to supportive policy action (12 Oct. 2022) | India successfully created a world record by encouraging more than 2.5 lakh (250,000) people to donate blood for 14 days, which began on Prime Minister Modi’s birthday last month and concluded on 1 Oct, 2022 on National Voluntary Blood Donation Day.
• India reports 2,797 new Covid-19 infections, active cases drop below 30,000 (8 Oct. 2022)
• Delhi set to withdraw 500 Indian rupee fine for not wearing masks as Covid cases dip: Report (5 Oct. 2022) | Note: 500 Indian rupees = ~$6USD
• Chhattisgarh news: Emergency blood transfusion medicine department will open in state medical colleges (3 Oct. 2022)
• Blood donation saves lives (2 Oct. 2022) | It is estimated that over 12,000 persons die every day in India due to non-availability of blood.
• Importance of voluntary blood donation (30 Sept. 2022) | But today national blood supplies are based on 100% voluntary blood donation in just 62 countries, with 40 countries, including India, still dependent on family blood donors and even paid blood donors.
• Donate blood regularly without insisting on certain days (30 Sept. 2022) | National Voluntary Donation Day: Need to increase blood donation among women
• To encourage people to donate blood, a series of camps held in Pune (25 Sept. 2022)
• Dog helps dog as Charlie donates blood to save Maya, sniffer at Karnataka's Hubballi airport (20 Sept. 2022)
• Need to enhance availability of safe blood (17 Sept. 2022)
• Press conference of Sikkim State Blood Transfusion Council (16 Sept. 2022, 11:53 min video)
• Woman holds blood bag for transfusion as daughter sits on hospital floor (15 Sept. 2022)
• Kerala scientist wins international AABB award (13 Sept. 2022)
• Despite directives, replacement blood donation continues unabated in Maharashtra (13 Sept. 2022)
• Indore - ‘Registry of people of negative blood group must be prepared’ (12 Sept. 2022) | Rh negative in only 4-5% of India's population
• Telangana - Thalassemia society registers 2 lakh (200,000) units of blood donation (11 Sept. 2022)
• Safe blood transfusion is still a challenge for thalassemia patients (4 Sept. 2022)
• Docs, hospital asked to pay for blood transfusion death (3 Sept. 2022)
• Bhubaneswar witnesses Dengue spike, 2,309 cases detected in Odisha (3 Sept. 2022)
• Why India has still a long way to go to ensure blood safety (31 Aug. 2022)
• Blood bank shut, Abohar residents on warpath (27 Aug. 2022)
• TN govt doctors object to postings in non-parent departments (20 Aug. 2022)
• Blood bank gets transfusion officer (19 Aug. 2022)
• Bone marrow transplant saves five-year old from monthly blood transfusions (11 Aug. 2022)
• Case against Hyderabad blood bank after 3-year-old patient tests HIV positive (8 Aug. 2022)
• Two patients test HIV positive in Varanasi in last two months after getting tattoos on their bodies (7 Aug. 2022)
• Vijayawada: Blood bank staff in Andhra Pradesh to undergo training in Chennai (3 Aug. 2022)
• Measures to tackle black marketing of blood (2 Aug. 2022)
• Centre releases new National Standards for Blood Centres and Blood Transfusion Services after 15 years (2 Aug. 2022)
• Mumbai's JJ Hospital to start three new courses (1 Aug. 2022) | One is ImmunoHematology transfusion medicine.
• Woman with rare blood disorder treated at Odisha hospital (26 July 2022)
• AP govt. pays special attention for thalassemia patients who require blood transfusion (24 July 2022)
• AP Governor Biswabhusan Harichandan flags off four blood collection vans (24 July 2022)
• Mhow: 20K people to be screened for sickle cell anaemia (24 July 2022)
• Inforpark organizes blood donation camp for a day (17 July 2022)
• A recurrent cry for help and poor culture of blood donation in Nigeria, by Adaeze Oreh (17 July 2022)
• Researchers report India's first EMM-negative blood type case, world's 11th (15 July 2022)
• VP Venkaiah Naidu inaugurates blood transfusion unit & advanced diagnostic lab at TSCS (15 July 2022)
• Focus on preventive steps to ease burden of genetic diseases: VP (14 July 2022)
• Rule out HIV, hepatitis, syphilis: Pune's Mylab pushes govt, blood banks to adopt NAT-tested transfusions (7 July 2022)
• Give platelet test kits at subsidised rates: NGO (7 July 2022)
• Gandhi Memorial College Srinagar organises blood donation camp (1 July 2022)
• 14,000 employees participate in blood donation camp by Adani Foundation (26 June 2022) | Every year, on the Chairman’s birthday, the Adani Foundation organises a voluntary blood donation drive in line with the Adani Group’s philosophy of serving the nation and its people in multiple ways.
• No meds to raise platelet count after dengue fever, warn docs (23 June 2022)
• Nashik-based blood bank felicitated (19 June 2022)
• 3-month-old leopard cub receives blood transfusion at RESQ (16 June 2022)
• India's COVID-19 tally crosses 8k mark for second consecutive day; 8,582 fresh infections reported (11 June 2022)
• In Pune, a call for better blood screening standards to reduce infections through transfusions (10 June 2022)
• This Mumbai-based organisation's noble initiative brings ease to cancer patients, creates blood donation database (9 June 2022)
• Kasturba Hospital Blood Centre receives award ISBT Award for developing country (8 June 2022)
• Union Health Ministry engages with all states/UTs to review the preparation of World Blood Donor Day on 14th June (7 June 2022)
• Wrong blood transfusion resulting in death, a case of medical negligence; NCDRC (6 June 2022)
• Centre calls on all health centres to set up blood testing camps on World Blood Donor Day (6 June 2022)
• Transfusion of wrong blood kills 2 in Keonjhar, probe ordered (31 May 2022)
• Uttar Pradesh health worker took bribe for blood transfusion, then gave patient glucose mixed with red medicine (30 May 2022)
• 4 children become HIV positive after blood transfusion In Nagpur, 1 dies (26 May 2022) | Related:
  • Nagpur: Food and Drugs Administration begins probe into HIV through blood transfusion (27 May 2022)
• MS Education Academy offers free education to thalassemia students in Telangana (25 May 2022)
• Team effort helps patient with rare rare Bombay blood type (11 May 2022)
• Telangana governor lauds Red Cross Society (9 May 2022)
• Experts see blood stem cell transplant as a curative treatment for thalassemia (9 May 2022)
• 9-yr-old Rohtak child gets new lease of life (7 May 2022)
• Hospital ordered to compensate for patient’s death (7 May 2022)
• Blood stem cell transplantation shows 90% success rate in thalassemia patients who have HLA matched stem cell donors (5 May 2022)
• Impact of pandemic and way forward for thalassemia patients in India (4 May 2022)
• NGOs call on govt to adopt new WHO guidelines for management of cryptococcal meningitis (4 May 2022) | related:
  • New guidelines from WHO recommend a simpler, safer treatment for cryptococcal disease in people living with HIV (20 Apr. 2022)
• Sickle cell disease afflicts 872 children in Balaghat area (26 Apr. 2022)
• HIV+ blood transfusion: Bathinda police book 2 lab technicians after VB probe (22 Apr. 2022)
• The model donor:55-yr-old becomes one of the few women to have donated over 100 units of blood (12 Apr. 2022)
• Botched transfusion killed 45-year-old in Ahmedabad: Kin (8 Apr. 2022)
• HIV+ blood transfusion in Bathinda: 3 months on, VB probe report gathers dust (25 Mar. 2022)
• Only the 4th hospital in Nagaland to have a functional blood centre (19 Mar. 2022)
• Maharashtra: New RT-PCR kit out to check donated blood for infections (15 Mar. 2022)
• Indian Institute of Technology (IIT ISM) students chip in to end blood crisis in Dhanbad (27 Feb. 2022)
• 14 yrs, 400 blood transfusions later, 75-yr-old gets new life (24 Feb. 2022)
• 3rd wave impact: Blood transfusions hit hard (10 Feb. 2022)
• Covid-19 effect: Govt Rajindra Hospital, Patiala, faces blood shortage (29 Jan. 2022)
• Mumbai: Blood banks to reserve blood units for patient with blood disorders (21 Jan. 2022)
• Mancherial doctor, teachers collect 53 units of blood for thalassemia patients (16 Jan. 2022)
• Blood banks in Mumbai on alert, will start camps in housing societies (9 Jan. 2022)
• Double-lung transplant conducted without ECMO, on beating heart, without a single blood transfusion (6 Jan. 2022)

Indonesia

• The Port Moresby General Hospital appeal for blood donations (31 Dec. 2022)
• Aussie tourist who sliced open an artery in a freak accident at his Bali hotel is miraculously saved by his fiancée's desperate call-out (29 Dec. 2022)
  

Iran

• Blood donation rises by 9.5% in 11 months (4 Mar. 2023)
• Blood donation in Iran nearly twice Eastern Mediterranean average (18 Feb. 2023)
• Tehran to host first G5 blood transfusion organizations meeting (31 Jan. 2023)
• More than 1.7m Iranians donate blood in 9 months (7 Jan. 2023)
• Don’t forget to ‘donate blood’ in cold season (18 Dec. 2022)
• Blood Transfusion Organization receives AATM award (12 Dec. 2022)
• Oman praises Iran for saving pregnant mother with blood donation (27 Nov. 2022)
• Over 1.4m Iranians donate blood in 6 months (15 Oct. 2022)
• Australia-bound Iranian PhD candidates see hopes fade amid unrest (28 Sept. 2022)
• Iran holds 29% share of blood donation in EMRO (27 Sept. 2022)
• Nearly one million people donate blood in 5 months (2 Sept. 2022)
• Blood transfusion organization announces development plans (23 Aug. 2022)
• Iranians donate 13% more blood (4 July 2022)
• WHO, IBTO discuss fields of joint cooperation (20 Apr. 2022)

Ireland

• Irish Blood Transfusion Service issues urgent appeal for donations amid 'critically low' stocks (25 Jan. 2023)
• Covid numbers tumble in hospital as overcrowding crisis eases further (22 Jan. 2023)
• ‘I didn’t do it for charity or sympathy ­ I had no choice’ (13 Jan. 2023)
• IBTS urges donors to ensure blood is available for patients into the New Year (29 Dec. 2022)
• 'We buried our beautiful sons' - Irish couple's heartbreak after death of identical twins due to TTTS (29 Nov, 2022)
• Faulty phones and no-shows hinder work of blood transfusion service (27 Nov. 2022)
• Blood donation rules change to focus on individual risk assessment rather than sexuality (15 Nov. 2022)
• Tribunal on Ireland’s infected blood scandal led to treatment ‘culture change’ (8 Nov. 2022)
• Library resource (HSE): Blood transfusion leaflets (In 7 languages)
• Limerick people urged to give blood due to "very challenging" low supplies (5 Oct. 2022)
• Health system suffers blood shortage amid hospital demand (4 Oct. 2022)
• Health Minister Donnelly welcomes IBTS annual report and thanks those who save lives by donating blood (21 Sept. 2022) | Related:
  • ISBT 2021 Annual Report
• Solicitor to chair Irish Blood Transfusion Service (22 Aug. 2022)
• Urgent appeal for blood donations as supplies run low (27 June 2022)
• New research to help address blood shortages in Ireland (17 June 2022) | Related:
  • Fogarty H, Sardana M, Sheridan L, et al. Motivators and barriers to blood donation among potential donors of African and Caucasian ethnicity. Blood Transfus 2022. Epub 12 June, 2022. (Free access)
• Irish hospitals warned of serious challenges to blood stocks (7 Apr. 2022)
• Nation reduces deferral period for MSM, donors taking PrEP (6 Apr. 2022)
• The Irish Blood Transfusion Service says its ‘closer than ever’ to declaring amber alert amid critical shortage of blood supplies (17 Mar. 2022)
• Irish blood donation bags and masks on way to Ukraine (11 Mar. 2022)
• IBTS’s National Donor Screening laboratory is the first medical science laboratory to achieve ‘Green’ certification status (25 Feb. 2022)
• Baby died ‘gasping for breath’ over 13 hours after doctors withdrew care, court hears (26 Jan. 2022) | Lawyer said 'the expert evidence makes clear the baby was born with a “very significant” loss of blood and that a blood transfusion should have taken place within a few minutes of his birth.
• Drop in blood donations may mean supplies will soon need to be imported (12 Jan. 2022)
• National canine blood bank should also be set up in Ireland, top animal hospital says (2 Jan. 2022)

Isle of Man

• Isle of Man to update blood donation rules for gay men (16 Aug. 2022) | It's a self-governing British Crown Dependency with its own parliament, government and laws.

Israel

• A change of heart? Israel may drop ban on Brits giving blood related to CJD (19 Oct. 2022)
• How Israeli doctors treated a patient, whose faith forbids receiving blood transfusion (12 Oct. 2022)
• New shielded MDA Blood Services Center 1st of its kind worldwide (2 May 2022) | The facility was built at a cost of $135 million, funded primarily by American Friends of Magen David Adom (AFMDA).

Italy

• “He contracted hepatitis from a transfusion of infected blood”: Ministry of Health condemned (28 Oct. 2022)
• How is the man who caught the mosquito virus (WNV). Controls in Marsala (20 Sept. 2022)
• A two-year-old is waiting for surgery. Parents did not agree to blood transfusions from those who were vaccinated (11 Feb. 2022)
• US film-maker tried in Italy on fascist-era charge over tainted blood testimony (20 Jan. 2022)

Jamaica

• Supreme Ventures Limited (SVL) embarks on mega blood drive (28 Jan. 2023)
• The importance of giving blood with Jamaican Abi-Gaye T. Smythe (15 Jan. 2023)
• Blood drive saves Massy Distribution staff member (30 July 2022)
• A plea for blood donations for former Senator Delano Franklyn (30 Sept. 2022)
• Blood transfusion service issues call for blood donors (10 June 2022)
• Optimist Club hosts blood drive in Negril (19 Feb. 2022) | It's needed because of high incidents of crime,violence, and accidents

Japan

• Ex-Jehovah’s Witness opens up about trauma brought by faith (27 Feb. 2023)
• Japan lawyers to report on religion-based refusal of blood transfusions for kids (27 Feb. 2023)
• Legend Biotech wins approval of Carvykti for multiple myeloma in Japan (27 Sept. 2022)
• Japan pharma cranks up output of COVID vaccine materials (5 May 2022)

Kenya

• UNAIDS welcomes Kenya’s High Court judgement in landmark case of involuntary sterilization of women living with HIV (20 Dec. 2022)
• Kajiado has deficit of 3,420 pints of blood ­ official (19 Nov. 2022)
• Mandera satellite blood collection centre nears completion (23 Oct. 2022) | Kenya requires between 500, 000 and one million units of blood a year, yet collects less than a quarter of that volume.
• Kenya targets to collect 200,000 units of blood before December (30 Aug. 2022)
• Radical shift as President Kenyatta creates Kenya tissue and transplant authority (4 Aug. 2022)
• Relief as first ever blood bank opened in Lamu (2 Aug. 2022)
• Reforms in the blood transfusion unit yields remarkable improvement in service delivery (1 July 2022)
• Kenyans to be paid-in-kind for donating blood (16 June 2022)
• National Blood Transfusion Service installs system to stop blood theft (21 Feb. 2022)
• Kericho launches blood transfusion ambulance (30 Jan. 2022)

Kuwait

• MOH again launches blood donation campaign to coincide with 32 anniversary of IraQ's invasion of Kuwait (28 July 2022)
• Indians and Egyptians involved in blood test fraud (19 Feb. 2022)

Luxembourg

• Luxembourg Red Cross calls for blood donations (3 Aug. 2022)

Malawi

• CDH Investment Bank invests K2m towards procurement of blood bank fridge for MBTS (26 Apr. 2022)
• Illovo Sugar donates K13.1 million blood bank fridge to Lower Shire districts (4 Mar. 2022) | 13.1 million K equals $15,974.10 USD

Malaysia

• Budget 2023 shows higher reliance on contract doctors (10 Oct. 2022) | Significant percentage increases in emoluments were noted in blood transfusion services and more.

Malta

• Blood transfusion service's message to motorists: please drive safely (30 Jan. 2023)
• Blood Transfusion Service appeals for responsible driving during New Year celebrations (29 Dec. 2022)
• BOV employees respond enthusiastically to blood drive (11 Dec. 2022)
• A blood transfusion saved Luigi's life. Now he's paying it forward (14 June 2022)

Mexico

• Andrés García needs a blood transfusion for this reason (20 Jan. 2022)

Monaco

• Prince Albert II sets example by donating blood (24 Nov. 2022) | Don't play the video as it's in French/français | Related:
  • To make travel easier and blood donation even quicker, the Bloodmobile will pick you up, take you to give blood and drive you back home or to work.

Namibia

• Only 1% of Namibians donate blood (8 Jan. 2023)
• In Namibia, blood donations rise thanks to free transport to donor clinics (17 June 2022)

Nepal

• Blood bank warns of a looming crisis in two days amid a rapid surge in dengue cases (20 Sept. 2022) | Related:
  • As dengue becomes endemic to Nepal, infection, mortality risks escalate (20 Sept. 2022)
• Bagmati Province government ensures free blood transfusion service for needy (12 Sept. 2022)
• Spike in dengue cases leads to acute blood shortages (7 Sept. 2022)
• Surgeries affected at Karnali Academy of Health Sciences in lack of a blood bank (22 Aug. 2022)
• Blood transfusion turns costlier as govt ups the per-unit cost (5 June 2022) | 810-1640 Nerpalese rupees is $6.44-$13.04 USD;average salary in Nepal is $644 USD/mth

Nigeria

• Heart Surgery: Foundation, hospital solicit support for five-year-old (21 Feb. 2023)
• Lagos State Blood Transfusion Service (LSBTS) allays fear over blood wastage (13 Feb. 2023)
• Nigeria open to new technologies in medicine ­ NBSC (24 Dec. 2022)
• More patients at risk as myths drain blood banks (23 Jan. 2023)
• Blood unsafe for use after leaving bank ­ experts (15 Nov. 2022)
• Kelina inaugurates ultra-modern hospital in Lagos (12 Nov. 2022)
• Federal Government declares Dec. 8 National Blood Donor Day (18 Oct. 2022)
• Kaduna govt., UNFPA upgrade 10 facilities for blood transfusion (18 Oct. 2022)
• Kogi seals off ‘prayer house offering blood transfusion, psychiatric services’ (26 Sept. 2022)
• Commission boss decries unregulated blood transfusion (17 Aug. 2022)
• A database of donors Is filling blood supply gaps In Nigeria (26 July 2022)
• Blood transfusion: Donors, recipients protected by law ­ Commission (29 June 2022)
• Addressing acute blood shortage in Nigeria (23 June 2022)
• Blood transfusion turns costlier as govt ups the per-unit cost (5 June 2022) | 810-1640 Nerpalese rupees is $6.44-$13.04 USD;average salary in Nepal is $644 USD/mth.
• Automation of blood transfusion process to start soon (18 May 2022)
• Lagos govt partners civil society to advocate increase in blood donation (15 May 2022)
• Lack of blood donors, funds make transfusion difficult ­- Expert (15 May 2022)
• Embrace voluntary blood donation, Lagos govt urges citizens (12 May 2022)
• Lions Club partners Lagos State Blood Transfusion Service on annual target for blood donation (26 Mar. 2022)
• Sylvester Oromoni: Pathologist who conducted first autopsy testifies (14 Mar. 2022)
• Lagos State Blood Transfusion Service tasks blood logistics firms on quality service (13 Mar. 2022)

Norway

• Norway to assess changes to donor eligibility for MSM (31 May 2022)

Oman

• Call for blood donation as donor numbers fall (5 Apr. 2022)

Pakistan

• CM orders steps to combat dengue, coronavirus (18 Mar. 2023)
• Child killed, two injured in Waziristan blast (28 Feb. 2023)
• Awareness on prevention of thalassemia emphasised (28 Dec. 2022)
• Efforts urged to control thalassemia (18 Oct. 2022)
• 8,000 children born every year with thalassemia major: expert (14 Oct. 2022)
• Pakistan flood survivors battle rising tide of disease (20 Sept. 2022) | Health officials in Sindh Province... say they've seen a dramatic spike in cases of malaria, dengue and diarrhoea, as displaced families live in the open next to stagnant water.
• Unnecessary platelets transfusion revealed in dengue patients in Karachi (17 Sept. 2022)
• Health Dept. to outsource three regional blood centres (22 Aug. 2022)
• Policemen donate blood on Police Martyrs’ Day (6 Aug. 2022)
• Blood donation camps arranged in 4 districts (5 Aug. 2022)
• Bill to convert safe blood transfusion project to permanent tabled in assembly (18 July 2022)
• Students urged to become advocate for blood donation (3 July 2022)
• Blood transfusion centre approved at cost of Rs 80 million (26 June 2022) | 80 million Pakistan rupies is $384,259 USD
• Fatimid Center being established in DI Khan in collaboration with OGDCL (7 May 2022) | The Fatimid Foundation manages the largest blood bank & transfusion services in Pakistan and provides free of charge transfusion to its 14000+ registered underprivileged patients of thalassemia, hemophilia and other genetic blood disorder patients across the country.
• ‘Better health care increasing life expectancy of kids with thalassaemia’ (25 Apr. 2022)
• Safe blood transfusion (21 Apr. 2022) | Related: See 5 Apr. below
• Unsafe blood transfusion spreading hepatitis, HIV in haemophilia patients (18 Apr. 2022)
• Govt urged to allocate funds for haemophilia patients in budget (17 Apr. 2022)
• Sindh Blood Transfusion Authority, bleeding disorder community celebrate World Hemophilia Day (16 Apr. 2022)
• Expert urges public to donate blood for 'thalassemia' patients during Ramazan/ Ramadan (16 Apr. 2022)
• Safe blood transfusion (5 Apr. 2022) | Prevalence of unsafe medical practices has been a long-standing problem in Pakistan...The authorities need to wake up to the high human, financial, social and emotional cost of the absence of regulation of the health sector where unsafe medical practices proliferate.
• Health dept’s blood collection initiative focusing on students (27 Feb. 2022)
• Abandoned again (27 Feb. 2022) | Fifty years since the fall of Dhaka, the Bihari community continues to suffer systemic discrimination.
• Peshawar High Court orders blood transfusion of child suffering from rare disease (17 Feb. 2022)
• Sundas Foundation plans to set up hospital (31 Jan. 2022)

Panama

• Panama City hospitals tighten visiting restrictions as COVID-19 cases rise (11 Jan. 2022)

Papua New Guinea

• Hospital’s blood bank in dire need of blood donation (31Jan. 2023)
• Doctor appeals for more blood donors (15 June 2022)
• Little Peter, a boy with retinabloma, chronic anemia, and iron deficiency will undergo surgery this week (1 Mar. 2022)

Philippines

• PRC-Malabon, CMU to conduct life-saving mobile blood donation drive (24 Feb.2023)
• Cancer aid fund now accessible in Davao’s public hospital (17 Feb. 2023)
• PWDs encouraged to donate blood (19 Sept. 2022)
• NegOcc to reactivate infectious disease body vs. monkeypox (5 Aug. 2022) | NegOcc is a province on the island of Negros in the Philippines.
• NegOcc steps up blood drive due to dengue threats (2 Aug. 2022)
• Gordon touts blood requirements provided by PRC for dengue cases (23 July 2022)
• SM Foundation's blood donation drive generates 4,000 bags (21 July 2022)
• Girl with leukemia appeals for urgent help (20 Apr. 2022)
• Army conducts bloodletting to aid troops, dependents (30 Mar. 2022)

Portugal

• Experience accumulated over 18 months in Santarém District Hospital in Portugal demonstrates significant impact of Biolog-id solution (3 Aug. 2022)

Qatar

• Blood donation increases during Ramadan in Qatar (27 Apr. 2022)

Romania

• The Hem Association and the National Blood Transfusion Institute (INTS) launch a segmented campaign to communicate the need for blood (7 Mar. 2023)

Rwanda

• Rwanda Biomedical Centre issues critical appeal for type O blood donations (14 Aug. 2022)
• Rwanda looks to meet blood transfusion demand by 2025 (14 June 2022)
• Drones have transformed blood delivery in Rwanda (23 Apr. 2022) 

Saudi Arabia

• Dallah Hospital Riyadh performs first-ever rare procedure on fetus (24 Oct. 2022)
• Blood transfusion at IMC for patients with complex conditions qualifies him for surgery (29 June 2022)
• Transfusion Medicine & Stem Cells Master of Biomedical Sciences at Alfaisal University

Senegal

• Senegal takes to social media to boost blood donations (16 June 2022)

Seychelles

• Low turnout for Seychelles' blood donation drive (11 Dec. 2022)

Singapore

• More asked to defer donating blood after they travel overseas with borders reopening (3 Dec. 2022)
• SMART and NTU researchers develop test to detect immunity against Covid-19 (22 Sept. 2022) | SMART: Singapore-MIT Alliance for Research and Technology | Related:
  • Antimicrobial resistance is a global threat to public health, agriculture and food security
• Singapore is facing a dengue fever 'emergency' and peak season has only just begun (12 June 2022)
• Singapore approves clinical trial of TCR-T cell therapy for liver cancer (9 May 2022) | SCG101 is being developed to treat HBV-related liver cancer, the most common liver cancer.
• Forum: Extra care taken with seniors who are first-time blood donors (8 Feb. 2022)
• Number of young blood donors in declining in worrying trend: Singapore Red Cross (6 Mar. 2022)

Somalia

• Improving access to blood and transfusion services in Somalia (9 Aug. 2022)

South Africa

• Plea for blood donors as stocks run low (16 Feb. 2023)
• KZN mom in desperate search for stem cell donor for leukaemia-stricken 12-year-old daughter (12 Nov. 2022)
• Durbanites work together to donate O Rh negative blood to teen in need (16 Sept. 2022)
• Call to donate blood urgently (29 July 2022)
• Inside the Onderstepoort Animal Blood Bank, where dogs are prolific donors and lifesavers (21 July 2022)
• South Africa seeing another Covid surge, this time from new omicron subvariant, BA.4 (29 Apr. 2022) | Daily cases are over 6,000 per day, up from a few hundred just a few weeks ago.
• Patient blood management key for improving South Africa’s healthcare (9 Feb. 2022)

South Korea

• Bill in South Korea aims to boost blood donations for pets (22 Jan. 2023)
• Industry news: South Korea's Seegene develops Novaplex MPXV Assay for monkeypox virus detection (29 June 2022)
• BMS Korea gets regulatory nods for 2 myelofibrosis treatments (11 May 2022) | As Korea's blood stocks have plummeted due to the prolonged Covid-19 pandemic, the company expects that Reblozyl's effect on reducing blood transfusion requirements will help the country’s blood supply.
• 18,478 Shincheonji Church members donated blood to solve the blood shortage across South Korea (11 May 2022)

Spain

• UNAIDS welcomes the announcement that Spain will be making a new € 1 million contribution to UNAIDS (6 Jan. 2023)
• First out-of-hospital blood transfusion in Andalucía is carried out by an air ambulance crew in Ronda (5 May 2022)
• Malaria case in woman prompts a number of hypotheses (14 Feb. 2022)

Sri Lanka

• National blood transfusion center receives a donation of ELISA test kits worth Rs. 45 million (13 Oct. 2022) | 45 million Sri Lankan rupees = $122,215USD
• Act responsibly, blood bank can’t cope with emergency (17 July 2022)
• Sri Lankans in Australia are doing what they can to support those in their motherland (9 July 2022)
• Functions at National Blood Transfusion unit to turn critical soon (15 June 2022)
• Donating blood benefits donors and recipients health wise (12 June 2022) | NBTS officials say that they are now facing new challenges due to the severe shortage of foreign reserves and inflation which has crippled the country’s economy.
• National Blood Transfusion Service calls for critical donations of quality-assured consumables (4 May 2022)
• No HIV transmission by blood transfusion in last few years (29 Apr. 2022)
• No shortage of blood components - official (27 Apr. 2022)
• On Freedom Day, Arosha was discharged free of thalassaemia after first ever allogeneic bone marrow transplant in country (13 Mar. 2022)

Sweden

• Swedish Public Health Agency recommends 2nd booster for elderly (14 Feb. 2022)

Switzerland

• Blood shortage forces Swiss to consider their options (21 Aug. 2022)
• Industry news: Quotient receives CE mark for its MosaiQ extended IH microarray (14 Mar. 2022)

Taiwan

• Man to be paid NT$400,000 for adverse reactions to COVID-19 vaccine (15 Oct. 2022)
• Nation orders 700K units of Pfizer's COVID-19 pill as infections rise (11 Apr. 2022)

Tanzania

• Bank employees donate blood to the National Blood Transfusion Service (27 June 2022)
• Why voluntary blood donations should be encouraged (23 May 2022)
• Blood transfusion centres receive continental quality accreditation (14 May 2022)
• Tanzania targets 70 accredited blood transfusion centres (9 May 2022)

Thailand

• Thai Red Cross urges foreigners to donate Rh-negative blood to assist western tourists in emergencies (25 Feb. 2023) | Related:
  • Westerners asked to donate rare blood (24 Feb. 2023) | Only 0.3% of Thais are Rh negative

Trinidad and Tobago

• Mt Hope vet school: Blood transfusion can save your dog's life (12 Mar. 2022)

UAE

• Thalassaemia trials aim to reduce burden of blood transfusions for patients (20 Feb. 2023)
• Abu Dhabi to conduct clinical trials to develop thalassemia treatments (13 Feb. 2023)
• Abu Dhabi: SEHA urges residents to donate blood and save lives (27 Apr. 2022)

Uganda

• Women with HIV in Uganda have higher risk for chronic lung disease (18 July 2022)
• Collectors defy odds as demand for blood grows (14 Jan. 2023)
• Uganda declares end of Ebola disease outbreak (11 Jan. 2023)
• Acute blood shortage hits Uganda (3 Jan. 2023)
• MoH receives second batch of Ebola vaccine for clinical trials (22 Dec. 2022)
• WHO challenges Uganda to do more to attain universal health coverage (13 Dec. 2022)
• Ebola in Uganda: Three-week lockdown announced for two districts (15 Oct. 2022)
• Ebola disease caused by Sudan virus (26 Sept. 2022)
• Uganda wins bid to host Africa blood transfusion conference (26 Aug. 2022)
• Uganda seek to make sickle cell screening mandatory for couples before marriage (24 June 2022)
• Uganda needs 450,000 units of blood annually to save lives (18 June 2022)
• UBTS seeks law to punish persons selling blood (20 May 2022)
• Committee picks Health Centre IVs over hospital (23 Apr. 2022) | The money would ensure the facilities are equipped with blood transfusion services...
• MOH: 90% of Health Center IVs cannot offer blood transfusion (10 Feb. 2022)

UK

• Jump to Infected Blood Inquiry
• SHOT celebrates its Silver Jubilee in 2022
• Jersey blood donation a 'priority' for PFAS panel (17 Mar. 2023)
• Air ambulance service which covers Milton Keynes to trial the use of whole blood (13 Mar. 2023)
• New facility boosts UK’s cell and gene therapy manufacturing capacity (10 Mar. 2023)
• Blood and blood products for animal treatment (7 Mar. 2023)
• Mia the dog saved from death by blood transfusion at Cambridge vets (21 Feb. 2023)
• Scotland: Male blood donors still being turned away by SNBTS if they refuse to answer pregnancy question (18 Feb. 2023)
• Nearly 250,000 potential donors yet to give blood (15 Feb. 2023)
• Why is Britain’s health service, a much-loved national treasure, falling apart? (23 Jan. 2023) | Related:
  • NHS strike dates: Why are nurses and ambulance staff taking industrial action? (3 Feb. 2023)
• NHS-used premature baby milk urgently recalled over lead contamination fears (9 Jan. 2023)
• Research, innovation and health inequalities of blood transfusion (6 Jan. 2023) | Related:
  • Genetics and machine learning can improve blood transfusion outcomes (20 Dec. 2022)
• Gogglebox fans praise Tom Malone for 'saving lives' with blood donation (1 Jan. 2022)
• Longbenton boy, 12, who doctors first thought had long Covid is diagnosed with rare cancer (30 Dec. 2022)
• Mum's joy as sick son battles through three blood transfusions to make it home for Christmas (25 Dec. 2022)
• London's air ambulance takes part in 'whole blood transfusion' trial (15 Dec. 2022)
• UK air ambulances will carry whole blood in new clinical trial (14 Dec. 2002) | Related:
  • Air Ambulances begin trial transfusing ‘whole blood’ to potentially improve civilian and military trauma care (14 Dec. 2022)
• Patients with major blood loss to get ‘whole blood transfusions’ in new trial (14 Dec. 2022)
• Why Black blood donors so important for sickle cell treatment (9 Dec. 2022)
• Cayman Islands: Cayman retains ‘mad cow’ blood-donation ban (6 Dec. 2022)
• Scotland: Scottish Blood Transfusion Service looking for new donors over festive season (5 Dec. 2022)
• Asian-origin family claims NHS’ racial stereotyping caused senior member’s death: ‘We lost faith in NHS’ (22 Nov. 2022)
• ‘She absolutely loves it’: the dogs donating blood and saving lives (19 Nov. 2022)
• Sickle cell patient using condition to help future generations (28 Oct. 2022)
• ‘My blood transfusion was delayed for a month ­ I was in so much pain I was unable to walk’ (27 Oct. 2022)
• MY PAIN I live in constant agony that’s like a gunshot wound – but clueless doctors label me a ‘drug-seeker’ (24 Oct. 2022)
• NHSBT: Blood donors are urged to book ahead by NHS bosses to stave off prolonged winter crisis (22 Oct. 2022)
• ‘Hero’ horse helps save the life of critically ill pony (18 Oct. 2022)
• Scotland: Scotland blood stock appeal after England supplies fall (13 Oct. 2022)
• NHSBT: First ever amber alert for NHS blood supplies could mean cancelled surgery (12 Oct. 2022)
• N. Ireland: Northern Ireland blood transfusion service calls for those with type A and O blood to donate after ‘urgent low’ stock (12 Oct. 2022)
• NHSBT: Record demand for blood donations to help sickle cell patients prompts urgent call for more donors of Black heritage (6 Oct. 2022)
• Sickle cell - 'Blood transfusions have saved my life many times' (6 Oct. 2022)
• N. Ireland: NHSBT makes ‘urgent’ call for black blood donors (5 Oct. 2022)
• Covid-19 Inquiry: start of Preliminary Hearings (30 Sept. 2022)
• The one thing the Queen and her heirs always travel with (19 Sept. 2022)
• British Muslim charity breaks world record for most blood donations in a day (17 Sept. 2022)
• ‘I might need a blood transfusion’: Pregnant woman has hospital appointment cancelled for Queen’s funeral (15 Sept. 2022)
• NHSBT: Saved in the womb (Latest stories)
• Preston dad suffers 60% blood loss in chainsaw accident (7 Sept. 2022)
• Oxfordshire vet appealing for dog blood donations? (2 Sept. 2022)
• Sufferers of rare genetic blood disease plead with NHS for 'life-changing' US gene therapy which costs £1.5m per patient - after it was rejected for being too expensive (20 Aug. 2022)
• Wales: Generous Gareth reaches 100th blood donation (11 Aug. 2022)
• Timely reminder for potential Covid-19 Inquiry litigants (3 Aug. 2022) | Related:
  • UK Covid-19 Inquiry launches first investigation (21 July 2022)
  • The view from afar: litigation trends arising from the COVID-19 Inquiry (12 May 2022)
• Wrong blood given to patients at Birmingham hospitals and are mistakes that should never happen (1 Aug. 2022) | Ineffective record keeping has been blamed
• Blues x Give Blood: Beverley Momenabadi (22 July 2022) | Another of her aims is to encourage more people from Black, Asian and Minority Ethnic backgrounds to come forward. Her reasoning agrees with what the NHS and Blood UK state, with fewer than 5% of blood donors who donated in the last 12 months being from those communities.
• Victims of Hillsborough, Grenfell, and nuclear tests unite to demand an end to cover-ups (19 July 2022) | MPs and campaigners for Covid-19 bereaved families, Zane Gbangbola and contaminated blood are fighting for a new law that would end official cover-ups
• Our baby girl will die without a stem cell or bone marrow donation– we’re offering £20k to anyone who’s a match (12 July 2022)
• £1 billion in funding announced for the Francis Crick Institute (10 July 2022)
• N. Ireland: Mayor urges Derry people to ‘Do it for Daniel’ and become stem cell donors (8 July 2022)
• Boy born weighing less than a bag of sugar has life threatening condition (1 July 2022) | He has Diamond Blackfan Anaemia is forced to have a monthly blood transfusion to keep him alive.
• Delayed public inquiry into UK’s Covid-19 response opens (28 June 2022)
• 'Blood transfusions gave me an extra 24 hours with my dying mum - now I give blood in her memory' (20 June 2022)
• NHSBT: National Blood Week: More than 3,300 new blood donors are needed in Devon (19 June 2022)
• Scotland: Male blood donor turned away from clinic for refusing to say if he’s pregnant (18 June 2022) | SNBTS: ‘Whilst pregnancy is only a relevant question to those whose biological sex or sex assigned at birth is female, sex assigned at birth is not always visually clear to staff.'
• NHSBT: Black donor who has given the most blood of the most in demand type (16 June 2022) | Peter Jones has donated R_o blood 102 times
• NHS says one million more blood donors are needed in next five years (12 June 2022)
• Blood drives scheduled to aid community, benefit leukemia patient Kenzie Gulick (7 June 2022)
• NHSBT: Donated blood has kept us together (Includes 2:07 min. video) | Suki is one of the youngest sickle cell patients to rely on regular blood transfusions.
• Scotland: Lanarkshire man helps hundreds of people by donating 150 pints of blood over the years (24 May 2022)
• Leona Harris: Fairfield nurse vows to fight on after 'whitewash' appeal decision (18 May 2022) | Related:
  • Employment Tribunal of Leona Harris (18 Oct. 2019) | The complaint of unfair dismissal is not well-founded and is dismissed.
• NHSBT: £20 million for new blood and transplant research units - with Oxford University partnership (16 May 2022)
• Scotland: Readers' Letters: New donor questions too bleeding political (16 May 2022)
• Scotland: Scots cancer teen thanks ‘lifesaver’ blood donors as brave fighter leaves hospital (10 May 2022)
• Norfolk leukaemia patient in diverse heritage donor call (7 May 2022)
• NHSBT: ‘Doctor Strange in the Multiverse of Madness’ stars inspire public to ‘become real-life heroes’ by donating blood as NHS teams up with Marvel Studios (5 May 2022)
• Northumberland rescue dog who nearly died from random wound is saved by blood transfusions (3 May 2022)
• Scotland: SNP accused of sowing division with Scot or British blood donor question (26 Apr. 2022)
• Wales: Two dogs, one special connection: The tale of Bridget, Cora and the gift of life (18 Apr. 2022) | Two dogs met for the first time after a blood transfusion from one dog saved the other's life.
• Black church leaders call for black and mixed-race blood and organ donors – amid ‘urgent shortage’ (15 Apr. 2022)
• Scotland: Celebration as Blantyre man makes incredible 700th blood donation (11 Apr. 2022)
• Anticipation key to tackling perioperative anemia (7 Apr. 2022) | British Society for Haematology 62nd Annual Scientific Meeting: Abstract BSH22-PO119. Presented April 4, 2022.
• Poorly Harrogate boy, 6, has to sleep with needle in his leg every night and gets transfused every 3 weeks (27 Mar. 2022)
• I've had a blood transfusion every 3 weeks since I was 2 months old due to a rare disease that can kill people in their 30s (17 Mar. 2022)
• MHRA: Medicines and Healthcare Products Regulatory Authority issues marketing authorisation for Aspaveli® (pegcetacoplan) in adults with paroxysmal nocturnal haemoglobinuria (1 Mar. 2022) | Related:
  • NICE recommends Aspaveli ahead of MHRA decision (9 Dec. 2021)
• Lanarkshire schoolgirl champions pioneering campaign to persuade young people to give blood (26 Feb. 2022)
• Library resource (UK - SHOT): Part 1 (5:11 min. video): Anti-D immunoglobulin errors and immunisation in pregnancy: Insights from SHOT (24 Feb. 2022)
• Library resource (UK - SHOT): Part 2 (5:19 min. video): Anti-D immunoglobulin errors and immunisation in pregnancy: Insights from SHOT (24 Feb. 2022)
• NHSB: Mother of three has sickle cell disorder and receives red cell exchanges every five weeks Related:
  • NHSBT: Down memory lane | Many stories of long time blood donors
• Dad thanks blood donors for giving him three extra years with son who died aged 11 (14 Feb. 2022)
• The Air Ambulance Service -TAAS brings blood on board (11 Feb. 2022) | TAAS press release
• New transfusion medicine course for VNs and technicians launched (3 Feb. 2022)
• Scotland: Hero pooch Missy donates blood and saves a life after dog plunged from Salisbury Crag (27 Jan. 2022)
• N. Ireland: Dundonald three-year-old battling cancer asks public to give blood instead of gifts for birthday (19 Jan. 2022)
• NHSBT resumes convalescent plasma collection on a small scale (17 Jan. 2022)
• SHOT issues alert on preventing transfusion delays in bleeding and critically anaemic patients (17 Jan. 2022)
• Expect another omicron wave in early summer, SAGE says (14 Jan. 2022) | SAGE
• N. Ireland: Northern Ireland blood transfusion service issue appeal after donations fall by a third (12 Jan. 2022)
• 'Blood transfusions saved my life but a delay in blood donation rule changes had put Black communities at risk' (10 Jan. 2022)
• Infected Blood Inquiry+
• Dorset widower backs prosecution calls for 'worst treatment disaster in NHS history' (13 Feb. 2023)
• Mother found out her sons had HIV from the list on the hospital fridge (7 Oct. 2022)
• HIV: How 175 British children were infected with disease (6 Oct. 2022)
• Mother tells blood inquiry of her 'guilt' over death of her son who died aged 24 after he got HIV from infected batch of clotting product Factor VIII which was used to treat his haemophilia (6 Oct. 2022
• **Infected Blood Inquiry NEWS ITEMS**
• Infected Blood Inquiry: Victims including Treloar pupils await report (9 Feb. 2023)
• The infected blood scandal ­ how a key warning was ignored (6 Feb. 2023)
• Infected Blood Inquiry chair says final report due 'in autumn' but promises 'there will be criticism' (4 Feb. 2023)
• Norfolk: Blood scandal victim Michelle Tolley speaks out (4 Feb. 2023)
• Infected blood inquiry: Five things we have learned (3 Feb. 2023)
• Government has blood on its hands, says survivor of transfusions scandal (3 Feb. 2023)
• Infected blood victims ‘truly lived through worst of times’, public inquiry told (3 Feb. 2023)
• Infected blood inquiry: Son 'will never come to terms' with scandal (2 Feb. 2023)
• Northern Ireland Blood Transfusion Service and Belfast Trust apologise to victims of contaminated blood scandal (27 Jan. 2023)
• 'What were you apologising for?' - Government lawyer refuses to say what Infected Blood apology was actually for (19 Jan. 2023)
• Blood scandal victim Roger Newman wants full government apology (19 Jan. 2023)
• Blood scandal victim's three recommendations on how Government should ensure disaster never happens again (18 Jan. 2023)
• Closing submission from Treloar's in Alton to infected blood Inquiry (18 Jan. 2023)
• Ely woman whose father died of Aids from infected blood calls for government apology (18 Jan. 2023)
• Infected blood scandal was ‘preventable catastrophe’, inquiry told (17 Jan. 2023)
• Victims and families call for prosecutions as contaminated blood inquiry nears end (16 Jan. 2023)
• Seeking closure - Infected blood victims' quest for compensation (10 Jan. 2023)
• Department of Health lawyers warn Infected Blood Inquiry of risks of using 'hindsight and suggestion' in analysis of NHS treatment disaster (5 Jan. 2023)
• Jesmond contaminated blood scandal campaigner praised for 'selfless' fight for justice (3 Jan. 2023)
• Sister of infected blood scandal victim calls for justice (3 Jan. 2023)
• No timetable for infected blood victims' compensation (15 Dec. 2022)
• Alex Burghart MP, Brentwood and Ongar (6 Dec. 2022)
• 'No more delays' - Contaminated blood scandal victim urges government to publish its report (29 Nov. 2022)
• Westminster Hall to hold a debate on the Infected Blood Inquiry and compensation framework (21 Nov. 2022) | Related:
  • The infected blood inquiry and compensation framework (House of Commons Library, 23 Nov. 2022) | Includes documents to download.
• Infected blood scandal: final expert appears before the inquiry (17 Nov. 2022)
• 'More than double': Contaminated blood inquiry finds much higher rate of HIV infection in children - and new evidence 'vindicates' Jesmond campaigner (12 Nov. 2022)
• Teacher, 62, died as direct result of receiving blood infected with hepatitis C decades earlier, coroner rules (2 Nov. 2022)
• Inquest into Kent man who died in NHS infected HIV and hepatitis blood scandal closes today (28 Oct. 2022)
• Infected blood scandal - Victims to get £100,000 by end of month (22 Oct. 2022) | Related:
  • Infected blood £100,000 interim compensation payments to be made this month (22 Oct. 2022; UK govt. press release)
  • Infected blood victims and bereaved partners will receive £100,000 in October (21 Oct. 2022) | Interim compensation payments are expected to reach around £400 million for the whole UK
• Parents and children miss out on infected blood compensation to survivors and bereaved partners (22 Oct. 2022)
• Headline lands journalist Wheeler’s ‘powerful investigation into the NHS infected blood scandal’ (20 Oct. 2022)
• Last of infected blood victims’ evidence heard in ‘significant milestone’ (7 Oct. 2022)
• Mother found out her sons had HIV from the list on the hospital fridge (7 Oct. 2022)
• HIV: How 175 British children were infected with disease (6 Oct. 2022)
• Mother tells blood inquiry of her 'guilt' over death of her son who died aged 24 after he got HIV from infected batch of clotting product Factor VIII which was used to treat his haemophilia (6 Oct. 2022)
• Blood scandal victim slams NHS for not 'learning from its mistakes' (3 Oct. 2022)
• Norfolk victim of the 'worst treatment disaster in NHS history' speaks out (1 Oct. 2022)
• Black and Asian infected blood victims feel let down, inquiry told (30 Sept. 2022)
• Infected blood transfusions killed 1,820 in UK, study estimates (17 Sept. 2022)
• Top Newcastle haemophilia doctor 'was lying' in complaint about 1983 infected blood reporting says journalist (15 Sept. 2022)
• | Related:
  • Newcastle's haemophiliacs 'should have been told' they were at 'clear and special' risk of AIDS, inquiry hears (10 June 2022)
• No estates should be excluded from infected blood compensation payouts (22 Aug. 2022)
• The contaminated blood scandal will reveal a government unwilling to learn from its mistakes (19 Aug. 2022)
• Seaham infected blood victim speaks out after 40 years: 'I've hidden away, been ostracised and lost jobs because of this' (19 Aug. 2022)
• Infected blood victims to get £100,000 compensation (17 Aug. 2022) | Related:
  • Infected Blood victims to receive £100,000 interim compensation payment (UK govt. press release, 17 Aug. 2022)
• Contaminated blood: If I was paid in tears I'd be a billionaire (17 Aug. 2022)
• 'A lot of work still needed' for victims of NHS infected blood scandal as payouts confirmed (17 Aug. 2022)
• Ex-health secretaries call for urgent blood scandal payouts (30 July 2022)
• Infected blood victims set for £400m in compensation (29 July 2022)
• UK minister said compensation for infected blood victims was mistake ­ inquiry (28 July 2022)
• Jeremy Hunt calls contaminated-blood scandal a huge failing of democracy (27 July 2022)
• Scottish ministers given 'inaccurate' blood scandal briefing (25 July 2022)
• Scotland's inaugural first minister Donald Dewar feared open cheque book over blood scandal (26 July 2022)
• East Hants MP Damian Hinds backs early compensation for blood victims (21 July 2022)
• 'Possible case for corporate manslaughter charges' over infected blood scandal (17 July 2022)
• Two former Scottish secretaries to give evidence in blood scandal inquiry (16 July 2022)
• Andy Burnham mayor of Greater Manchester and former secretary of state for health to give evidence at Infected Blood Inquiry (13 July 2022)
• Hull man given infected blood at routine dental op takes fight to Boris Johnson (11 July 2022)
• Pay infected blood scandal victims before they die, Boris Johnson urged (10 July 2022)
• 'They made a series of choices': Newcastle infected blood campaigner gives harrowing evidence at public inquiry (10 July 2022)
• John Major’s ‘bad luck’ comment on infected blood scandal angers victims (27 June 2022)
• Man 'lost everything' after receiving blood infected with hepatitis C by NHS (27 June 2022) | He was misdiagnosed with haemophilia at age eight and given a blood transfusion that he didn't need.
• Former PM to give evidence at Infected Blood Inquiry (21 June 2022)
• Newcastle's haemophiliacs 'should have been told' they were at 'clear and special' risk of AIDS, inquiry hears (10 June 2022)
• Infected blood scandal victims should be compensated at least £100,000, report suggests (8 June 2022)
• Infected blood scandal payments could run into billions, report suggests (7 June 2022)
• Victims of contaminated blood scandal should receive interim payments – report (7 June 2022)
• Mother given infected blood says 'money can never make up for what happened to me' (7 June 2022)
• UK patients affected by infected blood scandal to receive payouts (29 May 2022)
• Government was wrong on risk of Aids to blood scandal victims, inquiry told (20 May 2022)
• 'I'm sorry people had to wait 30 years,' former minister tells Infected Blood Inquiry (20 May 2022)
• Government accused of ‘Hillsborough cover-up’ after court hears doctors were asked to ‘tone down’ reports of contaminated blood scandal which infected up to 30,000 patients with HIV and hepatitis (11 May 2022)
• A doctor appointed chief medical officer at the Ministry of Health had no training for the position (10 May 2022)
• Government changed its mind on Infected Blood Inquiry 'because of pressure from campaigners' (30 Mar. 2022)
• 'Don't treat us with disdain' - Blood scandal victims demand publication of compensation report (21 Mar. 2022)
• “We need justice, we need someone to say we are sorry” (21 Mar. 2022)
• Mum did not require blood transfusion at hospital which led to hepatitis C (28 Feb. 2022)
• Court of Appeal refuses permission to judicially review infected blood compensation scheme (21 Feb. 2022)
• 'My husband was given a virus that killed him' (21 Feb. 2022)
• Jesmond infected blood campaigner's anger over being 'left out' of key compensation meeting documents (14 Feb. 2022)
• 'Embarrassingly large' stocks of available UK blood products weren't used by Newcastle doctors, blood inquiry hears (10 Feb. 2022)
• Dr Frank Boulton gives evidence at blood inquiry (9 Feb. 2022)
• Health officials thought victims would win court case, secret memo reveals (4 Feb. 2022)
• N. Ireland: Army and jails helped keep up NI blood stocks during the Troubles, inquiry told (4 Feb. 2022)
• N. Ireland: Financial payments for bereaved NI families affected by NHS infected blood scandal to be backdated to 2019 (31 Jan. 2022)
• Ex-pupils and relatives sue Hampshire school, Treloar College (23 Jan. 2022)
• Mystery over fate of blood components from donors, inquiry told (19 Jan. 2022)
• Lib Dems call for Scotland's Covid inquiry to give update within a year (15 Jan. 2022)
• Edinburgh woman 'robbed of chance to be a mum' after infected blood transfusion (14 Jan. 2022)
• Inquiry hears how a Sydney schoolboy was given blood from a heroin addict (6 Jan. 2022)

Ukraine

• Occupiers speed up blood collection in Crimea due to large number of wounded (15 Feb. 2023)
• Ukraine creates a single information space for all parties involved in the blood- and blood products-related healthcare (1 May 2022)
• Science comes to a halt in Ukraine, at risk in Russia (4 Mar. 2022)
• Ukrainian parents brace their children for a Russian invasion, sending them to school with stickers identifying their blood type (23 Feb. 2022)

USA^

• FDA: Recommendations for evaluating donor eligibility using individual risk-based questions to reduce the risk of human immunodeficiency virus transmission by blood and blood products - Draft Guidance for Industry (January 2023)
• How states approach Medicaid eligibility redetermination will have big implications for enrollees: KFF analysis (16 Mar. 2022)
• CMS gives an early look at how it plans to negotiate Part D drug prices in 2026 (15 Mar. 2023)
• Blood community urges congress to center the blood supply in disaster response legislation (15 Mar. 2023)
• West Nile, lyme, and other diseases are on the rise with climate change. Experts warn the U.S. is not prepared (15 Mar. 2023)
• Becerra asks insurers for help on getting data as COVID-19 health emergency nears end (14 Mar. 2023)
• Get paid to give blood - maybe $3000! (13 Mar. 2023)
• CDC recommends universal screening for hepatitis B virus (10 Mar. 2023) | Related:
  • Conners EE, Panagiotakopoulos L, Hofmeister MG, et al. Screening and testing for hepatitis B virus infection: CDC recommendations - United States, 2023. MMWR Recomm Rep. 2023 Mar 10;72(1):1-25. (Free full text) | PubMed abstract
  • Summary of 2023 HBV screening and testing recommendations
• More than one-third of Americans haven’t filled a prescription due to cost: survey (10 Mar. 2023)
• FDA draws roadmap for pandemic era guidances (10 Mar. 2023)
• Industry news: FDA advisory panel backs Genentech's polatuzumab vedotin-piiq benefit-risk profile in first-line DLBCL (10 Mar. 2023)
• Industry news: FDA advisory panel backs Genentech's polatuzumab vedotin-piiq benefit-risk profile in first-line DLBCL (10 Mar. 2023)
• US President Joe Biden To seek more than $2.8B from Congress for cancer fight (9 Mar. 2023)
• Northwest Florida mother encourages blood donations after baby receives transfusion (10 Mar. 2023)
• Mass General to test VR digital therapeutics for cancer patients (8 Mar. 2023)
• Senators introduce legislation to expand protection of personal health information- PHI (8 Mar. 2023)
• Biden proposes increased tax rate on high earners to keep Medicare solvent (7 Mar. 2023)
• CDC: XBB.1.5 responsible for 90% of new coronavirus infections (3 Mar. 2023)
• California to alter COVID rules in healthcare settings: Masks and vaccinations not required (3 Mar. 2023)
• Industry news: FDA clears Haemonetics next-gen autotransfusion system software (2 Mar. 2023)
• Industry news: Vertex to develop conditioning agent for SCD gene editing therapy (2 Mar. 2023)
• CDC warns about the rise in almost untreatable Shigella bacterial infections (1 Mar. 2023) Related:
  • Outbreak of Shigella sonnei in the EU/EEA and the United Kingdom among travellers returning from Cabo Verde (17 Feb. 2023)
• Bill banning vaccinated blood donations would ‘decimate’ blood supply, opponents say (27 Feb. 2023)
• State emergency health orders during the coronavirus (COVID-19) pandemic, 2021-2023 (27 Feb. 2023)
• Blood Needed! It’s so cold out that people are forgetting to donate and there’s a really critical shortage, blood bank says (27 Feb. 2023)
• Recent winter weather leads to “dangerously low” blood supply for Community Blood Center (27 Feb. 2023)
• SBU, New York Blood Center celebrate ‘100,000 lives saved’ (27 Feb. 2023)
• 'Hands in the dirt' | Frayser church prepares blood drive especially 'personal' for organizers (26 Feb. 2023)
• Industry news: FDA grants priority review to Pfizer's elranatamab for R/R multiple myeloma (22 Feb. 2023) | Related
  • Pfizer’s elranatamab receives FDA and EMA filing acceptance (22 Feb. 2023, Pfizer press release)
• Twins born at Riley Hospital marks first twin-to-twin transfusion syndrome procedure in Indiana (22 Feb. 2023)
• HHS prioritizing FDA labeling, DTC advertising, and compounded drug rules (21 Feb. 2023)
• Survival lower for children with leukemia living on Texas-Mexico border (21 Feb. 2023) | Related:
  • Castellanos MI, Oluyomi AO, Chambers TM, et al. Ethnic disparities in childhood leukemia survival by border residence: A Texas population-based analysis. Cancer. 2023 Feb 21. Epub ahead of print. (Full access) | PubMed abstract
• Central California Blood Center plays pivotal role during 'Be the Match' campaign (21 Feb. 2023)
• Veterinary College seeking qualified dogs and cats to become blood donors (21 Feb. 2023)
• Guidance: FDA details ANDA PSG meetings under GDUFA III (20 Feb. 2023) | Related:
  • FDA updates guidances to clarify new generic drug meeting requirements in GDUFA III (5 Oct. 2022)
• Industry news: Nanite nabs $6 million to debut AI platform for polymer design (20 Feb. 2023)
• FDA to require diversity plan for clinical trials (16 Feb. 2023) | Related:
  • Hwang TJ, Brawley OW. New federal incentives for diversity in clinical trials. N Engl J Med. 2022 Oct 13;387(15):1347-9. Epub 2022 Oct 8. (Free full text)
• New Orleans EMS using technique developed on the battlefield to save lives(16 Feb. 2023)
• New Centers for Medicare and Medicaid Services (CMS) model aims to expand access to cell and gene therapies (15 Feb. 2023)
• Industry news: Purdue U digital health app (HemaChrome) wins first phase of NIH competition (15 Feb. 2023)
• Millions of children are at risk of losing Medicaid coverage starting in April (15 Feb. 2023)
• Industry news: Disc Medicine raises $62.5M for hematology programs (14 Feb. 2023)
• Northern Light Eastern Maine Medical Center (EMMC) accused of not getting patient timely blood transfusion before death (14 Feb. 2023) | Related:
  • Mother claims Maine hospital's negligence led to daughter's death after surgery (14 Feb. 2023)
  • The full lawsuit (13 Feb. 2023)
• Industry news: Tasso lassos EU approval for at-home high-volume blood collection device (14 Feb. 2023)
• Mother of 2 with sickle cell disease reunites with her lifesaving blood donors in NYC (14 Feb. 2023)
• Study: 10% of FDA approved drugs since 2018 had pivotal trials that missed primary endpoints (13 Feb. 2023) | Related:
• • Johnston JL, Ross JS, Ramachandran R. US Food and Drug Administration approval of drugs not meeting pivotal trial primary end points, 2018-2021. JAMA Intern Med. 2023 Feb 13:e226444. Epub ahead of print. (Free full text)
• Because you might need it, he’s been donating blood for more than 50 years (13 Feb. 2023)
• Give a gift from the heart with blood donation on Valentine’s day (13 Feb. 2023) | Those who donate blood in February will receive a $10 Amazon.com gift card redeemable by email.
• Red Cross blood drive held in memory of Joyce Lane (11 Feb. 2023)
• XBB.1.5's prevalence jumps to 75%: 6 CDC updates (10 Feb. 2023)
• HHS renews COVID-19 public health emergency (PHE) through May 11, releases transition fact sheet (10 Feb. 2023) | Related:
  • Fact Sheet: COVID-19 public health emergency transition roadmap (9 Feb. 2023)
• HHS renews COVID-19 public health emergency (PHE) through May 11, releases transition fact sheet (10 Feb. 2023) | Related:
  • Fact Sheet: COVID-19 public health emergency transition roadmap (9 Feb. 2023)
• Industry news: Phase 2 KOMET-001 trial of Kura Oncology's ziftomenib begins dosing patients with NPM1-mutant AML (10 Feb. 2023) | Related:
  • First in human study of ziftomenib in relapsed or refractory acute myeloid leukemia (Updated: 16 Feb. 2023)
• FDA outlines criteria for conducting long-term neurodevelopmental safety studies in neonates (10 Feb. 2023)
• Industry news: Bristol Myers Squibb details landmark Abecma multiple myeloma data that ASH turned down (10 Feb. 2023) | Related:
  • Rodriguez-Otero P, Ailawadhi S, Arnulf B, et al. Ide-cel or standard regimens in relapsed and refractory multiple myeloma. N Engl J Med. 2023 Feb 10. Epub ahead of print.
• CDC adds Covid-19 vaccinations to immunization schedules for children, adults (9 Feb. 2023)
• HHS secretary sends letter to state governors on what’s to come when Covid-19 public health emergency ends (9 Feb. 2023)
• CDC adds Covid-19 vaccinations to immunization schedules for children, adults (9 Feb. 2023)
• Goodbye flu, RSV, and COVID waves; hello, norovirus! (8 Feb. 2023) | Outbreak data is lagging, but test positivity has exceeded last year's peak.
• FDA officials offer advice on gene therapy trials (8 Feb. 2023)
• Industry news: Exact Sciences launches cancer therapy selection test (8 Feb. 2023)
• Industry news: WellSky^® joins collaborative effort to improve transfusion safety through national Alloantibody Exchange (7 Feb. 2023)
• Proposed legislation in Michigan would offer tax credits for blood donations (7 Feb. 2023)
• Industry news: Seagen vets land $4.4M for Univ. of Washington spinout using fresh approach for cancer vaccines (7 Feb. 2023) | The leaders of the biotech startup spun out of the University of Washington, Abacus Bioscience, say they’ve landed on a new, potentially powerful approach to create vaccines to treat people with cancer.
• Hispanic dialysis patients face 40% higher risk of staph infection than whites, CDC says (6 Feb. 2023)
• The virus threat is easing, but US hospitals are still as full as ever (6 Feb. 2023)
• FDA has now cleared more than 500 healthcare AI algorithms (6 Feb. 2023)
• DARPA puts $46.4M toward synthetic blood development (4 Feb. 2023) | Twelve universities and labs are participating in the effort to try to make a synthetic product to treat blood loss in people
• U.S. plans to stop buying Covid shots for the public this fall. Here’s what that means for you (4 Feb. 2023) | The U.S. will transition the federal Covid vaccination program to the private market as soon as the fall.
• COVID-19 admissions fall 8% this week: 7 CDC updates (3 Feb. 2023)
• Health care - White House offers new cancer investments (2 Feb. 2023)
• Mpox is almost gone in the US, leaving lessons and mysteries in its wake (31 Jan. 2023)
• USA blood community issues new joint statement to combat misinformation regarding vaccines and the blood supply (31 Jan. 2023) | AABB, ABC, and ARC joint statement
• The end of the Covid health emergency won’t slow FDA clearance of shots and treatments (31 Jan. 2023)
• Number of people with long COVID appears to be declining, according to CDC data (31 Jan. 2023)
• US spends most on health care but has worst health outcomes among high-income countries, new report finds (31 Jan. 2023)
• Artificial blood product one step closer to reality with $46 million in federal funding (31 Jan. 2023) | Related:
  • DARPA team begins work on field deployable whole blood equivalent (31 Jan. 2023)
• Biden administration plans to end Covid public health emergency in May (30 Jan. 2023)
• Industry news: Gilead, Arcellx close agreement on developing T-cell therapy for multiple myeloma (30 Jan. 2023)
• Southington blood drive to honor ill resident (30 Jan. 2023)
• Scout Blood: Local girl scout founds nonprofit to save lives (30 Jan. 2023)
• FDA to resume in-person formal meetings in February (30 Jan. 2023)
• UB receives $2.1 million grant to prevent toxic side effects of leukemia treatment (29 Jan. 2023)
• Uvalde shooting survivor meets blood donors who helped save her life (28 Jan. 2023)
• FDA panel approves path toward one-shot yearly COVID vaccine (27 Jan. 2023)
• Industry news: FDA approved Eli Lilly's Jaypirca for relapsed/refractory mantle cell lymphoma (27 Jan. 2023)
• Industry news: FDA doesn’t see increased risk of stroke for seniors who received Pfizer’s omicron booster (26 Jan. 2023)
• CDC Study: Updated COVID-19 booster shots cut risk of symptomatic infection from XBB.1.5 (25 Jan. 2023) | Related:
  • Link-Gelles R, Ciesla AA, Roper LE, et al. Early estimates of bivalent mRNA booster dose vaccine effectiveness in preventing symptomatic SARS-CoV-2 infection attributable to omicron BA.5- and XBB/XBB.1.5-related sublineages among immunocompetent adults - Increasing community access to testing program, United States, December 2022-January 2023. MMWR Morb Mortal Wkly Rep. 2023 Feb 3;72(5):119-24. (Free full text) | PubMed abstract
• Industry news: EMA validates Vertex's CRISPR application, clearing barrier on road to landmark approval (25 Jan. 2023)
• It's ‘liquid gold': Young blood-transfusion recipients talk about importance of donors (25 Jan. 2023)
• Industry news: VieCure and Labcorp collaboration will improve clinical workflow, increasing patient access to genomic testing (25 Jan. 2023)
• CDC informs staff of reorganization after pandemic criticisms (24 Jan 2023)
• FDA Commissioner Califf: Current evidence generation system in clinical research needs an overhaul (24 Jan. 2023) | Related:
  • Califf RM. Now is the time to fix the evidence generation system. Clin Trials. 2023 Jan 17:17407745221147689. Epub ahead of print.
• Arup Laboratories, University of Utah receive $3 million for clinical laboratory training center (24 Jan. 2023) | Related:
  • Advanced Practice Clinical Laboratory Training Center at ARUP secures $3 million in federal funding (10 Jan. 2023)
• Industry news: FDA clears study of ImmPACT Bio's novel CAR T-cell therapy for aggressive B-cell lymphoma (24 Jan. 2023) | Related:
  • Larson SM, Walthers CM, Ji B, et al. CD19/CD20 bispecific chimeric antigen receptor (CAR) in naïve/memory T cells for the treatment of relapsed or refractory non-hodgkin lymphoma. Cancer Discov. 2022 Nov 23:CD-22-0964. Epub ahead of print.
• The FDA considers a major shift in the nation's COVID vaccine strategy (23 Jan. 2023)
• Study will test method of lowering toxic firefighter foam blood levels through transfusions (23 Jan. 2023) | Related:
  • Study aims to reduce firefighter cancer risk (21 Nov. 2022)
• Take action now: Arizona's blood supply is at a critically low level - Donate (23 Jan. 2023)
• Person who makes a difference: Dubuque woman reaches 300 blood donations (22 Jan. 2023)
• People who donate blood in January could win trip to Super Bowl LVII (21 Jan. 2023)
• New poll shows jump in adults who rate the quality of US health care as ‘poor’ (19 Jan. 2023) | Related:
  • Americans sour on U.S. healthcare quality (19 Jan. 2023)
• FDA issues draft guidance on mpox drug development (19 Jan. 2023)
• FDA extends shelf life of some popular COVID tests (19 Jan. 2023)
• HHS CIO Mathias says tree-based AI models helping to combat Medicare fraud (18 Jan. 2023)
• Local high school student becomes Houchin Blood Bank spokesperson (18 Jan. 2023)
• Industry news: FDA clears new sepsis diagnostic from Cytovale (18 Jan. 2023)
• 'Miracle Baby' receives blood transfusions while inside the womb (18 Jan. 2023)
• Compensated-donor model ‘could be a long-term solution’ to blood, platelet shortages (17 Jan. 2023)
• FDA details approach for finding optimal dosages for new cancer drugs (17 Jan. 2023)
• Industry news: AlloVir's posoleucel efficacious for stem cell transplant recipients (17 Jan. 2023)
• Santa Rosa mom advocates for blood donations years after transfusion saved her baby (16 Jan. 2023)
• ‘People aren’t taking this seriously’: experts say US Covid surge is big risk (15 Jan. 2023)
• National Blood Donor Month: Set a date to donate (15 Jan. 2023)
• Blood supply sinks to lowest level in a year: National nonprofit Vitalant declares emergency blood shortage (14 Jan. 2023)
• XBB.1.5 rises to 43% of cases: 4 COVID-19 updates (13 Jan. 2023)
• FDA issues draft guidance on dosage and administration labeling (13 Jan. 2023)
• Blood bank has 'emergency' need for donors (13 Jan. 2023)
• Eisenhower Health’s Chief Medical Officer discusses issues at hospital caused by blood shortages (13 Jan. 2023) | Lifestream Blood Bank unable to fulfill 90% of hospital blood orders.
• US cancer death rate falls 33% since 1991, partly due to advances in treatment, early detection and less smoking, report says (12 Jan. 2023) | Related:
  • Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023 Jan;73(1):17-48. (Open access) | PubMed abstract
• The plan to ‘Trump-proof’ US science against political meddling (12 Jan. 2023)
• Industry news: Microsoft strikes partnership with Paige to advance cancer diagnostics and treatment (12 Jan. 2023) | Related:
  • Paige collaborates with Microsoft to transform cancer diagnosis and treatment with the use of pathology AI (11 Jan. 2023)
• USU student’s dedication leads to mission critical, lifesaving blood drives (12 Jan. 2023)
• White House extends COVID-19 public health emergency once again (11 Jan. 2023)
• North Carolina woman suffered a period that lasted 83 DAYS and was so heavy she needed a blood transfusion — due to condition that affects one in EIGHT females (11 Jan. 2023)
• Blood Money - On selling plasma (10 Jan. 2023)
• Biden team eyes end of Covid emergency declaration and shift in Covid team (10 Jan. 2023)
• Why blood transfusions are critical for those with sickle cell disease (10 Jan. 2023)
• CDER director calls for simplifying clinical trials to boost diversity (10 Jan. 2023) | Related:
  • FDA recommends sponsors plan to include race, ethnicity in clinical trial design (13 Apr. 2022)
• 3-year-old girl with cancer thriving after treatment made possible by blood transfusions (10 Jan. 2023)
• US acceptance of COVID vaccines rises, now like other Western democracies (9 Jan. 2023) | Related:
  • Lazarus JV, Wyka K, White TM, et al. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med. 2023 Jan 9. Epub ahead of print. (Free full text) | PubMed abstract
• Cincinnati Zoo aardvark receives life-saving blood transfusion from Columbus Zoo aardvark (9 Jan. 2023)
• China’s Covid wave threatens another snarl of U.S. medical supply chain (8 Jan. 2023)
• Red Cross to host annual blood drive in memory of fallen Columbia police officer (8 Jan. 2023)
• HIV, HBV, HCV testing up among Medicaid enrollees, although missed opportunities remain (6 Jan. 2023) | Related:
  • Ahrens K, Sharbaugh M, Jarlenski MP, et al.; Writing Committee for MODRN. Prevalence of testing for HIV, HBV, and HCV among Medicaid enrollees treated with medications for opioid use disorder in 11 states, 2016-2019. Clin Infect Dis. 2023 Jan 3:ciac981. Epub ahead of print.
• Regulatory Update: CDC shares resources for health care professionals following sepsis investigation (6 Jan. 2023) | Related:
  • FDA: Important Information for Blood Establishments and Transfusion Services Regarding Bacterial Contamination of Platelets for Transfusion (22 Dec. 2022)
• Lifestream Blood Bank needs you immediately (6 Jan. 2023)
• Durham woman's battle with sickle cell highlights need for more Black blood donors (5 Jan. 2023)
• Industry news: FDA grants orphan drug designation to Lantern Pharma's lymphoma treatment candidate (5 Jan. 2023)
• Blood community unites to thank America’s donors this national blood donor month (4 Jan. 2023)
• Industry news: Eli Lilly, seeking better CNS gene therapies, pays $55M to join AbbVie on AAV specialist's list of partners (4 Jan. 2023)
• Industry news: Geron's imetelstat provides durable transfusion independence in lower-risk MDS (4 Jan. 2023) | Related:
  • Geron announces positive top-line results from IMerge phase 3 trial of imetelstat in lower risk MDS (4 Jan. 2023)
• Chicagoan with sickle cell disease may no longer need blood transfusions thanks to clinical trial (3 Jan. 2023)
• Industry news: Study backs use of Masimo hemoglobin monitoring during cesarean delivery (3 Jan. 2023)
• 2023 Blood drive for life: How blood donations gave parents priceless memories with their son (3 Jan. 2023)
• Need a New Year's resolution? Your donated blood is critically needed in Chattanooga (2 Jan. 2023)
• Putnam County Hospice and Palliative Care Association (PCHPCA) advocates giving blood regularly (2 Jan. 2023)
• The Blood Connection suggests a new resolution: donate blood (2 Jan. 2023)
• Kaneohe girl in need of bone marrow, blood donors (1 Jan. 2023)
• Local blood supplies in Southeast Texas at critical lows (31 Dec. 2022)
• TV5 anchor shares experience as platelet donation recipient (29 Dec. 2022)
• Bloodworks Northwest calls on public to donate blood amid ‘Code Red’ emergency shortage (29 Dec. 2022)
• OBI holding drive in first week of 2023 to ready for emergency response (29 Dec. 2022)
• Vaccine-tainted blood warning (28 Dec. 2022) | More on Church Militant and More in the news
• State employee blood drive aids in end of year collection push (28 Dec. 2022)
• Industry news: QuidelOrtho to Present at the J.P. Morgan Healthcare Conference (28 Dec. 2022) | Related:
  • 2023 J.P. Morgan Healthcare Conference
• Kentucky Blood Center supply reaching critical lows (28 Dec. 2022)
• How police in Fairfax County can now do blood transfusions in the field (27 Dec. 2022)
• Winter storm cancels blood drives, causes blood shortage (27 Dec. 2022)
• American Red Cross seeking blood donors in Holiday Hero Donorama (27 Dec. 2022)
• Storm delays life-saving blood donations for West Jordan toddler (27 dec. 2022)
• Montana Red Cross seeks blood donors (24 Dec. 2022)
• US may see early peak to flu season (22 Dec. 2022)
• FDA: Regulatory update: FDA updates safety communication on bacterial contamination of platelets (22 Dec. 2022) | Related:
  • FDA: Important information for blood establishments and transfusion services regarding bacterial contamination of platelets for transfusion (22 Dec. 2022)
• Covid-19 and drug overdoses drive US life expectancy to lowest level in 25 years, CDC reports (22 Dec. 2022)
• Anemic red fox needed blood transfusion (22 Dec. 2022)
• FDA: 2023 forecast: FDA revamps cancer drug approvals, and Big Pharma is willing to fall in line (21 Dec. 2022)
• Epidemiology society urges reduced COVID-19 screening at hospitals (21 Dec. 2022)
• Industry news: FDA approves Rigel's olutasidenib in relapsed/refractory AML (21 Dec. 2022) | Related:
  • Cortes J, Fenaux P, Yee, K, et al. Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed/refractory mIDH1 acute myeloid leukemia. Results from a planned interim analysis of a phase 2 pivotal clinical trial. Blood. 2022;140(suppl 1):6193-6.
• Congress' last-minute $1.7 trillion omnibus package: 8 healthcare takeaways (20 Dec. 2022)
• Industry news: Gilead’s Kite unit strikes another cell therapy deal to pursue next-gen CAR T (20 Dec. 2022)
• Syphilis cases in Missouri have jumped 259% in the last few years. Here's what to know (20 Dec. 2022)
• Industry news: Atara Biotherapeutics' Ebvallo approval ushers in off-the-shelf T-cell immunotherapies (20 Dec. 2022)
• HHS, NHLBI release materials to encourage blood donation (20 Dec. 2022)
• Industry news: Analysis of bluebird bio's beti-cel for severe ß-thalassemia shows extensive, long-term patient improvement (20 Dec. 2022) | Related:
  • Longterm follow-up of subjects with transfusion-dependent ß-thalassemia treated with ex vivo gene therapy
• FDA mulls new COVID-19 primary vaccines as study finds updated booster more effective (19 Dec. 2022) | Related:
  • Surie D, DeCuir J, Zhu Y, et al. Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19­associated hospitalization among immunocompetent adults aged 65 years ­ IVY Network, 18 States, September 8­November 30, 2022. MMWR Morb Mortal Wkly Rep. ePub: 16 December 2022. (Free full text)
• Industry news: Health Canada grants license for Quidel^® TriageTrue^® high-sensitivity troponin I Test to aid in the diagnosis of myocardial infarction (19 Dec. 2022)
• Baby tragically dies after doctors ignore parents' request for unvaccinated blood, develops a blood clot within hours of his transfusion (19 Dec. 2022)
• Industry news: Ordaos and Yatiri Bio to tackle AML (19 Dec. 2022)
• Q&A: On eve of retirement from NIAID, Fauci tells Healio what’s next (19 Dec. 2022)
• Industry news: bluebird's adolescent sickle cell ambitions are back in flight after yearlong partial hold lifted (19 Dec. 2022) | Related:
  • FDA lifts partial clinical hold for bluebird bio’s sickle cell disease (SCD) studies for patients under the age of 18 (19 Dec. 2022)
• The impact of the US vaccination program on reducing infections, hospitalizations, and deaths (16 Dec. 2022) | Related:
  • Two years of U.S. COVID-19 vaccines have prevented millions of hospitalizations and deaths (Blog, 13 Dec. 2022)
• 3 subvariants expand their dominance to 76% of cases: 10 CDC notes (16 Dec. 2022)
• White House to resume program sending free COVID tests by mail (15 Dec. 2022)
• Three county EMS agencies roll out new blood transfusion service (15 Dec. 2022)
• Cullman Regional EMS 1st in Alabama to provide blood transfusions in the field (15 Dec. 2022)
• Long Covid responsible for thousands of US deaths, report says, but true numbers are likely much higher (14 Dec. 2022)
• U.S. Preventive Services Task Force recommends clinicians prescribe PrEP to those at high risk for HIV (13 Dec. 2022)
• U.S. to pay Pfizer nearly $2B for more Paxlovid courses in 2023 (13 Dec. 2022)
• HHS: COVID-19 flexibilities apply to flu, RSV response efforts (13 Dec. 2022)
• Industry news: Keros Therapeutics presents clinical data from its KER-050 and KER-047 programs and preclinical data from its KER-050 and ALK2 Inhibitor programs at 64th ASH meeting (12 Dec. 2022)
• Industry news: Pfizer shares updated pivotal phase 2 elranatamab data for multiple myeloma (12 Dec. 2022)
• 6-year-old girl from Moody gets special snow day before January transplant (11 Dec. 2022)
• Industry news: New data from bluebird bio’s gene therapies for transfusion-dependent beta-thalassemia and sickle cell disease presented at 64th ASH annual meeting (10 Dec. 2022)
• The gift of life: SC blood banks urge donations to prevent holiday blood shortage (10 Dec. 2022)
• Hospitals in the US are the fullest they’ve been throughout the pandemic ­ but it’s not just Covid (9 Dec. 2022)
• NIH plans grant-review overhaul to reduce bias (9 Dec. 2022)
• FDA: Combo vaccine candidate for influenza and COVID-19 gets fast track status from FDA (9 Dec. 2022)
• CDC: Adults who took Pfizer's Paxlovid 50% less likely to be hospitalized with COVID-19: 10 CDC findings (9 Dec. 2022)
• Industry news: BioGX introduces pixl real-time PCR platform with expanded use (9 Dec. 2022)
• Industry news: First-in-class investigational Syntrix Biosystems' SX-682 demonstrates single-agent efficacy in patients with hypomethylating agent failure myelodysplastic syndromes (9 Dec. 2022) | Related:
  • 855 Phase 1 results of the first-in-class CXCR1/2 inhibitor SX-682 in patients with hypomethylating agent failure myelodysplastic syndromes (Oral & poster abstracts at 64th ASH Annual Meeting)
• Industry news: The promise of Geron's telomerase inhibitors for treating blood cancer (8 Dec. 2022)
• Industry news: VBI Vaccines announces Health Canada approval for PreHevbrio™ for the prevention of hepatitis B in adults (8 Dec. 2022)
• FDA: Regulatory Update: FDA issues final malaria guidance (7 Dec. 2022)
• These graphs show just how dramatically different this flu season is right now (7 Dec. 2022) | Related:
  • New flu hospitalizations spike nearly 74% in one week: 8 FluView notes (2 Dec. 2022)
• Industry news: Routine use of Kite Pharma's axicabtagene ciloleucel could be cost effective in relapsed/refractory diffuse large B-cell lymphoma (5 Dec. 2022) | Related:
  • Kambhampati S, Saumoy M, Schneider Y, et al. Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma. Blood. 2022 Nov 10;140(19):2024-36.
• CDC director urges vaccination amid record high reports of flu, RSV (5 Dec. 2022)
•  Chattanooga pastors plead for more Black blood donors (4 Dec. 2022)
• 'Stay Strong Michael' blood drive in Chatham turns into a reunion of people willing to provide life-saving blood transfusions (4 Dec. 2022)
• Industry news: FDA accepts BLA for Citius Pharmaceuticals' denileukin diftitox in cutaneous persistent/recurrent T-cell lymphoma (4 Dec. 2022)
• More asked to defer donating blood after they travel overseas with borders reopening (3 Dec. 2022)
• Industry news: Adaptive Biotechnologies rolls out clonoSEQ assay for DLBCL patients (2 Dec. 2022)
• Industry news: Rigel Pharmaceuticals wins US approval of rival drug to Servier Pharmaceuticals leukemia treatment (2 Dec. 2022)
• Industry news: Beam Therapeutics announces FDA has lifted the clinical hold on the investigational new drug application for BEAM-201 (2 Dec. 2022)
• Why the FDA is moving away from restricting certain LGBTQ blood donors (1 Dec. 2022) | Related:
  • American Red Cross statement on FDA MSM deferral policy (1 Dec. 2022)
• FDA: FDA approves first fecal transplant therapy for prevention of CDI recurrence (1 Dec. 2022) | Related:
  • Khanna S, Assi M, Lee C, et al. Efficacy and safety of RBX2660 in PUNCH CD3, a phase III, randomized, double-blind, placebo-controlled trial with a Bayesian primary analysis for the prevention of recurrent Clostridioides difficile infection. Drugs. 2022 Oct;82(15):1527-38. Epub 2022 Oct 26. Erratum in: Drugs. 2022 Nov 7. (Open access) | PubMed abstract
• Biden administration prepares to end monkeypox emergency declaration (30 Nov. 2022)
• CDC will test sewage for polio outside New York to see if it’s circulating elsewhere in nation (30 Nov. 2022)
• COVID-19 admissions up in 32 states (30 Nov. 2022)
• CDC awards over $3 billion to strengthen U.S. public health infrastructure (29 Nov. 2022)
• Industry news: C2N Diagnostics launching next-generation blood test for Alzheimer's disease detection (29 Nov. 2022)
• FDA: FDA grants investigational CAR-T cell therapy CB-010 2 designations for B-cell non-hodgkin lymphoma (29 Nov. 2022) | Related:
  • Caribou Biosciences announces the FDA granted regenerative medicine advanced therapy (RMAT) and fast track designations to CB-010, an allogeneic anti-CD19 CAR-T cell therapy (29 Nov. 2022)
• Legislators must address state healthcare needs (29 Nov. 2022) | We continue to urge legislators to look into the situation and see what can be done to keep hospitals open and solvent in the state of Georgia.
• Industry news: Gilead gets European approval for use of HIV drug Biktarvy in children (29 Nov. 2022)
• Audra Taylor joins executive team for Blood Operations at South Texas Blood & Tissue (29 Nov. 2022) | Taylor, who recently retired from military service as the Division Chief of the Armed Services Blood Program for the Defense Health Agency, has more than 15 years of executive-level leadership over military blood programs.
• New COVID-19 variant XBB gaining ground among Americans (28 Nov. 2022)
• As booster rates continue to lag, a collaborative government effort pushes for more jabs by year-end (28 Nov. 2022)
• White House resists declaring national emergency amid surge of flu, RSV cases in kids (27 Nov. 2022)
• New Orleans medics manage blood transfusions in the field | Healthcare/Hospitals (27 Nov. 2022)
• ‘The Perfect Storm’ author on his near-death experience (26 Nov. 2022) | Junger's pancreatic artery had ruptured & he needed a transfusion of 10 pints of blood right into his jugular. Now he feels donating is a vital part of being a good citizen.
• Shortages of antivirals, antibiotics compound stress of a rough season for viral illnesses in kids (23 Nov. 2022)
• AABB urges congressional leaders to pass SCD comprehensive care act (23 Nov. 2022)
• FDA: FDA approves CSL Behring's Hemgenix, the first gene therapy to treat adults with hemophilia B (FDA press release, 22 Nov. 2022)
• Industry news: The fruits of synthetic biology (22 Nov. 2022; Author: CEO Senti Biosciences)
• FDA: FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Amgen's Prolia/ denosumab (22 Nov. 2022)
• It’s game time for stem cell donor Tyler Mueller ’25 (21 Nov. 2022)
• Half of COVID-19 cases are now BQ.1 + BQ.1.1 infections: 10 CDC findings (18 Nov. 2022)
• Flu H3N2 variant that hits kids and seniors harder than other strains is dominant in U.S. right now (18 Nov. 2022)
• With hospitals full and blood supply low, Hawaiian Blood Bank makes plea for donors (18 Nov. 2022)
• Career blood donor preps for 151st pint donation (18 Nov. 2022)
• Industry news: Kriya acquires Redpin Therapeutics (18 Nov. 2022)
• Industry news: Regeneron swoops in with $2B bispecifics biobucks pact for empty-handed CytomX (17 Nov. 2022)
• Boy with Crohn's disease hopes book will ease fears for kids needing blood transfusions (17 Nov. 2022)
• Red Cross aims to diversify blood donor pool (16 Nov. 2022) | One in every 365 Black infants are born with sickle cell disease, according to the Centers for Disease Control and Prevention.
• Pediatricians beg for more federal help to fight wave of RSV (16 Nov. 2022)
• HHS: HHS to partner with health systems on national patient safety alliance (16 Nov. 2022)
• South County Fire launches county's first program to provide in-field blood transfusions (15 Nov. 2022)
• New omicron subvariants now dominant in the U.S., raising fears of a winter surge (11 Nov. 2022)
• FDA: FDA approves Seagen's brentuximab vedotin for previously untreated high-risk pediatric lymphoma (10 Nov. 2022) | Related:
  • Seagen announces U.S. FDA approval of new indication for ADCETRIS^® (brentuximab vedotin) for children with previously untreated high risk hodgkin lymphoma (10 Nov. 2022)
• After 55 years as Red Cross blood donor, Mesquite resident hits donation milestone: 28 gallons (9 Nov. 2022)
• COVID-19 cases to jump 39% by Nov. 17, Mayo forecasts (7 Nov. 2022)
• Industry news: AMPEL BioSolutions rolls out genetic test to predict heart disease in lupus patients (7 Nov. 2022)
• Researchers at Duke School of Medicine receive $25.9 million grant for HIV vaccine research (7 Nov. 2022)
• Paxlovid reduces risk of long Covid, Veterans Affairs study finds (6 Nov. 2022) Related:
  • Xie Y, Choi T, Al-Aly Z. Nirmatrelvir and the risk of post-acute sequelae of COVID-19. medRxiv. 2022 5 Nov. Preprint. (Free full text)
• FDA: FDA finalizes umbrella trial guidance for cell and gene therapies (4 Nov. 2022) | Related:
  • For gene therapies, FDA drafts trial guidance, finalizes "sameness" for orphan exclusivity (30 Sept. 2021)
• FDA: FDA grants breakthrough therapy tag to Pfizer's elranatamab (3 Nov. 2022)
• Donating blood keeps 2-year-old boy alive (3 Nov. 2022)
• FDA: FDA updates guidance on expanded access for investigational drugs under IND (2 Nov. 2022)
• HHS: HHS renews public health emergency for monkeypox outbreak (2 Nov. 2022)
• FDA: FDA clarifies advertising and marketing rules for certain COVID-19 drugs (2 Nov. 2022)
• Blood Assurance seeking donors amid O-negative red cell shortage (2 Nov. 2022) | Blood Assurance officials say they’re offering $20 to all donors.
• FDA: FDA approves Gilead's vemlidy for pediatric patients with chronic HBV infection (2 Nov. 2022)
• Industry news: Natera awarded VA contract for MRD testing and monitoring (2 Nov. 2022)
• Regulatory update: FDA issues HCT/P small entity compliance guide (1 Nov. 2022) | Related:
  • FDA: Regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps) - Small entity compliance guide (November 2022)
• Industry news: BLA submitted for AbbVie's epcoritamab for the treatment of relapsed/refractory diffuse large B-cell lymphoma, large B-cell lymphoma (1 Nov. 2022) | Related:
  • AbbVie announces submissions of regulatory applications for epcoritamab (DuoBody®-CD3xCD20) for the treatment of relapsed/refractory diffuse large B-cell lymphoma -DLBCL and large B-cell lymphoma -LBCL (28 Oct. 2022)
• The worst pediatric-care crisis in decades (31 Oct. 2022)
• Industry news: Bristol Myers' blockbuster-to-be Reblozyl scores a Phase III trial (31 Oct. 2022)
• Industry news: Actinium Pharmaceuticals' radiotherapy spooks AML in elderly patients, prompting a sweet tooth for regulatory approval (31 Oct. 2022)
• His 4-year-old brother relied on blood donors while fighting leukemia. Now, he’s donating (30 Oct. 2022)
• Industry news: Ludwig Chicago nanotechnology induces therapeutic immune responses against multiple types of tumors (28 Oct. 2022)
• FDA: FDA's ODAC unanimously votes against Y-mAbs Therapeutics' pediatric neuroblastoma treatment (28 Oct. 2022)
• Industry news: Gilead's hopes for HDV approval delayed after FDA's complete response letter - CRL (28 Oct. 2022) | Related:
  • Gilead receives complete response letter from U.S. FDA for bulevirtide for the treatment of adults with hepatitis delta virus (27 Oct. 2022)
• FDA: FDA releases draft guidance to spur development of CDI drugs (28 Oct. 2022)
• FDA: MT-101 granted fast track designation by FDA for CD5+ relapsed/refractory peripheral T-cell lymphoma (28 Oct. 2022) | Related:
  • Myeloid Therapeutics announces FDA fast track designation for MT-101 for the treatment of CD5+ relapsed/refractory PTCL (27 Oct. 2022)
• A local business and hospital help a 2-year-old with leukemia celebrate Halloween (28 Oct. 2022)
• Industry news: PTC Therapeutics snags up to $1B from Blackstone to accelerate pipeline (28 Oct. 2022)
• FDA: FireGene’s monkeypox virus nucleic acid detection kit gains CE-IVD mark (FDA news: 27 Oct. 2022)
• Teen, saved by transfusions, now organizes his own blood drive (27 Oct. 2022)
• How annual Dia De Los Muertos Blood Drive helps Abilene cancer patients (27 Oct. 2022)
• HHS: HHS launches giving=living blood and plasma innovation challenge (26 Oct. 2022)
• Industry news: Moderna nears US deal to develop shots for ebola, other biological threats (26 Oct. 2022)
• FDA: Regulatory update - FDA final guidance addresses development of gene therapies for neurodegenerative diseases (26 Oct. 2022) | Related:
  • FDA:Human gene therapy for neurodegenerative diseases - Guidance for industry (Oct. 2022)
• FDA: FDA issues final guidance on developing drugs for treatment of AML (25 Oct. 2022) | Related:
  • FDA: Acute myeloid leukemia - Developing drugs and biological products for treatment (17 Oct. 2022)
• ARC executive director Kesselring asks for blood donations (25 Oct. 2022) | Those donating 1-22 Nov. will receive a $10 e-gift card to a merchant of choice.
• Industry news: Judge agrees CSL plasma clinics are 'service establishment, ' per ADA, can be sued by IL for allegedly violating disability laws (24 Oct. 2022)
• Industry news: Daiichi Sankyo's quizartinib gets FDA priority review to treat blood cancer subtype (24 Oct. 2022)
• Memphis blood transfusion recipient advocates for more donors (24 Oct. 2022)
• Six people who tested positive for monkeypox have died, health departments confirm (23 Oct. 2022)
• Local blood bank urges donations as holiday season approaches (22 Oct. 2022) | Donors who give Nov. 22-28 will receive a $5 Amazon.com gift card
• 'Escape variants' account for 16% of US COVID-19 cases: 10 updates (21 Oct. 2022)
• FDA: FDA proposes breakthrough status for devices that address health disparities (21 Oct. 2022)
• Biden biodefense plan seeks more research, tech to fend off outbreaks (21 Oct. 2022)
• Industry news: Gilead's Kite Pharma and Refuge Biotechnologies join to develop potential treatments for blood cancer (21 Oct. 2022)
• FDA: FDA finalizes multiple endpoints guidance (20 Oct. 2022)
• Industry news: BD and Magnolia Medical partner to commercialise Steripath platforms (19 Oct. 2022)
• FDA: FDA starts PDUFA VII programs for real-world evidence, innovative trial designs (19 Oct. 2022) | Related:
  • Industry lauds PDUFA VII focus on innovation, transparency (26 Aug. 2022)
• Physicians from Ukraine examine blood transfusion services in the Chicago area's healthcare system (19 Oct. 2022)
• FDA: Sol-Millennium receives FDA clearance for sol-guard safety pull button blood collection set (19 Oct. 2022) | Related:
  • Sol Millennium gets 510(k) clearance for blood collection set (FDA: 21 Oct. 2022)
• Martin University joins Versiti in a mobile blood drive during Homecoming Week (19 Oct. 2022)
• Alpha Sigma Alpha sorority brings blood drive to UNC campus (19 Oct. 2022)
• Midwest Marlins sponsor a blood drive with ARC in honour of 10-yr-old Brady Martin (19 Oct. 2022)
• ‘Pretty troublesome' BQ.1, BQ.1.1 COVID variants spread in U.S. as BA.5 cases decrease (18 Oct. 2022)
• CDC report warns of serious ocular complications with monkeypox (18 Oct. 2022) | Related:
  • Cash-Goldwasser S, Labuda SM, McCormick DW, et al. Ocular monkeypox ­ United States, July­September 2022. MMWR Morb Mortal Wkly Rep. ePub: 17 October 2022.
• Industry news: Thermo Fisher Scientific unveils new solution for cell therapy manufacturing (18 Oct. 2022)
• Kentucky facing blood shortage as hospital blood needs rise (18 Oct. 2022)
• New fire rescue units hit the streets in Jacksonville (18 Oct. 2022) | The unit carries blood clot stabilizers/drugs to lower rapid heart rates and blood and plasma for transfusions.
• Industry news: Secure Transfusion Solutions presents data demonstrating feasibility and safety of its novel compensated blood donation model (17 Oct. 2022)
• Nurses trek fresh blood into woods to rescue 18-year-old hiker who fell from NC mountain (17 Oct. 2022)
• Industry news: Gilead pays $60M to strike up another cancer drug alliance with MacroGenics (17 Oct. 2022)
• Increase in HIV diagnoses in SF from previous year; likely due to delayed testing during COVID-19 pandemic (14 Oct. 2022)
• Industry news: US BioTek laboratories rolls out diagnostic testing for monkeypox (14 Oct. 2022)
• Biden administration extends COVID-19 public health emergency (13 Oct. 2022)
• COVID-19 exposed supply chain challenges, new procedures needed, expert says (13 Oct. 2022)
• Industry news: Eligo Bioscience’s EB300 gains orphan drug and rare pediatric disease designations from U.S. FDA (12 Oct. 2022)
• CDC: 11.5M Americans have received updated COVID booster: CDC (12 Oct. 2022)
• Red Cross to include previously banned blood donors related to vCJD (10 Oct. 2022)
• HHS: COVID-19 shots prevented 650,000+ Medicare admissions last year, HHS says (10 Oct. 2022)
• Inventor Dr. Charles Drew had medical genius in his blood (10 Oct. 2022)
• Kansas City Zoo mourns loss of gorilla due to congestive heart failure (10 Oct. 2022) | Related:
  • Innovative and rare blood transfusion saves life of gorilla at Kansas City Zoo (13 Sept. 2021)
• ‘There was nowhere in Nebraska’: Lack of dog blood sends family out of state for urgent care (10 Oct. 2022)
• Fairfield high school senior uses 'Make-A-Wish' to start community blood drive (7 Oct. 2022)
• CDC to stop reporting daily COVID-19 cases, moving to weekly reports (6 Oct. 2022) | Beginning on October 20, 2022, CDC will report updates to COVID-19 aggregate case and death data and line level data weekly, rather than daily.
• Less than a third of FDA regulatory actions backed by research (6 Oct. 2022) | Related:
  • Dhodapkar MM, Shi X, Ramachandran R, et al. Characterization and corroboration of safety signals identified from the US Food and Drug Administration adverse event reporting system, 2008-19: cross sectional study. BMJ. 2022 Oct 5;379:e071752. (Open access) | PubMed abstract
• FDA: FDA issues guidances on facility readiness and early DMF assessments under GDUFA III (4 Oct. 2022)
• FDA: FDA offers details on PDUFA VII STAR review pilot (4 Oct. 2022)
• California adopts legislation to allow blood collections with RNs available via telehealth (4 Oct. 2022) | Related:
  • Senate Bill No. 1475 (29 Sept. 2022)
• Industry news: FDA approval sought for Citius Pharmaceuticals' denileukin diftitox for persistent or recurrent cutaneous T-cell lymphoma (4 Oct. 2022)
• CDC: CDC revises 'up to date' term on COVID-19 vaccination (3 Oct. 2022)
• FDA: FDA clears Oncternal to proceed with dose escalation study for lymphoma car-T therapy (3 Oct. 2022)
• Industry news: CTI BioPharma's pacritinib improves transfusion independence, anemia through ACVR1 inhibition in myelofibrosis (3 Oct. 2022) | Related:
  • Oh S, Mesa R, Harrison C, et al. MPN-145 retrospective analysis of anemia benefit of pacritinib from the PERSIST-2 trial. Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S327.
• After Glenwood boy dies from rare blood disorder community holds blood drive (3 Oct. 2022)
• CDC: Monkeypox eradication unlikely in the U.S. as virus could spread indefinitely, CDC says (1 Oct. 2022)
• Blood drive, basketball tournament set for Marshfield teen with rare disease (1 Oct. 2022)
• HHS - More than 1,200 drugs' prices rose past inflation in 2021 (30 Sept. 2022)
• Industry news: After prior rejection, BioMarin tries again with hemophilia gene therapy in the US (30 Sept. 2022)
• OIG raises concerns about accelerated approval pathway (30 Sept. 2022)
• Texans urged to pitch in to help fellow Americans by giving blood and platelets now to support areas hard-hit by Hurricane Ian (30 Sept. 2022)
• Industry news: 5-year follow-up suggests luspatercept safely reduces anemia in patients with lower-risk myelodysplastic syndromes (30 Sept. 2022) | Related:
  • Platzbecker U, Götze KS, Kiewe P, et al. Long-term efficacy and safety of luspatercept for anemia treatment in patients with lower-risk myelodysplastic syndromes: The Phase II PACE-MDS Study. J Clin Oncol. 2022 Aug 23:JCO2102476. Epub ahead of print. (Free full text) | PubMed abstract
• ImpactLife ships blood components to region affected by Hurricane Ian (29 Sept. 2022)
• LifeShare sending hundreds of blood products to help Florida hospitals (29 Sept. 2022)
• Industry news: Genentech Teams Up with ArsenalBio in Cell Therapy Partnership -Updated (28 Sept. 2022)
• Industry news: Rallybio announces positive preliminary results for RLYB212, an anti-HPA-1a monoclonal antibody for the prevention of hetal and neonatal alloimmune thrombocytopenia (28 Sept. 2022)
• Woman uses experience with disease to raise awareness (27 Sept. 2022)
• FDA wants COVID test developers to shift from EUAs to traditional premarket pathways (27 Sept. 2022)
• Industry news: PerkinElmer launches Cellaca PLX image cytometry system (27 Sept. 2022)
• Industry news: Vertex, CRISPR to submit exa-cel to FDA for sickle cell and beta thalassemia (27 Sept. 2022)
• CDC no longer recommends universal masking in health facilities (26 Sept. 2022)
• CDC starts tracking BF.7: 5 notes on the subvariant (26 Sept. 2022) | Related:
  • CDC: Monitoring variant proportions (as of 1 Oct. 2022)
• Older workers are struggling with a new disability: long COVID (26 Sept. 2022)
• HHS: HHS to pay for 60K doses of Eli Lilly's COVID-19 drug following its commercialization (26 Sept. 2022)
• Sheridan blood drive underway to address emergency blood shortage (26 Sept. 2022)
• Industry news: Immunotek Plasma expands to Delaware for 70th donation center (26 Sept. 2022)
• Blood bank sends out plea for donors (24 Sept. 2022)
• Biden announces $1.5B in funding to battle opioid overdoses, support recovery (23 Sept. 2022)
• Industry news: Merck to initiate phase 3 HIV-1 clinical programme with a lower dose of islatravir (23 Sept. 2022)
• FDA: New FDA guidance aims to protect children who participate in clinical trials (23 Sept. 2022) | Related:
  • Ethical considerations for clinical investigations of medical products involving children (FDA Draft Guidance Sept. 2022)
• 4.4M Americans have rolled up sleeves for omicron-targeted boosters (23 Sept. 2022)
• FDA: ODAC votes against duvelisib for relapsed or refractory CLL/SLL (23 Sept. 2022)
• Industry news: Pfizer's marstacimab reduces patients’ bleeds, even with inhibitors (23 Sept. 2022)
• Rochester Hills mothers share stories of sons who rely on blood transfusions amid shortage (23 Sept. 2022)
• Federal investigators recommend changes to FDA's EUA policy for tests (21 Sept. 2022)
• Doctor and office manager convicted for health care kickback conspiracy (21 Sept. 2022)
• Blood community asks CMS to consider alternative reimbursement policies for new blood products in OPPS rule (21 Sept. 2022)
• Easton woman saved by blood transfusion volunteers with Red Cross (21 Sept. 2022)
• FDA: FDA approves first gene therapy for rare neurodegenerative disease (20 Sept. 2022) | Related
  • bluebird bio receives FDA accelerated approval for SKYSONA® gene therapy for early, active cerebral adrenoleukodystrophy - CALD (16 Sept. 2022)
• Legislation proposed to fund nationwide treatment center network for SCD care (20 Sept. 2022)
• FDA: Califf - FDA committed to boosting complex generic drug development (20 Sept. 2022)
• Blood centers look to rejuvenate high school donor drives (19 Sept. 2022)
• Versiti Blood Centers celebrates 75 years, looks forward to the future (19 Sept. 2022)
• Biden - ‘The pandemic is over’ (18 Sept. 2022) | U.S. still records an average >400 deaths/day from COVID-19 and more than 1 million Americans have died from the virus since the pandemic began in early 2020.
• White House pushes for monkeypox funding as cases fall (18 Sept. 2022)
• Time to register for Adelyn Troutman’s blood drive (18 Sept. 2022)
• Industry news: Blockchain-based supply chain management can greatly optimize blood bank operations: Raj Chowdhury HashCash CEO (17 Sept. 2022)
• Law would help those fighting deadly diseases tackle out-of-pocket costs | Opinion (16 Sept. 2022)
• Chicago organizations team up to address blood crisis in Black, Latino communities (16 Sept. 2022) | Need for blood group O blood is high, which the majority of Black and Latino people have
• FDA: FDA approves Spectrum Pharmaceuticals' eflapegrastism-xnst injection for adult patients with non-myeloid malignancies (16 Sept. 2022)
• U.S. seeing decline in monkeypox new case growth, CDC says (15 Sept. 2022) | Related:
  • Monkeypox cases dropping, but racial disparities growing (7 Sept. 2022)
• FDA: TPOXX use should be restricted to ensure drug’s efficacy against monkeypox (15 Sept. 2022) | Related:
  • CDC: Fast Facts on TPOXX (19 Sept. 2022)
• Industry news: Pfizer's Xalkori gets EMA panel nod for expanded use in blood cancer subtypes (15 Sept. 2022)
• FDA: Kymera KT-333 gets FDA orphan drug status for blood cancer subtype (15 Sept. 2022)
• Washington suffering statewide blood shortage (15 Sept. 2022) | Bloodworks NW spokesman:We depend upon blood donations from high school and college students and 25% of blood donations come from students.
• Industry news: Starry syndicate powers $165M bet on in vivo CAR-T therapies, enabling Penn spinout Capstan to set sail (14 Sept. 2022) | Related:
  • Rurik JG, Tombácz I, Yadegari A, et al. CAR T cells produced in vivo to treat cardiac injury. Science. 2022 Jan 7;375(6576):91-6. Epub 2022 Jan 6.
• Biden admin officials worried about potential polio spread (14 Sept. 2022)
• Industry news: Tasso earns FDA clearance for its home blood collection device for telehealth tests (14 Sept. 2022)
• Kentucky Blood Center to hold drive in Richmond (13 Sept. 2022) | Donors will be given two tickets for Cinemark Theaters and a fall-themed t-shirt.
• FDA: Marker Therapeutics (MRKR) announces $2M FDA grant to support phase 2 ARTEMIS trial of MT-401 (13 Sept. 2022)
• Second person in US dies after monkeypox diagnosis (12 Sept. 2022) | Related:
  • Public Health confirms first death due to monkeypox (12 Sept. 2022)
• Fact Sheet: President Biden to launch a national biotechnology and biomanufacturing initiative (12 Sept. 2022)
• Industry news: MagBio Genomics receives 510(k) clearance and CE mark for MagXtract collection tube for COVID-19 testing (12 Sept. 2022)
• A community blood drive to raise awareness about sickle cell disease (SCD) in Northeast Florida (11 Sept. 2022)
• Industry news: SpringWorks Therapeutics entered a deal with GSK for $575 million to advance nirogacestat (11 Sept. 2022) | Related:
  • DeFi trial: Smart design and impressive results for the benefit of patients with rare cancers [ ESMO Congress 2022 Press release]
• New York governor declares disaster emergency after polio found in wastewater (9 Sept. 2022)
• FDA: FDA issues emergency guidance to spur development of monkeypox tests (9 Sept. 2022) | Related:
  • Monkeypox update: FDA takes significant action to help expand access to testing (7 Sept. 2022)
  • Policy for monkeypox tests to address the public health emergency: Guidance for laboratories, commercial manufacturers, and FDA staff (7 Sept. 2022)
• American Red Cross looking for additional blood donors during Sickle Cell Awareness Month (9 Sept. 2022) | As a special incentive, the Red Cross will give all donors an exclusive T-shirt, while supplies last.
• White House buys 100M at-home COVID-19 tests with ‘limited funding’ (8 Sept. 2022)
• FDA: FDA drafts guidance on pediatric clinical pharmacology studies (8 Sept. 2022) | Related:
  • General Clinical Pharmacology Considerations for Pediatric Studies of Drugs, Including Biological Products Guidance for Industry (Draft Guidance: Sept. 2022)
• Henderson County EMS now able to provide blood transfusions on ambulances (8 Sept. 2022)
• Industry news: CSL Plasma provides free flu vaccines to U.S. plasma donors (8 Sept. 2022)
• Wastewater surveillance becomes more targeted in search for poliovirus, monkeypox and coronavirus (8 Sept. 2022)
• Industry news: Theranos founder Elizabeth Holmes requests a new trial (8 Sept. 2022)
• Here we go again: FDA opens up emergency authorizations to monkeypox tests (8 Sept. 2022)
• FDA awards $2.6M grant to study HyBryte as treatment for lymphoma (8 Sept. 2022)
• Montana moms' blood drive aims to help kids battling cancer (8 Sept. 2022)
• Industry news: Silence Therapeutics sees fast-track tag as proof of FDA confidence in blood cancer drug that faced trial troubles (8 Sept. 2022)
• U.S. monkeypox outbreak is slowing as vaccines become more accessible, health officials say (7 Sept. 2022
• Nurse administrator to lead CDC overhaul (6 Sept. 2022)
• Covid vaccines will likely become annual like flu shots, White House officials say (6 Sept. 2022)
• Industry news: Freenome kicks off study melding multiomics blood test, real-world data for cancer screening (6 Sept. 2022)
• HHS: HHS awards $20 million contract to AmerisourceBergen to expand, quicken distribution of vaccines and treatments for monkeypox (6 Sept. 2022)
• Industry news: BMS-backed Arsenal Bio pulls trigger on $220M series B, touting potential fleet of gene-edited cell therapies (6 Sept. 2022)
• More diverse pool of blood donors needed to help sickle cell patients (6 Sept. 2022)
• After cancer battle, family of young Lexington girl urges others to donate blood (5 Sept. 2022)
• Donors sought as dwindling blood supplies hit emergency level (4 Sept. 2022) | The worker shortage is one factor contributing to critically low blood supply, according to Vitalant.
• Fresenius Kabi and AABB celebrate 17th annual blood collectors week from September 4-10, 2022 (4 Sept. 2022)
• White House asks for $47 billion for Ukraine, COVID-19, monkeypox and disasters (2 Sept. 2022)
• Blood Bank of Hawaii joins first-in-the-nation Blood Emergency Readiness Corps, to assist in blood transfusion access (2 Sept. 2022) | 1:02 min. video
• 'Broken glass being stabbed into my bones': Springfield IL reporter fights sickle cell (2 Sept. 2022)
• Blood is medicine: Raising awareness to inspire action (2 Sept. 2022) | ImpactLife campaign celebrates the role of blood donors in supporting pediatric cancer patients
• US FDA approval tracker: August 2022 (1 Sept. 2022) | Details all FDA approvals in August
• CDC: CDC clears reformulated Covid shots targeting omicron in time for school (1 Sept. 2022)
• AABB urges federal action to alleviate laboratory workforce challenges (31 Aug. 2022) | AABB believes that adding a nursing degree without additional laboratory training or education to the testing personnel qualifications for high-complexity testing is not the right approach.
• White House to boost monkeypox vaccination through large LGBTQ events (30 Aug. 2022)
• Fact Sheet: White House monkeypox response team announces new plans to support large LGBTQI+ events and equity interventions to reach communities at highest risk of contracting the virus (30 Aug. 2022)
• Monkeypox tracker: Texas reports first U.S. death tied to the virus (30 Aug. 2022)
• FDA: FDA partially clears Curis leukema trial in second August regulatory win - updated (30 Aug. 2022)
• FDA: Important information for human cell, tissue, and cellular and tissue-based product (HCT/P) establishments regarding monkeypox virus and HCT/P donation (29 Aug. 2022)
• Industry news: FDA approves Incyte’s Pemazyre for treating myeloid/lymphoid neoplasms (29 Aug. 2022)
• Federal government to halt free COVID-19 at-home tests by early September (27 Aug. 2022)
• Codagenix attracts DOD funding for synthetic biology approach to dengue vaccine (25 Aug. 2022)
• Oconee Memorial Hospital saves newborn with first-time procedure (25 Aug. 2022) | As a rural hospital, they haven't had the capabilities to do neonatal blood transfusions. But they had a video call to doctors at the Greenville hospital, who guided them through it.
• Industry news: AbbVie, J&J's Imbruvica wins first pediatric nod, this one for chronic graft-versus-host disease (25 Aug. 2022)
• AABB: AABB reminds blood collection facilities to report reactive donations to its WNV network to advance transfusion safety (24 Aug. 2022)
• ‘I think your tiny twin saved her sister’s life.’ Mom shares twins’ miracle survival through twin to twin transfusion syndrome (24 Aug. 2022)
• Wyoming confirms 1st monkeypox case; outbreak reaches all 50 states (23 Aug. 2022)
• AMA develops toolkit to help providers improve infectious disease screening (23 Aug. 2022)
• Americans take part in world blood donation record attempt to save lives (23 Aug. 2022) 
• Industry news: Elotuzumab triplet improves overall survival in relapsed/refractory multiple myeloma (22 Aug. 2022) | Related:
  • Dimopoulos MA, Dytfeld D, Grosicki S, et al. Elotuzumab plus pomalidomide and dexamethasone for relapsed/refractory multiple myeloma: Final overall survival analysis from the randomized phase II ELOQUENT-3 Trial. J Clin Oncol. 2022 Aug 12:JCO2102815. Epub ahead of print. (Free full text) | PubMed abstract
• FDA: FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 to 17 (20 Aug. 2022)
• Fact Sheet - White House announces new actions to combat monkeypox outbreak (18 Aug. 2022)
• FDA approves Zynteglo for patients with beta-thalassemia needing regular blood transfusions (18 Aug. 2022) | Related:
  • FDA approves first cell-based gene therapy to treat adult and pediatric patients with beta-thalassemia who require regular blood transfusions (News release, 17 Aug. 2022) | Also see General news above ($2.8m gene therapy treatment...)
• CDC: CDC director orders agency overhaul, admitting flawed Covid-19 response (17 Aug. 2022)
• HHS: HHS says it plans to extend Covid-19 public health emergency (17 Aug. 2022)
• FDA approves beti-cel for ß-thalassemia requiring transfusions (17 Aug. 2022)
• CDC: Pets suspected of having monkeypox should be isolated, CDC says (17 Aug. 2022)
• Biden administration will stop buying Covid-19 vaccines, treatments and tests as early as this fall, Dr. Jha says (16 Aug. 2022)
• FDA: Genentech lymphoma treatment gets FDA approval (16 Aug. 2022)
• National blood shortages beginning to affect some local healthcare providers (15 Aug. 2022)
• Health First is 1st in Florida to offer whole blood on air ambulances (15 Aug. 2022)
• FDA: Information for blood establishments regarding the monkeypox virus and blood donation (12 Aug. 2022)
• CDC takes back control of pandemic hospitalization data despite criticism (12 Aug. 2022)
• Industry news: Graphite Bio doses first subject in Phase I/II sickle cell disease trial (12 Aug. 2022)
• CDC: CDC loosens COVID-19 guidance, regardless of vaccination (11 Aug. 2022)
• FDA: At-home COVID-19 antigen tests-take steps to reduce your risk of false negative: FDA Safety Communication (11 Aug. 2022)
• Industry news: Regen BioPharma develops new approach for boosting CAR-T cell efficiency to treat solid tumors (11 Aug. 2022)
• FDA: FDA announces enforcement discretion to expand monkeypox testing (10 Aug. 2022)
• Industry news: U.S. government places $26 million order for Siga’s monkeypox drug (10 Aug. 2022)
• Less than a third of insured hepatitis C patients get timely treatment, study shows (9 Aug. 2022) | Related:
  • Thompson WW, Symum H, Sandul A, et al. Vital Signs: Hepatitis C Treatment Among Insured Adults ­ United States, 2019–2020. MMWR Morb Mortal Wkly Rep 2022;71:1011-17. (Free full text) | PubMed abstract
• COVID sewage surveillance labs join the hunt for monkeypox (8 Aug. 2022)
• Nebraska Community Blood Bank declares blood emergency (8 Aug. 2022)
• FDA: New Acalabrutinib Tablet formulation approved for current indications, including CLL, SLL, and MCL (5 Aug. 2022)
• Valkyrie training for Navy Hospital Corpsmen part of 2nd Battalion, 24th Marines’ time at Fort McCoy (5 Aug. 2022)
• CDC: CDC expected to ease Covid-19 recommendations, including for schools, as soon as this week (4 Aug. 2022)
• U.S. declares monkeypox a public health emergency (4 Aug. 2022)
• HHS: HHS announces new campaign to increase U.S. blood and plasma donations (4 Aug. 2022)
• Red Cross beginning to screen blood donors for monkeypox (3 Aug. 2022) | Related:
  • Adler H, Gould S, Hine P, et al.;England High Consequence Infectious Diseases (Airborne) Network. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022 Aug;22(8):1153-1162. Epub 2022 May 24. Erratum in: Lancet Infect Dis. 2022 Jul;22(7):e177. (Open access) | PubMed abstract
  • Thornhill JP, Barkati S, Walmsley S, et al.; SHARE-net Clinical Group. Monkeypox virus infection in humans across 16 countries - April-June 2022. N Engl J Med. 2022 Jul 21. Epub ahead of print. (Free full text) | PubMed abstract
• Industry news: Poseida Therapeutics and Roche to focus on therapies for hematologic malignancies (3 Aug. 2022)
• CDC: CDC releases monkeypox isolation guidance as cases near 6,000: 4 updates (2 Aug. 2022) | Related:
  • Isolation and Prevention Practices (2 Aug. 2022)
• FedEx: Why we give to the Red Cross (2 Aug. 2022)
• Assimilation, depression associated with sleep duration among Mexican Americans (1 Aug. 2022) | Related
  • Ormiston CK, Lopez D, Ishino FAM, et al. Acculturation and depression are associated with short and long sleep duration among Mexican Americans in NHANES 2005-2018. Prev Med Rep. 2022 Jul 21;29:101918. (Open access) | PubMed abstract
• California and Illinois declare monkeypox emergencies (1 Aug. 2022)
• FDA: OptraSCAN’s OS-Ultra scanners receive CE-IVDR mark (1 Aug. 2022)
• Industry news: Rebinyn for routine prophylaxis to prevent bleeding in patients with hemophilia B (1 Aug. 2022)
• New York becomes second major US city to declare health emergency over monkeypox (30 July 2022)
• Versiti and Amazon to host blood drive, Aug 1-10 (30 July 2022)
• FDA finalizes guidance on including patients with incurable cancers in oncology trials (29 July 2022)
• Blood donors Aug. 1-31 get a chance to win gas for a year, a $6,000 value (29 July 2022)
• Industry news: Mission Bio launches new cancer assay (28 July 2022)
• CDC: CDC set to make monkeypox a nationally notifiable condition (27 July 2022)
• Blood drive to be held in honor of Lawrence fifth-grader; regional blood shortage persists (27 July 2022)
• ICER releases final evidence report on beti-cel to treat beta thalassemia (27 July 2022) | Related:
  • Betibeglogene autotemcel for beta thalassemia: effectiveness and value. Final Evidence Report (19 July 2022)
• Mercy Flight will now carry type O blood, perform transfusions in transit (27 July 2022)
• A mother and her baby meet the blood donors that saved their lives (26 July 2022)
• FDA: Beckman Coulter teams with Scopio Labs over blood smear apps (25 July 2022)
• Industry news: $9.9M deal to end class action vs CSL Plasma over donor fingerprint scans; $433 each for donors, $3.5M for lawyers (22 July 2022)
• Critics worry government surveillance of HIV may hurt more than It helps (20 July 2022)
• Secure Transfusion Solutions announces company name change and opening of its third Trusting Heart Blood Center in Beaverton, Oregon (20 July 2022)
• FDA: Thousands more now eligible to donate blood after FDA rule change on CJD (19 July 2022)
• Urbana City Council worries whether plasma businesses are predatory. Transfusion physician and local plasma donors do not (19 July 2022)
• HealthTrackRx partners with the CDC to study monkeypox in the U.S. (18 July 2022)
• ARC hosts 9th annual Super Sam blood drive this week (18 July 2022)
• FDA: Therapeutic Solutions International granted emergency IND by FDA for expanded patient access to JadiCell™ universal donor stem cell for COVID-19 ARDS outside of ongoing phase III clinical trial (18 July 2022)
• FDA: Werfen receives US FDA 510(K) clearance for ROTEM sigma thromboelastometry system (18 July 2022)
• How drones will transform battlefield medicine, save lives (17 July 2022)
• Covid-19 public health emergency extended in the US (15 July 2022)
• The omicron subvariant BA.5 is dominating U.S. COVID-19 cases is more vaccine-resistant (15 July 2022)
• More than 1 in 2 Americans now live in an area where CDC urges indoor masking to curb COVID-19 surges (14 July 2022)
• Quest launches monkeypox PCR test as U.S. attempts to catch up with rising cases (13 July 2022)
• Eureka blood bank facing shortage, calls for donors (13 July 2022)
• Blood transfusions saved the life of a local toddler battling cancer (13 July 2022)
• Clea Shearer says L.A. trip took 'scary turn' after she ended up in the emergency room (13 July 2022) | "Very thankful for the ER nurses and doctors who endure SO MUCH," she wrote. "Being there all night, we saw and heard things I will never forget…. Screaming, fighting, police having to guard rooms - and the entire team is utterly unflappable while they do their jobs saving everyone's life."
• Industry news: Three-gene signature predicts selinexor response in patients with multiple myeloma (13 July 2022) | Related:
  • Restrepo P, Bhalla S, Ghodke-Puranik Y, et al. Three-gene signature predicts response to Selinexor in multiple myeloma. JCO Precis Oncol. 2022 Jun;6:e2200147.
• Air Evac ambulances now carrying red blood cells and plasma to treat patients in flight (12 July 2022)
• Biden administration discussing Covid boosters for everyone (11 July 2022)
• FDA: Biosystems granted FDA Breakthrough Device Designation for Lyme disease test (11 July 2022)
• Parents credit blood donations for saving 7-year-old’s life following cancer diagnosis (7 July 2022)
• FDA: Repeat dosing of Evusheld recommended for ongoing COVID-19 protection (6 July 2022) | Related:
  • FDA authorizes revisions to Evusheld dosing. (News release, 29 June 2022)
• Covid-19 reinfections may increase the likelihood of new health problems (5 July 2022) | Related:
  • Al-Aly Z, Bowe B, Xie Y. Outcomes of SARS-CoV-2 reinfection. Natureportfolio preprint. Epub 17 Jun 2022. (Free full text)
• Fort Hunter Liggett first in army to receive prehospital whole blood transfusion capability (5 July 2022)
• U.S. maternal deaths spiked upwards during pandemic (4 July 2022) | Related:
  • Thoma ME, Declercq ER. All-cause maternal mortality in the US before vs during the COVID-19 pandemic. (Research letter) JAMA Netw Open. 2022 Jun 1;5(6):e2219133. Epub 28 June 2022 (Open access)
• CDC: Rate of sickle cell disease-related death appears higher during the COVID-19 pandemic | Related:
  • Payne AB, Schieve LA, Abe K, et al. COVID-19 and sickle cell disease-related deaths reported in the United States. Public Health Rep. 2022 Mar-Apr;137(2):234-8. Epub 2022 Jan 21. (Free full text) | PubMed abstract
• CDC: Children <12 need not repeat HIV, Hep B/C tests before transplant surgery (1 July 2022) | Related:
  • Free RJ, Levi ME, Bowman JS, et al. Updated U.S. Public Health Service Guideline for Testing of Transplant Candidates Aged <12 Years for Infection with HIV, Hepatitis B Virus, and Hepatitis C Virus - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):844-6. (Free full text) | PubMed abstract
• Life-saving program provides pre-hospital blood transfusions to multiple patients (30 June 2022)
• FDA: Coronavirus (COVID-19) update: FDA recommends inclusion of omicron BA.4/5 component for COVID-19 vaccine booster doses (30 June 2022)
• Could your dog be a blood donor superhero? (30 June 2022) | The DoveLewis Blood Bank is in critical need of canine blood donors to provide life-saving donations for other pets in need. Learn how local dog owners can help.
• FDA: FDA grants breakthrough therapy designation to talquetamab for relapsed/refractory myeloma (29 June 2022)
• U.S. begins targeted vaccine rollout against monkeypox (28 June 2022)
• Regulatory affairs: Tick-borne diseases working group announces July meeting (28 June 2022)
• Senate Democrats ask FDA for update on MSM blood donation deferral policy (28 June 2022) | Related:
  • Baldwin, Gillibrand, Warren lead 23 colleagues in pushing FDA for an update on changes to discriminatory blood donation policies (24 June 2022)
• Vitalant experiencing critical blood shortage ahead of July 4th (27 June 2022)
• Industry news: Cepheid, BioGX partner on PCR tests as monkeypox spreads (27 June 2022)
• FDA: FDA updates 2022 CBER guidance agenda (24 June 2022)
• CDC identifies adenovirus infections in 45% of acute hepatitis cases in children (24 June 2022) | Related:
  • Cates J, Baker JM, Almendares O, et al; Hepatitis of Unknown Etiology Group. Interim analysis of acute hepatitis of unknown etiology in children aged <10 years - United States, October 2021-June 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):852-8. (Free full text) | PubMed abstract
• Industry news: Genentech releases positive data from broad blood cancer portfolio (24 June 2022)
• Las Cruces boy finds bone marrow match in sister. Here is their transplant story (24 June 2022)
• FDA: Regulatory update: Blood community sends joint letter to FDA on HBsAg testing requirements (22 June 2022) | Related:
  • The letter from AABB, ABC, ARC (21 June 2022)
• FDA: FDA opens way to COVID vaccines for kids under 5, CDC up next (17 June 2022)
• FDA: CareDx awarded CE mark for AlloSeq HCT in hematopoietic cell transplantation (17 June 2022)
• Industry news: Long-term treatment with Enjaymo safe and effective, trial data show (17 June 2022)
• Former FDA officials call for more transparency for drug approvals (15 June 2022)
• Regulatory update: Regulatory update:FDA’s CBER plans to resume normal operations in 2023 (15 June 2022)
• FDA: Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies [Draft Guidance for Industry, June 2022]
• Industry news: FDA grants fast track designation to Veralox Therapeutics' VLX-1005 for heparin-induced thrombocytopenia (13 June 2022)
• FDA: Israel's Scopio Labs gets US FDA clearance blood smear device (12 June 2022)
• US seeks to expand monkeypox testing as cases rise (10 June 2022)
• Industry news: bluebird bio soars as FDA Adcom recommends second gene therapy (10 June 2022)
• Industry news: FDA Advisory Committee unanimously supports beti-cel gene therapy for people with beta-thalassemia who require regular red blood cell transfusions (10 June 2022)
• White House lays out plans for distributing vaccines to youngest children (9 June 2022)
• California clinical laboratory owners among 21 defendants indicted or criminally charged for COVID-19 test fraud and other schemes totaling $214 million (8 June 2022)
• Not your average blood drive: Giraffe to donate plasma at Columbus Zoo and Aquarium (8 June 2022)
• Industry news: Moderna eyes fall vaccine season for omicron booster after phase 2/3 success (8 June 2022)
• FDA: FDA advisers vote in favor of authorizing Novavax Covid vaccine (7 June 2022)
• FDA: Effects of the COVID-19 Public Health Emergency on Formal Meetings and User Fee Applications for Medical Devices-Questions and Answers (Revised); Withdrawal of Guidance (7 June 2022)
• Industry news: Pfizer to invest $120M, add jobs in Paxlovid production push (7 June 2022)
• FDA: FDA approves tisagenlecleucel for advanced follicular lymphoma (6 June 2022)
• Industry news: Bristol Myers Squibb withdraws supplemental biologics license application (sBLA) for Reblozyl® (luspatercept-aamt) for non-transfusion dependent (NTD) beta thalassemia (4 June 2022)
• FDA: FDA Grants Sanofi and Sobi factor VIII therapy breakthrough designation (3 June 2022)
• Industry news: Cepheid receives CE Mark for its Xpert Xpress CoV-2 Plus test (3 June 2022)
• Industry news: J&J, AbbVie cancer drug significantly slows progression of rare lymphoma: Study (3 June 2022)
• TMH’s helicopter service can now perform mid-air blood transfusions (3 June 2022)
• ‘Help one another’: Indy doctor, patient with sickle cell push for black blood donors (2 June 2022) | World Sickle Cell Day is June 19
• Why you should donate blood for mass shooting victims, even if they don’t benefit directly (2 June 2022)
• Industry news: Even at $2M+, ICER calls bluebird's potential gene therapy for blood disorder 'superior' to standard of care (2 June 2022)
• Industry news: California-based genomics startup (Ultima Genomics) secures $600 million in funding to deliver $100 whole human genome with its new high-throughput, low-cost sequencing platform (1 July 2022)
• Program allows blood recipients to thank their donors (1 June 2022)
• Plans underway to ramp up monkeypox testing if outbreak grows quickly (30 May 2022)
• CDC identifies 9 monkeypox cases in 7 states (27 May 2022)
• Seattle blood banks step in to help after Texas school shooting (26 May 2022)
• CDC plans to stop reporting suspected Covid cases to ease burden (26 May 2022)
• Industry news: J&J's multiple myeloma toolkit expands with bispecifics data (26 May 2022)
• Blood Emergency Readiness Corps activated to respond to the school shooting in south Texas (25 May 2022)
• Industry news: Pfizer to offer low-cost medicines, vaccines to poor nations (25 May 2022)
• Industry news: Lithuanian Northway Biotech (CDMO) to open facility in Boston (25 May 2022)
• One organization has already sent 25 units of blood to Uvalde. Here's how you can help (24 May 2022) | The death count is now 19 children & 2 adults & it may rise.
• FDA: Recommendations to reduce the possible risk of transmission of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease by blood and blood components (Final Guidance for Industry, May 2022: As of 24 May 2022)
• Regulatory update: AABB's Regulatory update: AABB's TTD committee monitoring monkeypox outbreak (23 May 2022)
• CDC recommends Pfizer booster shot for kids ages 5 to 11 as Covid cases rise across the U.S. (19 May 2022)
• A third of people in US should consider masking based on their Covid-19 risk, CDC director says (18 May 2022)
• The Ray brothers: Kelly Ring talks with Florida family years after children's deaths from AIDS (18 May 2022)
• National Academies report cites ‘urgent’ need to recruit more diverse participants for clinical trials (17 May 2022) | Related:
  • Lack of equitable representation in clinical trials compounds disparities in health and will cost U.S. hundreds of billions of dollars; urgent actions needed by NIH, FDA, others to boost representation (17 May 2022)
• As Red Cross moves to pricey blood treatment method, hospitals call for more choice (17 May 2022)
• Industry news: Indian drugmaker seeks to toss 'bloated' billion-dollar lawsuit over Covid vaccine candidate (16 May 2022) | Indian firm is Emcure Pharmaceuticals & U.S. firm suing them is HDT Bio
• The AP Interview: US 'vulnerable' to COVID without new shots (12 May 2022)
• Tampa Bay cancer patient in critical need of transfusion during historic shortage (12 May 2022)
• Industry news: Hologic secures US FDA approval for Aptima CMV Quant assay (11 May 2022)
• FDA outlines benefit-risk approach to drug or biologic product quality assessment (10 May 2022) | Related:
  • FDA Guidance Document: Benefit-Risk Considerations for Product Quality Assessments (May 2022)
• Industry news: CSL, plasma companies win reversal on Border Patrol blockade of visas for paid collections (10 May 2022)
• Connecticut and Rhode Island Blood Centers announce blood emergency (9 May 2022)
• First patient receives whole blood from PA ground-based EMS unit (9 May 2022)
• Coronavirus wave this fall and winter could potentially infect 100 million Americans, White House warns (7 May 2022)
• Wife, 75, died in 2020 while sitting in 110F car outside Nevada VA hospital waiting for her husband to finish blood transfusion alone due to COVID rules, says coroner (7 May 2022)
• CDC still unsure on cause of hepatitis cases in children, issues new guidance for adenovirus testing (6 May 2022)
• FDA limits use of Johnson & Johnson COVID-19 vaccine (6 May 2022)
• Covid's toll in the U.S. reaches a once unfathomable number: 1 million deaths (4 May 2022)
• Diseases in the news: CDC issues treatment recs for suspected bird flu cases (2 May 2022) Related:
  • CDC: U.S. case of human avian influenza A(H5) virus reported (28 Apr. 2022)
• Industry news: Gilead snaps up rights to promising Dragonfly NK engager program (2 May 2022)
• COVID-19 admissions jumped 18% last week: 9 CDC findings (2 May 2022)
• Pleasanton man donates blood one year after farming accident nearly took his life (30 Apr. 2022)
• Dayton's CBC joins ‘Blood Emergency Readiness Corps’ to help supply blood outside the region (27 Apr. 2022)
• Nearly 60% of Americans now have antibodies from Covid-19 infection, CDC study finds (26 Apr. 2022)
• Industry news: Pfizer, BioNTech seek U.S. authorization of COVID-19 booster shot for younger kids (26 Apr. 2022)
• Blood transfusions at emergency scenes could save lives (26 Apr. 2022) | Palm Beach County Fire-Rescue is now training some of its firefighter-paramedics on how to do blood transfusions in the field.
• Penn State researchers receive more than $3 million to develop new-look artificial heart (25 Apr. 2022)
• Former soldier stresses importance of blood donations (25 Apr. 2022)
• Give blood, get chance to win camper (25 Apr. 2022)
• Giving a stranger a new life: One student's story about donating stem cells (24 Apr. 2022)
• COVID-19 again the 3rd-leading cause of U.S. deaths (23 Apr. 2022)
• Biden admin to promote availability of COVID antiviral pill (22 Apr. 2022)
• CDC issues health advisory about acute hepatitis in children (21 Apr. 2022)
• Walking blood banks: Why US children were tattooed with their blood type In the 1950s (21 Apr. 2022)
• DOJ to appeal travel mask mandate ruling after CDC says masks still needed on public transportation (20 Apr. 2022)
• CDC launches new center for forecasting and outbreak analytics (Press release, 19 Apr. 2022)
• Unvaccinated U.S. children hospitalized at twice the rate during Omicron surge, CDC study says (19 Apr. 2022)
• CAR T-cell therapy currently in UC Davis Health clinical trial study as potential cure for HIV (19 Apr. 2022)
• FDA: Illinois company receives untitled letter for marketing unapproved HCT/PS (19 Apr. 2022)
• COVID-19 cases to jump 94% by April 30 + 2 more forecasts (18 Apr. 2022)
• Iowa State blood stem cell research may help treat leukemia (18 Apr. 2022)
• Blood centers across America unite to provide blood supplies to Ukraine (18 Apr. 2022) | Related:
  • Blood supplies for Ukraine (Fresenius Kabi will match up to the equivalent of $250,000 in blood collection supplies)
• Iowa State blood stem cell research may help treat leukemia (18 Apr. 2022)
• Arkansas Blood Institute faces critical blood shortage (16 Apr. 2022)
• 11 highest paying plasma donation centers (15 Apr. 2022)
• COVID-19 update: FDA authorizes first COVID-19 diagnostic test using breath samples (14 Apr. 2019)
• Stephenson Cancer Center, OBI, Hospice Agencies partner on clinical trial studying home-based blood transfusions (14 Apr. 2022)
• Orphaned mountain lion receives blood transfusion (14 Apr. 2022) | 58 sec. video
• Pandemic cut US life span almost 2 years, more than any peer nation (13 Apr. 2022) | Related:
  • Woolf SH, Masters RK, Aron LY. Changes in life expectancy between 2019 and 2020 in the US and 21 peer countries. JAMA Netw Open. 2022 Apr 1;5(4):e227067. (Free full text) | PubMed abstract
• CDC extends transportation mask mandate until May 3 (13 Apr. 2022)
• Child tax credit payments helped parents avoid selling plasma, taking payday loans (13 Apr. 2022) | Related:
  • The impacts of the 2021 expanded child tax credit on family employment, nutrition, and financial well-being (13 Apr. 2022, Brookings Institute)
• FDA finalizes guidance for hepatitis B drug development (11 Apr.2022)
• Impact of U.S. COVID-19 vaccination efforts: An update on averted deaths, hospitalizations, and health care costs through March 2022 (8 Apr. 2022)
• LGBTQ advocates want blood donation restriction lifted (8 Apr. 2022)
• American Red Cross encourages blood donations during National Minority Health Month (7 Apr. 2022)
• Federal appeals court upholds Biden vaccine mandate for federal workers (7 Apr. 2022)
• AABB affirms support for California bill authorizing telehealth to meet blood bank staffing requirements (6 Apr. 2022)
• Industry news: bluebird bio maintains its focus on gene therapy opportunities during structural changes (6 Apr. 2022)
• FDA: Regulatory update: important information from FDA to consider when implementing a new arm scrub (5 Apr. 2022)
• FDA: CBER director Marks calls for new gene therapy development paradigm (5 Apr. 2022)
• Industry news: Imara left reassessing after sickle cell and beta-thalassemia trials disappoint (5 Apr. 2022)
• The Biden administration accelerates whole-of-government effort to prevent, detect, and treat long COVID (5 Apr. 2022)
• CDC, under fire for COVID response, announces plans to revamp agency (4 Apr. 2022)
• FDA advisers to discuss additional COVID vaccine shots, booster design (4 Apr. 2022)
• CDC - Omicron sub-variant BA.2 makes up 72% of COVID variants in U.S.(4 Apr. 2022)
• Firms urge DC Circuit to revive suit over ban on visas for noncitizens donating plasma for pay (1 Apr. 2022)
• Medical City Lewisville saves mother's life with 31-unit blood transfusion (1 Apr. 2022)
• They're the 2nd set of twins in the world with this blood disorder. They need a miracle. (1 Apr. 2022)
• FDA approves ViiV Healthcare's Triumeq PD for children with HIV (31 Mar. 2022)
• CDC: Universal HepB vaccination recommended for adults age 19 to 59 (31 Mar. 2022) | Related:
  • Weng MK, Doshani M, Khan MA, et al. Universal hepatitis B vaccination in adults aged 19­59 years: updated recommendations of the Advisory Committee on Immunization Practices ­ United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:477­83. (Free full text)
• Industry news: OctaPharma launches pilot to get paid in bitcoin for plasma donations (30 Mar. 2022)
• Industry news: CSL Behring's EtranaDez under review in Europe as 1st gene therapy for hem B (30 Mar. 2022)
• Covid-19 pandemic isn’t over for Black Americans, report warns (29 Mar. 2022) | Related:
  • 2022 Report: The state of black America and COVID-19 a two-year assessment
• Industry news: Companies want your plasma, and they’re willing to pay big bucks to get it (29 Mar. 2022)
• Industry news: Sana on track to remove barriers for cell & gene therapy (29 Mar. 2022)
• FDA and CDC authorize second COVID-19 booster shot for Americans 50 and older (29 Mar. 2022)
• FDA seeks $8.4 billion to further investments in critical public health modernization, core food and medical product safety programs (28 Mar. 2022)
• Biden seeks $81.7 billion funding for future pandemics as Covid aid stalls (28 Mar. 2022)
• Industry news: CytoImmune Therapeutics opens clinical cell manufacturing facility in Puerto Rico (28 Mar. 2022)
• Senators introduce healthcare Cybersecurity Act (28 Mar. 2022)
• FDA halts use of GlaxoSmithKline and Vir's COVID-19 drug Xevudy in 8 northeast states (28 Mar. 2022)
• 1.2 million initiated direct-acting antiviral treatment for HCV between 2014 and 2020:65% were baby boomers (27 Mar. 2022)
• Local blood center joins partnership (Blood Emergency Readiness Corps) to prepare for mass transfusion events (26 Mar. 2022)
• FDA postpones decision on luspatercept-aamt for anemia in adults with NTD beta thalassemia (25 Mar. 2022) | Related:
  • Bristol Myers Squibb announces new prescription drug user fee act goal date for Reblozyl® (luspatercept-aamt) supplemental biologics license application (25 Mar. 2022)
• CDC updates Covid-19 guidance to allow patients wear N95s (24 Mar. 2022)
• FDA: Label update for Cabotegravir and Rilpivirine long-acting HIV treatment (24 Mar. 2022)
• Washington State Attorney General sues stem cell clinic over misleading claims (22 Mar. 2022)
• Industry news: FDA clears ‘rapid’ Terumo BCT collection system, Rika, as demand for plasma-based therapies grows worldwide (22 Mar. 2022)
• Plasma Services Group recruits and pays donors for diagnostic research who are actively taking Coumadin (22 Mar. 2022)
• Diversity in the blood donor pool protects patients in need of rare blood (21 Mar. 2022)
• Versiti Blood Centers to enter blood donors in $100 gas card giveaway (21 Mar. 2022)
• FDA: Circular of Information for the Use of Human Blood and Blood Components (22 Mar. 2022) | Related:
  • FDA Guidance Document for Industry: An Acceptable Circular of Information for the Use of Human Blood and Blood Components (March 2022)
• Blood Shortages — How Can Hospitals Help? ( ABC Blood Bulletin 2022;22(1)1-2: March 2022)
• FDA: Use and store at-home COVID-19 tests properly to avoid potential harm: FDA Safety Communication (18 Mar. 2022)
• Layton canine blood bank calls for doggy donors amid shortage (18 Mar. 2022)
• Industry news: Horizon Technology Finance leads $15M venture loan facility to Secure Transfusion Services, Inc. (17 Mar. 2022)
• What is causing the national blood shortage? (16 Mar. 2022)
• FDA: Draft guidance addresses gene therapy product development (16 Mar. 2022)
• CDC: CDC confirms uptick in Covid virus found in wastewater (15 Mar. 2022)
• CDC: CDC: Omicron variant fueled rise in COVID-19 hospitalizations among young children (15 Mar. 2022)
• Blood community urges Assistant Secretary for Preparedness and Response (ASPR) to consider blood sustainability when developing national health security strategy (15 Mar. 2022)
• Industry news: Nutcracker snags $167M series C to develop 'push-button' RNA manufacturing, signs on former Gilead CFO (14 Mar. 2022)
• Industry news: Fresenius Kabi receives US FDA 510(k) clearance for wireless Agilia® Connect Infusion System with Vigilant® Software Suite-Vigilant® Master Med technology (14 Mar. 2022)
• Blood donations dropped when schools closed. Here’s what teens learn by giving a pint (11 Mar. 2022)
• Former CDC directors: Coordinating our nation's health data will save lives (10 Mar. 2022)
• Lab Advisory: HHS updates COVID-19 laboratory reporting guidance (10 Mar. 2022)
• Industry news: Intellia's CRISPR-engineered cell therapy secures FDA orphan drug status after AML trial launch (9 Mar. 2022)
• Harborview, Airlift Northwest study in-flight transfusion (9 Mar. 2022)
• FDA final guidance presses industry to be 'recall ready' (4 Mar. 2022)
• Healthcare agencies request data on COVID misinformation (4 Mar. 2022) | Related:
  • HHS: Call for stories and research on health misinformation (Reviewed 7 Mar. 2022)
• Industry news: New startup Andson Biotech makes developing gene therapies faster and easier (3 Mar. 2022)
• FDA grants orphan drug designation to Priothera's mocravimod for acute myeloid leukemia (3 Mar. 2022)
• Blood Emergency Readiness Corps expands to 30 blood centers (2 Mar. 2022)
• Alabama couple travels to Houston for treatment for 'twin to twin transfusion syndrome' (2 Mar. 2022) | 4:22 min. YouTube video
• FDA declines to approve Gilead's HIV drug on glass vial concerns (1 Mar. 2022)
• FDA: Guidance document - Considerations for the development of chimeric antigen receptor (CAR) T cell products (Mar. 2022)
• Pennsylvania woman donates plasma to pay for Disney World trips (28 Feb. 2022)
• A clinical trial aims to reduce complications in life-saving lung and heart treatment, ECMO (28 Feb. 2022)
• FDA authorizes revisions to Evusheld dosing (24 Feb. 2022)
• CDC changes guidance and advises longer interval between vaccine doses (23 Feb. 2022)
• The Lehigh Valley desperately needs blood donors, health officials say (21 Feb. 2022) | Related:
  • Staffing issues, too, hinder blood donation in the Lehigh Valley (2 Feb. 2022)
• New FDA chief says he will prioritize fighting misinformation (17 Feb. 2022)
• FDA approves treatment for anemia in adults with rare inherited disorder (PK deficiency) (17 Feb. 2022)
• Industry news: Reducing contamination during blood tests: Magnolia Medical lands $46M to fuel growth (16 Feb. 2022)
• CareFlight first and only air service in Ohio to carry whole blood on aircraft (15 Feb. 2022)
• Proposed Hawaii legislation would establish tax credits to encourage blood donation (11 Feb. 2022)
• FDA - CBER: International engagements to respond to Covid-19 pandemic (11 Feb. 2022)
• FDA: Coronavirus (COVID-19) update: FDA postpones Advisory Committee Meeting to discuss request for authorization of Pfizer-BioNTech COVID-19 vaccine for children 6 months through 4 years of age (11 Feb. 2022)
• Share the love - give blood (11 Feb. 2022) | Church of Jesus Christ of Latter-day Saints partners with blood center to hold blood drive
• CMS to cover blood-derived products for chronic, non-healing wounds(10 Feb. 2022) | Related:
  • CMS: National Coverage Determination (NCD) 270.3 Blood-Derived Products for Chronic, Non-Healing Wounds
• At-home COVID-19 test gets FDA warning: what to know (8 Feb. 2022) | Related:
  • Do not use E25Bio COVID-19 tests: FDA Safety Communication (4 Feb. 2022)
• Industry news: FDA approves Sanofi's Enjaymo for adults with rare type of anemia (4 Feb. 2022)
• Surgeon General reassures parents FDA won't cut corners on under-5 vaccine review (3 Feb. 2022)
• Industry news: Pfizer alleges stolen trade secrets at heart of Regor Therapeutics launch (3 Feb. 2022)
• ARC offers Amazon gift cards for donors to ease the pandemic-driven shortage:
  • Lake Forest residents can get paid if they give blood this month (3 Feb. 2022)
  • Get paid for giving blood in Laguna Niguel (3 Feb. 2022)
• Why the COVID death rate in the U.S. is so much higher than other wealthy nations (2 Feb. 2022)
• ‘At a breaking point’ | Virginia veterinary blood bank announces massive canine blood supply shortage (2 Feb. 2022)
• Proposed California legislation would establish $500 tax credit for blood donors (1 Feb. 2022) | Related:
  • Assemblymember Rodriguez introduces urgent legislation to immediately address critical blood supply shortage (27 Jan. 2022)
• AABB: Regulatory update: new AABB toolkit describes options for collections from female blood donors with hgb levels of 12 to <12.5 g/dl (1 Feb. 2022)
• Industry news: Takeda launches Oak Hill Bio to solve rare autoimmune diseases (1 Feb. 2022)
• Texas woman receives 2 lifesaving blood transfusions, encourages donations (30 Jan. 2022) | U.S. experiences a national blood shortage, the worst in decades
• US officials: Indications Russia has moved blood supplies to Ukraine border (29 Jan. 2022)
• The latest Covid variant is 1.5 times more contagious than omicron and already circulating in almost half of U.S. states (28 Jan. 2022)
• Millions of routine vaccinations have been missed amid the Covid-19 pandemic (28 Jan. 2022)
• AABB developed a fact sheet for clinicians considering the use of COVID-19 convalescent plasma re-FDA's revised EUA
• HIV killed Paul Michael Glaser’s wife and daughter. Now his son is fighting to end stigma around the virus (24 Jan. 2022)
• 15% of US hospitals critically understaffed, 24% anticipate shortages: Numbers by state (20 Jan. 2022)
• 80-year-old Morrison man gives his 233rd blood donation amid national shortage (20 Jan. 2022)
• City calling for San Antonio's youth to help raise dangerously low blood supply levels (14 Jan. 2022) | The blood bank says there has been a 60% drop in donations from donors aged 16 to 19, and a 30% drop in new donors altogether.
• How the national blood crisis is impacting patients who rely on blood transfusions (14 Jan. 2022)
• Red Cross declares first-ever national blood crisis (11 Jan. 2022)
• Henrico mom of 22-year-old battling cancer pleads for blood donations as shortage continues (10 Jan. 2022)
• Nearly a quarter of hospitals are reporting a critical staff shortage as Omicron drives a rise in Covid-19 cases (10 Jan. 2022)
• Chicago mother says blood donations, transfusions saved her during complicated birth (7 Jan. 2022)
• U.S. doctors group calls out CDC for ‘confusing’ isolation guidance (5 Jan. 2022)
• Industry news: Jury finds Theranos founder Elizabeth Holmes guilty on multiple charges in criminal fraud trial (3 Jan. 2022)
• States report record COVID-19 cases entering 2022 - 2.7 million new cases (1 Jan. 2022)

Vietnam

• International experts transfer advanced cell therapy technologies to Vietnam (26 Nov. 2022)
• Red Journey marks 10 years of blood donation (2 Aug. 2022)
• 2nd facility of HCMC Blood Transfusion Hematology Hospital inaugurated (20 May 2022)